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ABSTRACT
Cephalotaxine is a naturally occurring alkaloid which is the structural motif of a number of
compounds which have shown promising anti-cancer properties. This fact together with its
relatively complex pentacyclic structure, which incorporates an azaspirocycle annular to a
benzazepine moiety, has resulted in its popularity as a synthetic target.
The aim of this project was to synthesise the azaspirocycle of cephalotaxine using a Noyori
annulation method involving the reaction of an enamine and an a,a' -dibromo ketone in the
presence ofFez{CO)9' In the first attemptthe reaction ofl-benzyl-2-methylenepyrrolidine (117)
with methyl 2,4-dibromo-3-oxobutanoate (116) proved to be unsuccessful, the electron
withdrawing ester functionality of methyl 2,4-dibromo-3-oxobutanoate (116) being unable to
stabilise the intermediates formed during the reaction and thus resulting in its failure. Reaction
of l-benzyl-2-methylenepyrrolidine (117) and 2,4-dibromo-3-pentanone (114) resulted in the
formation of an azaspirocycle though in an extremely poor yield and the reaction was deemed
inefficient for the synthesis of the cephalotaxine spirocycle. Finally, reaction of2-(l-benzyl-2-
pyrrolidinylidene)acetonitrile (129) and 2,4-dibromo-3-pentanone (114) resulted in the successful
synthesis of a novel azaspirocycle. The product, l-benzyl-7,9-dimethyl-8-oxo-l-
azaspiro[4.4]nonane-6-carbonitrile (130), contained four stereogenic centres and one of the
diastereomers was successfully crystallised out. The X-ray structure in conjunction with
NOESY NMR experiments showed the relative stereochemistry to be 5s", 6s", 7s", 9s".
Significant progress was made in the application of this methodology to the construction of the
cephalotaxine pentacYclic skeleton with the synthesis of a novel lactam, 1-[2-(6-iodo-I,3-
benzodioxol-5-yl)ethyl]-2-pyrrolidinone, being achieved. In the course of this work a novel
compound, 2-(6-Iodo-1 ,3-benzodioxol-5-yl)ethyl 4-methylbenzenesulfonate (98), was also
synthesised and its X-ray structure revealed it to be conformationally interesting. As a result a
conformation analysis study was carried out on this compound as well as 2-(6-Iodo-I,3-
benzodioxol-5-yl)ethyI4-nitrobenzenesulfonate (lSa). The Noyori annulation reaction was not
implemented in the route to the basic pentacyclic structure of cephalotaxine due to time
constraints, however synthesis of analogues of cephalotaxine and other alkaloids possessing




1.1. BRIEF INTRODUCTION TO ALKALOIDS
Alkaloids are a unique class of natural products found predominantly in plants though they are
also present in animals, insects and marine organisms to a lesser extent. Most of us are familiar
with alkaloids such as caffeine, quinine, strychnine, morphine and nicotine. These compounds,
as well as many other alkaloids, are well known to be biologically-active and thus alkaloids have
become one of the classes of compounds used in the development of pharmacologically-active
compounds. Alkaloids always have at least one nitrogen atom present, usually as a primary,
secondary, or tertiary amine. The biological activity of many alkaloids stems from this amine
functionality which can be transformed into a quaternary system by protonation at pH's found
in the body. Defining an alkaloid precisely is no easy task and workers in the field have agreed
that the various proposed definitions are guidelines with numerous exceptions. I However, to
obtain an impression of an alkaloid one suggested "definition" is as follows: " An alkaloid is a
cyclic organic compound containing nitrogen in a negative oxidation state which is of limited
distribution among living organisms."l
Though drugs containing alkaloids have been used for about 4000 years,2 interest in alkaloids
themselves started from 1803 when a semipure alkaloid named narcotine was isolated from
opium.2 Synthetic organic chemists have also come to see alkaloids as challenging synthetic
targets with coniine being the first alkaloid synthesised in 1886. I With 40 % of plant families
having at least one species containing an alkaloid I there is still plenty ofopportunity for isolation
of unknown alkaloids and subsequent synthesis and investigation of their biological activity.
Alkaloids are sure to hold the attention ofnatural product chemists, pharmacologists, and organic
synthetic chemists for many years to come.
Our interest in alkaloids lies with one particular compound, cephalotaxine. This naturally
occurring alkaloid is stru.cturally interesting and certain esters ofthe compound have anti-cancer
properties which is why it has excited not only our interest but that of many others. A fuller
introduction to this compound will now be given.
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1.2. ISOLATION AND CHARACTERISATION OF CEPHALOTAXINE
In 1963 Paudler et al. investigated the alkaloids of the trees Cephalotaxus fortunei and
Cephalotaxus drupacae.3 Cephalotaxusfortunei is found only in North China and is commonly
called the Chinese plwn yew while Cephalotaxus drupacae, also known as the Japanese plum
yew, is found in both China and Japan. In their work Paudler et al. reported the isolation of the
major alkaloid in these trees.3 The alkaloidal material was first extracted from the powdered
leaves and stems of the plants using a standard acid-base extraction of the concentrated alcohol
extracts. Cephalotaxus fortunei was found to contain 0.39 % alkaloidal material and
Cephalotaxus drupacae 0.35 %. Of the four alkaloids present in Cephalotaxus fortunei, one
alkaloid constituted 50 % of the mixture. Similarly, 54 % of the alkaloidal material of
Cephalotaxus drupacae was a single alkaloid, five alkaloids being present in all. Comparison
of the major alkaloid of each tree indicated they were in fact the same, and this crystalline
compound was named cephalotaxine (1). Paudler et al. obtained a molecular formula,
ClsH21N04' and achieved a partial elucidation of the structure of cephalotaxine. The actual
structure was later determined by NMR,4 and X-ray diffraction of cephalotaxine methiodide. 5
These characterisations provided the relative configuration for cephalotaxine with an absolute
configuration being provided later by Arora et al. 6 who carried out an X-ray crystallographic
study of the p-bromobenzoate of cephalotaxine and showed that natural (- )-cephalotaxine has
a 38, 48, 5R configuration (Figure 1.1). The unique and challenging structure of cephalotaxine
(1), which contains two spiro-fused five-membered rings annular to a benzazepine moiety with
three stereogenic centres, has excited general interest in its laboratory synthesis. A further reason
for interest in its synthesis is that it provides access to related esters which have pharmacological
activity.
(1)
Figure 1.1. (- )-Cephalotaxine.
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1.3. USES OF CEPHALOTAXINE ESTERS
Harringtonine (2), isoharringtonine (3), homoharringtonine (4), and deoxyharringtonine (5)
(Figure 1.2) are esters of cephalotaxine which were first isolated from Cephalotaxus
harringtonia,4,7,8 and are now know to be present in other plants of the Cephalotaxus genus.9
Though cephalotaxine itself is pharmacologically inactive these esters show anti-tumor activity
with harringtonine (2), isoharringtonine (3), and homoharringtonine (4) having marginal activity
against L1210 leukemia in mice with more significant activity being shown against P388
leukemia. 10 Deoxyharringtonine (5) only shows activity against the latter type.
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Figure 1.2. Some esters ofcephalotaxine which exhibit anti-cancer properties.
3
More recently other minor ester-type Cephalotaxus alkaloids isolated from Cephalotaxus
harringtonia have shown activity against P388 leukemic cells as well. ll These esters,
neoharringtonine (6), homoneoharringtonine (7), and 3' S-hydroxyneoharringtonine (8), are also
shown in Figure 1.2. Interestingly, all the above-mentioned compounds exhibit the same R
stereochemistry at the 2' position in the ester side chain and furthermore (3) and (8) have identical
S stereochemistry at the seconday alcohol chiral centre 3'.
The anti-tumor activity ofthe cephalotaxine esters results from the inhibiting effect they have on
protein synthesis in eukaryotic cells. 12 They act by blocking peptide bond formation and
aminoacyl-tRNA binding. 13 Though all of the cephalotaxine esters shown in Figure 1.2 have
exhibited anti-cancer activity, most interest has been focussed on homoharringtonine (4).
Investigations into its biological activity have shown it to be active against a number ofdifferent
types of cancer such as mouse colon carcinoma; 14 breast, lung, ovarian, and cervical tumors to
varying degrees; 15 and acute nonlymphoblastic leukemia (a particularly promising study showed
a 25 % remission in patients with this disease). 16 The use ofhomoharringtonine in the treatment
of chloroquine-resistant malaria has even been investigated and has proved effective in initial
testing. 17 A study on the pharmacology of homoharringtonine concluded that it is rapidly
metabolised in the body with the resulting metabolites having very different pharmacokinetics
from homoharringtonine itself. 18 It seems to be mainly eliminated from the body by metabolism
or tissue sequestration as urinary excretions play only a small part in removal of
homoharringtonine from the body. Unfortunately phase II trials ofhomoharringtonine have not
produced encouraging results. In a trial which treated patients with a variety ofsolid tumors that
had been exposed previously to chemotherapy it was concluded that homoharringtonine given
by an intermittent schedule was inactive for these cases. 19 Another phase II trial dealing with
advanced acute nonlymphocytic leukemia (ANLL) stated that even though homoharringtonine
has an anti-leukemic effect it is not useful on its own in treating ANLL, as no patients treated
experienced remission.20 Recently, in 1999, a trial using homoharringtonine for the treatment
of patients with advanced large bowel cancer concluded that it had no activity again colorectal
carcinoma.21 This trial was actually terminated prior to completion because ofthe unacceptable
toxicity of homoharringtonine which was experienced. In fact, toxicity of homoharringtonine
is noted by almost all workers who carried out human trials. The major side effects are
cardiovascular with tachycardia, arrythmia and ECG changes being experienced by patients.22
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Other side effects noted in a phase I trial treating children with refractory leukemia included
nausea, vomiting, mucositis, diarrhoea, and skin rashes, with this study finding that the dose-
limiting toxic effect was pain.23 A phase I trial using adult patients noted the dose-limiting effect
was myelosuppression.24 Obviously the toxicity ofhomoharringtonine is the major obstacle to
it becoming widely used as' an anti-cancer agent. There is no doubt it has some anti-cancer
properties but, as the phase II trials indicate, these are not necessarily as effective as initially
hoped. Clearly structure-activity relationship (SAR) studies should be carried out on
homoharringtonine and the other cephalotaxine esters so even though they may not become
widely used as drugs themselves, other drugs may be developed based on their structures, with
these drugs having reduced toxicity and increased activity. So far what is known from SAR
studies is that a slight modification ofthe ester moiety significantly affects the anti-tumor activity
of the esters of cephalotaxine. 10 This is obviously not surprising as cephalotaxine itself is
inactive as was mentioned earlier. What is also known from SAR studies is that the presence of
the nitrogen lone pair is required for the anti-cancer properties to exist.25 Thus it appears that
more SAR studies will have to be carried out on the cephalotaxine esters in order to identify the
structural features directly responsible for the anti-cancer properties and the groups that cause
the toxicity.
1.4. SYNTHESES OF CEPHALOTAXINE
It should now be clear why cephalotaxine has become a well researched synthetic target. Not only
is it structurally challenging for the synthetic chemist but there is real value in finding an efficient
route to synthesise cephalotaxine as it provides direct access to its biologically active ester
derivates. As the Cephalotaxus trees are not widely available26 and the alkaloids are only minor
constituents ofthe trees/ it is not ecologically or financially viable to obtain cephalotaxine or its
ester derivatives from their natural sources. Thus a laboratory synthesis of cephalotaxine is
especially appealing to allow reasonable quantities ofthe cephalotaxine esters to be obtained for
further SAR studies. To date seven total syntheses of(±)-cephalotaxine have been published27•38
along with two papers on the total synthesis of(- )-cephalotaxine,39,40 one ofwhich also reported
the synthesis of (+)-cephalotaxine.4o In addition, five formal syntheses have been reported for
(±)-cephalotaxine41 -45 and one for (- )-cephalotaxine.46 The first synthesis was published in
1972
27
with the most recent appearing in 1999,46 indicating that an efficient synthetic route to
cephalotaxine is still of current interest. Following is a review of the different syntheses of
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cephalotaxine which analyses the approaches of other researchers and will serve as a reference
for a comparison with our proposed synthetic route. The work which we carried out revolved
around developing a novel method to form the azaspirocycle, thus in the syntheses reviewed here
it is mainly the method for constructing the cephalotaxine azaspirocycle that is summarised. The
azaspirocycle is the most challenging feature of the cephalotaxine structure, and general routes
for the formation of spirocycles are not widely found in the literature. In general a basic outline
ofthe method for each cephalotaxine synthesis is given with detail being shown for the formation
of the azaspirocycle. Reference to the A, B, C, D, and E rings of cephalotaxine will often be
made and so the reader is referred back to Figure 1.1 which shows these ring labellings. The
syntheses have been divided into total and formal syntheses and are discussed in chronological
order though parallels are sometimes drawn between the approaches of different workers.
1.4.1. Total Syntheses of Cephalotaxine
Auerbach and Weinreb were the first workers to publish a total synthesis of (±)-cephalotaxine.
This synthesis appeared as a communication in October 197227 and was followed up with a full
paper in 1975.28 Their approach (Scheme 1.1) was linear with the synthesis starting with the A
and B rings of cephalotaxine intact and then the D, C and E rings were built on sequentially in
that order. This means the spirocycle was the last major feature built into the molecule and its
formation started once Auerbach and Weinreb had obtained enamine (10) in five steps from 3,4-
methylenedioxyphenylacetic acid (9). The enamine (10) was added to a mixture ofpyruvic acid
and ethyl chloroformate which formed a mixed anhydride that reacted with (10) to form the
diketone (11) in 73 % yield. The cyclisation to form the spirocycle was an intramolecular
Michael reaction using magnesium methoxide in methanol. The intermediate (12) was probably
formed during this reaction by the chelation of the enolate of (11) with magnesium methoxide.
The compound formed as a result ofthe Michael addition is known as demethylcephalotaxinone
(13) and is also a naturally-occurring Cephalotaxus alkaloid which was first isolated and
identified by Powell and Mikolajczak from Cephalotaxus harringtonia. 47
Demethylcephalotaxinone (13) was converted to cephalotaxinone (14) by methylation using 2,2-
dimethoxypropane and p-TsOH. Cephalotaxinone (14) is also a naturally-occurring
Cephalotaxus alkaloid~8 and was easily reduced to give (±)-cephalotaxine (1) which was obtained
in an overall yield of 8 % from 3,4-methylenedioxyphenylacetic acid (9). Even though this was
the first synthesis of cephalotaxine published it is one of the more elegant being carried out in
6












Scheme 1.1. (i) pyruvic acid, ethyl chlorofonnate, 0 °e, 73 %; (ii) MgOMe, MeOH, 58 %; (iii)
2,2-dimethoxypropane, p-TsOH, 45 %; (iv) NaBH4, 85 %.
Semmelhack et at. published their synthesis of (±)-cephalotaxine in November 1972 as a
communication,29 following closely on the heels of Auerbach and Weinreb.27 The full paper of
their work appeared alongside that of Auerbach and Weinrebs28 in 1975.30 In contrast to that of
Auerbach and Weinreb their synthesis featured a convergent strategy in which two major portions
of the molecule were prepared independently ofeach other before being brought together in the
final stages of the synthesis. The two key intennediates formed were p-nitrobenzenesulfonate
ester (15), containing the A and B rings ofcephalotaxine, and the spirocycle (16) which contains
the D and E rings. The two bicycle moieties were joined (Scheme 1.2) to form the four-ring
backbone (17) which was fmally cyclised and reduced to form (±)-cephalotaxine (1).
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Scheme 1.2. (i) Diisopropylethylamine, MeCN, 70 % (X = I) or 88 % (X= Cl).
Scheme 1.3 shows the synthesis ofthe spirocycle (16) which Sernmelhack et al. achieved in nine
steps from pyrrolidinone with a 22-23 % yield.30 The first step in the spirocycle formation was
the addition oftriethyloxoniurn fluoroborate to pyrrolidinone (18) in order to from the imidate







(n) •HNQ _on).!'NQ (lv).~ (v).
)\ )\ OOC CHO
R=-C02CMe3
(20) (21) (22)
(23) (24) (25) (26) (16)
Scheme 1.3. (i) triethyloxoniurn fluoroborate, 0 °C, 73 %; (ii) Mg, BrCH2CH=CH2, 78 %; (iii)
tert-butoxycarbonyl azide, MgO, I:!, 100 %; (iv) (a) 03' MeOH, -78°C, (b) Me2S; (v) Ag20, 13
% KOH; (vi) MeOH, H\ triethyl orthoformate; (vii) Na/K alloy, TMSCl; (viii) Br2, -78°C; (ix)
CH2N2,0°C.
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The diallyl derivative (20) was obtained by addition of the Grignard reagent allylmagnesium
bromide to imidate ester (19). In order to achieve the ring closure of the second five membered
ring in the spirocycle the two allyl groups were converted to methyl esters. However, before this
could be carried out the amine of the diallyl derivative (20) was protected using tert-
butoxycarbonyl azide. Without distillation or chromatography the protected amine (21) was
obtained quantitatively in what was considered to be sufficient purity. Conversion ofcarbamate
(21) to the required diester (24) was carried out in three steps without isolation of the
intermediates. Ozonolysis of carbamate (21) followed by the addition of Me2S resulted in the
formation of the dialdehyde (22) which was oxidised to the diacid (23) by addition of Ag20 in
the presence of an aqueous KOH solution. In order to obtain the diester (24) a Fisher
esterification was used with the conditions of this reaction also resulting in the removal of the
tert-butoxycarbonyl protecting group. The three-step conversion of the protected
diallylpyrrolidine (21) to the diester (24) was achieved in a 61 % overall yield. The final three
steps of the synthesis to form the desired azaspirocycle (16) were again carried out without
isolation of the intermediates because of the tendency of these compounds to decompose. In an
acyloin condensation reaction the diester (24) was reacted with a 1:5 sodium-potassium alloy and
TMSCI to effect the ring closure ofthe second five-membered ring. The structure ofthe silylated
spirocycle (25) was not assigned with complete confidence as only a crude sample was analysed
due to the decomposition of the compound during attempted purification by distillation. The
silylated compound was oxidised with a solution of bromine in dichloromethane to give the
diketone (26) which was finally selectively methylated with diazomethane to give the required
azaspirocycle (16). The conversion ofthe diester (24) to the azaspirocycle (16) was achieved in
a 66 % yield. For further reactions involving the azaspirocycle (16) the crude product was used
because large amounts were lost during purification steps as the compound was found to be fairly
unstable. The synthesis ofcephalotaxine by Semmelhack et al. was fairly lengthy in contrast to
that ofAuerbach and Weinreb.27,28 However, the overall yield achieved by Semmelhack's group
was 16 % from 3,4-methylenedioxyphenylacetic acid which was an improvement on that of
Auerbach and Weinreb's 8 %.
Hanaoka and co-workers synthesised (±)-cephalotaxine in 12 steps with an overall yield of6 %.31
Starting with the condensation of 3,4-dimethoxyphenylacetyl chloride (27) and ethyl prolinate
(28) the amide (29) was formed to join the B and D rings of cephalotaxine (Scheme 1.4). A
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further two steps facilitated the closure of the C ring to form tricycle (30). At this point the
spirocycle formation was carried out starting with the addition of2,3-dichloropropene and NaB
in DMF to tricycle (30) giving the allyl vinyl ether (31) in a 91 % yield. Heating ofthe allyl vinyl
ether (31) to 150 °C induced a Claisen rearrangement which formed tricycle (32). A quantitative
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Scheme 1.4. (i) 89 %; (ii) 2,3-dichloropropene, NaB, 91 %; (iii) 150°C, 97 %; (iv) NaBH
4
, 100
%; (v) 90 % H2S04, ~, 69 %; (vi) BBr3, -78°C, 79 %; (vii) CH2Br2, KF, 33 %.
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Before the functionalisation ofthe spirocycle was carried out the A ring was fonned in two steps.
This was accomplished by demethylation of the dimethoxy unit with boron tribromide to give
the diol which was then reacted with CH2Br2 to close the A ring giving the 3,4-methylenedioxy
derivative (35). The final three steps of the synthesis resulted in the correct functionalisation of
the E ring to give (±)-cephalotaxine (1) as required. In this synthesis the spirocycle moiety was
created efficiently and with good yields, thus it was unfortunate that the overall yield of (±)-
cephalotaxine was reduced by low yields for the fonnation of the A ring. The A ring fonnation
took two steps with the first step having a yield of 79 % and the second step a yield of only 33
% - the lowest yield of all 12 steps in this synthesis! Hanaoka and co-workers did not give a
reason why it was necessary to build the A ring during the synthesis rather that have it intact from
the beginning as in other syntheses of cephalotaxine. They may have experienced a situation
similar to that ofIsono and Mori in their synthesis of (- )-cephalotaxine39 (reviewed later) where
they found that the presence ofthe methylenedioxy A ring inhibited the cyclisation ofthe seven-
membered C ring. As a result the A ring fonnation was carried out in the later stages of the
cephalotaxine synthesis after the seven-membered ring had been successfully fonned.
In 1988 Kuehne and co-workers published a synthesis of (±)-cephalotaxine which they carried
out in twelve steps from 3,4-(methylenedioxy)nitrostyrene.32 The spirocycle fonnation in this
synthesis followed a notably different approach from that ofthe other groups reviewed up to this
point. Their spirocycle synthesis started with a cyclopentane ring fused to a o-lactam. Their
intention was that this system could be rearranged to the desired spirocycle as they expected that
a y-Iactam would be favoured over a o-lactam should these two be in a situation where they were
in equilibrium, as this is found to be the case for lactones. The overall cephalotaxine synthesis
ofKuehne and co-workers (Scheme 1.5) started with the amine (36) which had been fonned from
the corresponding nitrostyrene. This amine (36) was reacted with the cyclopentanone derivative
(37) (previously obtained from the alkylation of the pyrrolidine enamine of cyclopentanone) to
fonn the imine (38). Heating under vacuum effected the cyclisation of the imine (38) to the
desired lactam (39) and its unwanted double-bond isomer (40). Separation of the two isomers
was carried out and it was found that under mild conditions the purified compounds isomerised
to a 6:4 mixture of (~9) and (40) respectively. Thus to improve yields of lactam (39) the





















































Scheme 1.5. (i)p-TsOH; (ii) 8., vacuum, 96 % from (36); (iii) Pb(OAc)4'8.; (iv) NaOMe, MeOH,
78-94 % from (39).
To carry out the rearrangement to form the spirocycle the lactam (39) was reacted with Pb(OAc)4
and the desired spirocycle (44) was obtained along with the diacetate (43). This mixture was
converted entirely to (44) on stirring with NaOMe in MeOH resulting in a 89 % yield from (39).
It was thought that the spirocycle formation might follow a pathway in which a bridging acetal
carbocation (41) was formed initially from (39) with this resulting in the generation ofeither the
iminium ion (41a) or the carbocation (41b). A rearrangement of the C-C bond in the iminium
ion intermediate (41a) would effect the contraction of the o-lactam to the y-lactam (42) while a
N-C bond shift in (41b) would give the same product (42). Evidence for the existence of both
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pathways was obtained when a deuterium analogue of (39) (substituted at C-7) was used in the
reaction with Pb(OAc)4' The authors also felt that radical equivalents of the intennediates (41),
(41a), (41b), and (42) were feasible as oxidations with Pb(OAc)4 at elevated temperatures are
recognised as homolytic processes. The remainder of the synthesis of Kuehne and co-workers
resulted in the closing of the seven-membered C ring to give pentacycle (45) and the correct
functionalisation of the E ring to afford (±)-cephalotaxine in a 33 % overall yield from 3,4-
(methylenedioxy)nitrostyrene without double-bond isomerisation of the unwanted lactam (40)
or a 53 % yield with the double-bond isomerisation carried out. In comparison with the yields
of other syntheses of (±)-cephalotaxine the yield of Kuehne and co-workers is excellent.
Burkholder and Fuchs published a communication oftheir (±)-cephalotaxine synthesis in 198833
followed by the corresponding full paper in 1990.34 Their synthesis was comparatively lengthy,
requiring 18 steps to achieve the target molecule. It began with the A and B rings of
cephalotaxine intact in the fonn of piperonal alcohol (46) (Scheme 1.6). In six steps this was
converted to the lithiated compound (47) which underwent a conjugate addition to vinyl sulfone
(48). The a-sulfone anion intennediate that was fonned was trapped with allyl bromide to give
allyl sulfone (49) which now also contained the cephalotaxine E ring. A further three steps
provided the correct functionalisation for the molecule to undergo an intramolecular Diels-Alder
reaction which resulted in the fonnation of the seven-membered ring and provided the basis of
the spirocycle. Thus the hydroxamic acid (50) was reacted with tetra-n-butyl ammonium
periodate at -78 DC giving the acyl nitroso intennediate (51) which was allowed to warm to
room temperature over seven hours affording two Diels-Alder products (52a) and (52b).
Because the diene could attack from either face of the phenyl ring it resulted in two lactam
isomers (52a) and (52b) being fonned. With the seven-membered ring fonned the spirocycle
was obtained in three further steps without isolation ofthe intennediates or separation ofisomers.
The reductive cleavage of the N-O bond of both lactam isomers (52a) and (52b) afforded the
corresponding allylic alcohols which could be separated but were rather carried through the next
two steps where they were reacted with MsCI to give the corresponding mesylates and
subsequently reacted with NaH to effect the ring closure to afford spirocycles (53a) and (53b).
At this point (53a) and (53b) were separated and treated individually, both isomers ultimately
leading to demethylcephalotaxinone (13), which was converted in a further two steps to the












































Scheme 1.6. (i) (a) -78°C, (b) CH2=CHCH2Br, 77 %; (ii) tetra-n-butyl ammonium periodate,
-78°C to RT, 71 %; (iii) (a) 6 % Na(Hg), EtOH, (b) MsCl, Et3N, 0 DC; (c) NaH, 23 % (53a),
45 % (53b).
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Ikeda and co-workers achieved the synthesis of (±)-cephalotaxine in 17 steps from 3,4-
(methylenedioxy)nitrostyrene, the overall yield being 21 %.35,36 Scheme 1.7 shows how the
spirocycle formation was achieved in only three steps from the start ofthe synthesis which began
with the [3+2] cycioaddition of 3,4-(methylenedioxy)nitrostyrene (54) and 2-
(trimethylsilylmethyl)-2-propenyl acetate (55) to form the methylenecyclopentane (56), This was
then alkylated with methyl acrylate in a Michael addition reaction to give the ester (57).
Reduction of nitroester (57) with zinc in boiling ethanolic HCl resulted in a cyclisation reaction
to form the spirocycle moiety in the form ofthe lactam (58). At this point four of the five rings
of cephalotaxine were present with only the seven-membered C ring remaining to be formed.
It was the formation ofthe C ring which required more effort but was finally achieved in a further
nine steps by mean of a sulfur-assisted aromatic cyclisation giving pentacycle (59).
Desulfurisation of (59) followed by conversion of the acetyl group into a ketone gave the
ketolactam (35). This compound was an intermediate in the synthesis of Hanaoka and co-
workers31 and so following their procedure, Ikeda and co-workers achieved the conversion of














Scheme 1.7. (i) (i-Pr03)P, /)., 90 %; (ii) methyl acrylate, Triton B, t-BuOH, 100 %; (iii) (a) Zn,
EtOH, HCl, /)., (b) NaOH, /)., 81 %.
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Mariano and co-workers succeeded in making (±)-cephalotaxine by two different routes with
both leading. to the same intermediate which was then converted to (±)-cephalotaxine in six
steps.37,38 Their first route was quite lengthy and formed the spirocycle using a single electron
transfer (SET) promoted photocyclisation reaction. However, the spirocycle functionality was
later destroyed and reformed in the last six steps of the synthesis having made its original
formation unnecessary. This led to the development of the second, shorter route in which the
spirocycle formation was left to the end of the synthesis. Even though the second route was
shorter and more efficient both routes will be reviewed here as the SET promoted


















Scheme 1.8. (i) (-BuCOC1, AgCI04, 97 %; (ii) hv, MeCN, 46 % (64), 40 % (62); (iii) NaOMe,
MeOH,79%.
The first route (Scheme 1.8) began with 3,4-methylenedioxyphenyl alcohol (60) which was
converted to the diketone (61) in five steps to join the A and B rings to the E ring. The SET
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promoted cyclisation to form the spirocycle was based on methodology that Mariano's group had
previously developed49•50 and required the formation of a silylallyliminium salt. So in three
further steps the diketone (61) was converted to enaminone (62) which underwent 0-
pivaloylation to afford the desired silylallyliminium salt (63). The cyclisation was carried out
by irradiation of an acetonitrile solution of the salt (63) to give the spirocycle (64). Only about
50 % ofthe salt was converted as prolonged irradiation tended to lower the yield ofthe spirocycle
(64) as it was able to undergo a second photoreaction in its protonated form. Based on the
quantity of the salt converted the spirocycle (64) was obtained in a 46 % yield along with the
enaminone precursor (62) being obtained in a 40 % yield as a result ofdepivaloylation ofthe salt
(63). From mechanistic studies it appeared that the silylallyliminium salt forms a diradical
intermediate that can undergo either cyclisation followed by desilylation or desilylation followed
by cyclisation, both routes giving the desired spirocycle (64). With the spirocycle intact a further
five steps enabled the C ring of cephalotaxine to be formed creating the basic pentacyclic
structure. Unfortunately the next step destroyed this structure, notably the spirocycle moiety.
The original intention was to transform the pentacyclic ester (65) to the corresponding ketone and
then form the Auerbach and Weinreb intermediate, demethylcephalotaxinone (13), which can be
easily converted to cephalotaxine.27•28 Reduction of pentacyclic ester (65) with NaOMe in
MeOH gave the desired ketone (66). Unfortunately (66) was only the minor part of an
inseparable 10:1 mixture, the other major part consisting of the ring opened amino enone (67).
Spectroscopic data confrrmed the presence of both products with evidence indicating that (66)
and (67) interconvert rapidly, as neither reaction temperature nor chromatography altered the
10: 1 ratio. This situation did not fit in with the intended strategy to form











Mariano and co-workers suggested that this rapid equilibrium might also exist with
demethylcephalotaxinone, but here the equilibrium would favour the ring closed fonn. Scheme
1.9 shows this interconversion between demethylcephalotaxinone (13) and the ring opened
enedione (68). Here demethylcephalotaxinone (13) exists as the keto tautomer rather than as the
enol tautomer we have seen earlier. The strategy based on this hypothesis was to use the ring
opened enone (67), that was unintentionally fonned, and convert it to the enedione (68) which
would spontaneously cyclise to the desired demethylcephalotaxinone (13). This strategy
essentially meantthat many ofthe steps leading up to fonning enone (67) were unnecessary, most
especially the spirocycle fonnation. Thus a significantly shorter route to (67) was developed with









Scheme 1.10. (i) diisopropylethylamine, 64 % (reductive amination and cyclisation steps); (ii)
H2, Pel/C, 83 %; (iii) DMSO, trifluoroacetic anhydride, -78°C; (iv) trimethylsilyl
trifluoromethanesulfonate, 0 DC, 50 % [from (71)].
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The second route is shown in Scheme 1.10 and again started with the alcohol (60) which was
converted to the mesylate (69) in eight steps. Ring closure of (69) carried out by treatment with
diisopropylethylamine afforded the macrocycle (70) which gave the desired product (67) on
debenzylation. With enone (67) formed via a shorter route, the rest ofthe synthesis, which is also
shown in Scheme 1.10, could be attempted. The nitrogen atom of the amino enone (67) was
protected with a Boc group and the alcohol functionality incorporated to give the a-hydroxy
ketone (71) in two steps. This was oxidised to the diketone (72) which only required
deprotection of the amine to form the hypothesised ring-opened form of
demethylcephalotaxinone (68) which would presumably cyclise spontaneously to
demethylcephalotaxinone (13). This is the result that was obtained, thus proving the theory
proposed by Mariano and co-workers correct. Again the modified Auerbach and Weinreb
procedure was employed to convert demethylcephalotaxinone (13) to (±)-cephalotaxine.27.28 The
shorter of the two routes provided (±)-cephalotaxine in 16 steps with a 7 % overall yield from
the 3,4-methylenedioxyphenyl alcohol (60). It is interesting to note that Mariano's group was
dynamic and flexible in carrying out this work. The group started with a specific route in mind
which would make use of a SET promoted photocyclisation reaction developed in their
laboratory, but when this did not work as planned they capitalised by taking advantage of the
results they had obtained and completely abandoned the original route containing the novel
methodology to develop a new and quicker route to form their target molecule.
In 1995 Isono and Mori published the first synthesis of enantiomerically pure (-)-
cephalotaxine.39 As for the syntheses of many enantiomerically pure compounds their route
started with a substance from the chiral pool, in this case R-proline (73), which was converted
into the N-protected vinyl iodide (74) over six steps (Scheme 1.11). Removal of the Boc
protecting group followed by addition of 2-(3,4-dimethoxyphenyl)ethyl alcohol p-
nitrobenzenesulfonate ester afforded the bicycle (75) in an 88 % yield. To set the stage for the
spirocycle formation the ester functionality of (75) was reduced to give the aldehyde (76) with
the cyclisation of(76) being achieved by reaction with Me3SiSnBu3 and CsF giving two products
(77) and (78). The desired product was the alcohol (78) which was obtained in an 85 % yield,
while the undesired silyl ether (77) was only obtained in a 3 % yield and could be easily
converted to (78) by treatment with TBAF. With the B, D, and E rings intact, cyclisation to form
the C ring of cephalotaxine was achieved by reaction of the alcohol (78) with polyphosphoric
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acid. This reaction had been attempted with the methylenedioxy A ring already intact but was
unsuccessful, thus the A ring was formed after the seven-membered C ring in two steps using the
same procedure as Hanaoka and co-workers, )t This was followed by the conversion ofthe alkene
to a diol which was oxidised to give demethylcephalotaxinone (13). Reaction of (13) with 2,2-
dimethoxymethane in the presence ofp-TsOH gave the expected product ofcephalotaxinone (14)
though it was found to be racemic which, for the purposes of Isono and Mori, was undesirable.
The desired (- )-cephalotaxinone (14) was however obtained in a 47 % yield when (13) was
....reacted with methyl orthoformate and p-TsOH. Finally the reduction of (14) with NaBH4
afforded the enantiomerically pure product (- )-cephalotaxine (1) in an overall yield of 1.8 % in
16 steps from R-proline (73).51
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Scheme 1.11. (i) (a) CF)COOH, (b) 2-(3,4-dimethoxyphenyl)ethyl alcohol p_
nitrobenzenesulfonate ester, i-Pr2NEt, 88 %; (ii) (a) LiA1H4, (b) Et)N, SO)-pyridine, 81 % from
(75); (iii) Me)SiSnBu), CsF, 3 % (77),85 % (78); (iv) TBAF, 86 %; (v) polyphosphoric acid, 66
%; (vi) (MeO))CH,p-TsOH, 47 %; (vi) NaBH4, 95 %.
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Nagasaka et ai. also completed a synthesis of naturally occurring (- )-cephalotaxine as well as
its enantiomer, "(+)-cephalotaxine.40 Their synthesis of the two enantiomers was used to
demonstrate an application oftheir methodology for the synthesis and separation ofenantiomers
of l-azaspiro[4.4]nonane-2,6-dione (83). This spirocycle synthesis (Scheme 1.12) started with
the alkylation of cyclopentanone (80) which was achieved in two steps by conversion of
cyclopentanone (80) to the pyrrolidine enamine and then reaction with methyl acrylate to give
keto ester (37). Reaction of keto ester (37) with isopropenyl acetate afforded the enol acetate
(81) which was converted to the nitro ester (82) with a mixture oftrifluoroacetic anhydride and
NH4N03. Finally, reduction of the nitro ester (82) to give the racemic spirocycle (83) was
achieved with zinc in an acetic acid-ethanol mixture, the overall yield from cyclopentanone being
27 %. To facilitate the separation ofthe enantiomers, the spirocycle (83) was reacted with (R,R)-
2,3-butanediol and a catalytic amount ofp-TsOH. The resulting diastereomeric acetals (+)-(84)
and (- )-(84) were then easily separated by HPLC using CHCl3 on a silica gel column. The
application ofthis methodology to the synthesis ofcephalotaxine was then demonstrated. From
(+)-(84) and (-)-(84) two further steps allowed for the addition of the cephalotaxine A and B
rings to the spirocycle and removal ofthe acetal to reveal the ketone functionality of(+)-(44) and




2 steps A....-...... '"C~Me----V.....,
OAe 0
(ll • ~COzMe (li). ~COzMe
(81) (82)
"""'H 0o C1~o~t~<XYB~--(+(I)
(iii)~ A ",tJ,/.O~< "" (-)-(;4) (-)-(44)
LAJ "'H 0






Scheme 1.12. (i) isopropenyl acetate,p-TsOH, tJ., 72 %; (ii) (CF3CO)20, NH4N03, 68 %; (iii) Zn,
CH3C02H-EtOH, 80 %; (iv) (R,R)-( - )-2,3-butanediol, p-TsOH, tJ., 100 %.
21
Nagasaka et al. did not show the steps past this intennediate but stated that they synthesised (+)-
cephalotaxine and (- )-cephalotaxine by making use of the methods reported by Kuehne and co-
workers32 and Isono and Mori.39 Nagasaka and co-workers' synthesis of enantiomerically pure
(- )-cephalotaxine differs from that ofIsono and Mori as it relied on the production ofa racemic
mixture followed by separation of the enantiomers which were then converted to the
enantiomerically pure products. In contrast Isono and Mori used a compound from the chiral
pool to initiate their enantiomerically pure route which required no separation of racemic
mixtures during the course of its preparation.
1.4.2. Formal Syntheses of Cephalotaxine
By synthesising the enamine intennediate (10)41,42.43 found in the Auerbach and Weinreb27,28
synthesis or a precursor to it44 a number of research groups have succeeded in achieving fonnal
syntheses of (±)-cephalotaxine. The synthesis of this enamine (10) does not involve the
fonnation of the spirocycle and thus is not of great interest to us, as a result the work of these
groups has not been reviewed here. However the 1999 fonnal synthesis of (- )-cephalotaxine
published by Tietze and Schirok45 did involve a novel spirocycle synthesis and so will be
reviewed here.
The synthesis of Tietze and Schirok utilized two efficient palladium-catalysed cyclisations the
first of which resulted in the fonnation of the spirocycle and the second fonned the seven-
membered C ring. The general outline of their work can be seen in Scheme 1.13. Amine (86),
synthesised from piperonal (85), was alkylated with the tosylate (88) which had been previously
obtained from cyclopentane-l ,3-dione (87). The resulting secondary amine (89) then underwent
an allylic amination, this being the first of the Pd-catalysed cyclisation reactions, and gave the
spirocycle (90) in 88 % yield. Next a palladacycle catalyst (91) was used to carry out the second
cyclisation to fonn the pentacycle (92). At this point Tietze and Schirok claimed a fonnal
synthesis stating that the pentacycle (92) could be converted to (- )-cephalotaxine (1) in four steps
following the procedure Isono and Mori used in their synthesis of (- )-cephalotaxine (1).39
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Scheme 1.13. (i) Pd(PPh3)4' tetramethylguanidine, !::J., 88 %; (ii) n-Bu4NOAc, !::J., 81 %.
Ikeda and co-workers, in addition to their total synthesis of(±)-cephalotaxine,35,36 also published
a formal synthesis46 of(- )-cephalotaxine in 1999. Their formal synthesis was achieved with the
formation of the enantiopure ketolactam (35) which they had formed during their (±)-
cephalotaxine route as had Hanaoka and co-workers. 31 Ikeda and co-workers began their
synthesis of (- )-cephalotaxine with R-proline (73), as had Isono and Mon for their enantiopure
synthesis,39 and converted it to the N-protected product (93) in four steps (Scheme 1.14). Wacker
oxidation of (93) resulted in the diketone (94) which underwent base catalysed aldol
condensation with sodium 2-methyl-2-butanolate (formed from NaB and 2-methyl-2-butanol)
to form the a,~-unsaturated ketone spirocycle (95) in 43 % yield. Though this yield was only
moderate it was significantly better than the yields obtained under a number ofother conditions
that were investigated. Ketone (96) was formed as a single isomer by hydrogenation of(95), the
premise being that the hydrogen attacks from the less hindered re face ofthe double bond leading
to the stereochemical assignment for (96). A further six steps led to the formation of the
enantiopure pentacycle (59), seen earlier in the racemic cephalotaxine synthesis ofIkeda and co-
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workers35.36 (Scheme 1.7). Finally (59) was converted into the desired enantiopure ketolactarn
(35) resulting in a formal synthesis of (- )-cephalotaxine. To the best of our knowledge this is
the most recently published synthesis of cephalotaxine.
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Scheme 1.14. (i) 02' PdCI2, CuCI, 67 %; (ii) NaH, 2-methyl-2-butanol, 43 %; (iii) H2, Pt02, 84
%.
1.5. AIMS OF THE INVESTIGATION
The aim of this project was to apply the Noyori annulation reaction to the synthesis of the
cephalotaxine spirocycle. Noyori himself is a well respected chemist with his contributions to
organic chemistry being recognised in 2001 with the award of the Nobel Prize for Chemistry.
Though it will be dealt with in detail in Chapter 2, a brief introduction to the Noyori annulation
reaction will be given here. The reaction is an Fe2(CO)9 mediated cycloaddition reaction
involving a polybromoketone (di-, tri, or tetra-substituted bromoketone) and a compound
containing an electron-rich double bond to yield a cyclocoupled reaction product. Noyori and
co-workers showed this reaction could be carried out using I,3-dienes,52 aromatic oletins,53 and


















Scheme 1.15. Examples of Noyori annulation reactions between dibromoketones and (a) a 1,3-
diene, (b) an aromatic olefin, and (c) an enamine.
One of the useful aspects of the Noyori annulation reaction is its ability to synthesise rings
containing an odd number ofatoms as in general rings containing an even number of atoms are
more easily prepared e.g. six-membered rings by the Diels-Alder reaction.52 Applications ofthe
annulation reaction were demonstrated by Noyori and co-workers with the synthesis oftroponoid
compounds55 and tropane alkaloids56 which all contain seven-membered rings. Our interest in
the Noyori annulation reaction lies particularly with the cyclocoupling reaction involving an
enamine as shown in Scheme 1.15 (c). As in this example, all the enamine reactions carried out
by Noyori and co-workers used a morpholine derivative with the nitrogen ring always being
eliminated in the reaction.54 Our intended investigation of the Noyori reaction to form the
cephalotaxine spirocycle is shown in Scheme 1.16. The reaction would involve a dibromoketone
and an enamine, though here the enamine double bond is directly connected to the azacycle while
in the work ofNoyori and co-workers it was along the alkyl chain attached to the nitrogen. This
is a subtle but important difference as it should result in the formation of the desired




R}, R2 = H, alkyl, acyl or aryl
Scheme 1.16. Model study of the Noyori annulation reaction to form the cephalotaxine
azaspirocycle.
In Scheme 1.16 the functionalisation of the dibromoketone is not specified as the intention was
to investigate the tolerence ofthe reaction to various functional groups. This would be important
when the reaction was applied to the synthetic route to form the cephalotaxine skeleton as will
be seen shortly. The enamine chosen for our "test" Noyori reaction in Scheme 1.16 was intended
to be a model compound so that the initial investigative reactions into the Noyori coupling
reaction were carried out on a cheaper and more simply prepared compound than if the rest of
the cephalotaxine skeleton, namely the A ring and B ring, was already intact.
A further aim of the investigation was to pursue a novel route to the basic pentacyclic
cephalotaxine structure based on the spirocycle synthesis. The proposed synthetic route to apply
the Noyori coupling reaction to the synthesis ofthe cephalotaxine pentacyclic skeleton is shown
in Scheme 1.17. The proposed reagents for each step are shown. Most of the elements of the
route not involved with the spirocycle synthesis were based on the (±)-cephalotaxine synthesis
of Semmelhack et al. 29,30 Each step in the proposed route will now be briefly discussed, with
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Scheme 1.17. (i) LiAIH4; (ii) 12, Ag02CCF3; (iii) pyridine,p-TsCI; (iv) MeCN, i-Pr2NEt; (v)
Cp2TiMe2; (vi) Fe2(CO)9, hv, ~; (vii) potassium t-butoxide, NH3, hv.
Steps A and B: These first two steps of the synthesis were based on the work of Semmelhack et
al. 29•30 3,4-Methylenedioxyphenylacetic acid (9) is a readily available starting material and it was
anticipated it should be easily reduced to the corresponding alcohol (60) with the commonly used
reducing agent, LiAIH4• Step B is an electrophilic aromatic substitution reaction to place an
iodine atom on the cephalotaxine B ring thus forming iodoalcohol (97). The presence of the
iodine atom was required to facilitate the ring closure to form the seven-membered C ring in Step
G.
Step C: This step converts the iodinated alcohol (97) to the tosylate (98), thus inserting a good
leaving group in preparation for the next step involving the addition of the pyrrolidinone ring.
In the work of Semmelhack et al. a nosylate rather than tosylate leaving group was used. Our
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reason for preferentially intending to synthesise the tosylate (98) was simply that at the start of
the project there was no 4-nitrobenzenesulfonyl chloride in our laboratories, and this is the
reagent required for the nosylate synthesis. As large quantities ofp-TsCI were available it
seemed reasonable to synthesise the tosylate (98) as the tosylate moiety itselfshould act as a good
enough leaving group for Step D even though nosylates, in relative terms, are approximately
twenty times better leaving groups than tosylates.57
Step D: This step was intended to result in the coupling of the pyrrolidinone ring (18) (D ring)
to the cephalotaxine A and B rings. Again the intention was to use the method of Semmelhack
et aI.,29,30 though in their work the coupling was ofthe already completed spirocycle to the A and
B rings. Should the tosylate be an adequate leaving group it was not anticipated that this step
should present any problems.
Step E: The enamine (100) is formed in this step by the reaction ofthe corresponding lactam (99)
with Cp2TiMe2' We intended using the method ofPetasis and LU.58
Step F: This is the point at which the Noyori annulation reaction was to be implemented. For this
step the synthesis ofthe dibromoketone (101) is required. An idea ofhow successful this Noyori
annulation reaction of the dibromoketone (101) and the enamine (100) would be would have
been gained from the earlier model studies outlined in Scheme 1.16. Three chiral centres are
being created in this reaction and it was anticipated that a mixture of diastereomers of the
spirocycle (102) would be formed.
Step G: Should this step where the seven-membered ring is formed be reached, few problems
were anticipated in carrying it out. Semmelhack et al. 29,30 investigated a number of methods to
achieve this ring closure and showed that the use of a base combined with irradiation of the
reaction mixture achieved cyclisation efficiently. As discussed in Steps A and B, the presence
ofthe labile iodine atom should facilitate this ring closure based on the findings of Semmelhack
et al.
29
, 30 Thus using this method the pentacyclic cephalotaxine skeleton (103) would be
obtained.
28
Should the route be carried out as intended it would take only seven steps to achieve the
pentacyclic cephalotaxine skeleton (103). The functionality of the dibromoketone (101) would
then become important as it would determine the degree ofease that the five-ring system (103)
could be correctly functionalised to form cephalotaxine (1). In addition, varying R1 and R2 will
allow the flexibility to synthesise various analogues of cephalotaxine. It was known that
realistically, in the MSc time frame, it would not be possible to complete the synthesis of
cephalotaxine itself during this particular study. Thus the principal aim of this project was to
determine if the Noyori annulation reaction could be used to assemble the azaspirocycle of
cephalotaxine. Thereafter, if successful, there was every possibility that the work may be
completed by other members of the research group and so the overall synthetic route to
cephalotaxine was kept in mind and a broader approach was considered.
In the following chapters the work that has been carried out based on the above aims has been
described. It is now relevant to mention that the original intention was that the work for this
thesis be based purely in synthetic organic chemistry. However, during the course of the work
as a result of the synthesis, en route, of a particularly interesting novel compound, the
opportunity presented itselfto carry out a conformational analysis study. Thus Chapter 2 covers




Discussion of Synthetic Work
2.1 APPLICATION OF THE NOYORI ANNULATION REACTION TO THE
CEPHALOTAXINE SPIROCYCLE
2.1.1. Mechanism of The Noyori Annulation Reaction
It is relevant at this point to discuss the mechanism ofthe Noyori annulation reaction introduced
in the previous chapter. The mechanism of the reaction between a,a'-dibromo ketones and
Fe2(CO)9 was investigated thoroughly by Noyori and co-workers and is shown in Scheme 2.1.
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In the first step one of two things occurs. Either the dibromo ketone (104) undergoes a two
electron reduction to form the enolate (105) or an oxidative addition ofthe carbon-bromine bond
of (104) onto a zerovalent iron atom takes place which is followed by a rearrangement into the
enolate (105). In the next step the allylic bromine atom is removed by an SN1-type or ferrous ion
assisted elimination to give the oxyallyl-Fe(II) intermediate (106). In their paper on the
mechanism of the reaction between dibromo ketones and Fe2(CO)9 Noyori and co-workers






















Also shown in Scheme 2.1 is the reaction of the oxyallyl-Fe(II) intermediate (106) with a
heteroatom substituted olefin (107),54 where in our case the heteroatom would be nitrogen. The
zwitterionic intermediate (108) that forms is stabilised by the presence of the heteroatom due to
resonance involving a non-bonding electron pair on the heteroatom. The annulation can then
occur to form the cylised product (109).
Noyori and co-workers noted in their mechanistic studies59 that alkylated a,a'-dibromo ketones
undergo reactions characteristic of the oxyallyl-Fe(II) intermediate (106) while a,a'-
dibromoacetone does not. They reason that carbocation-stabilising subsituents are required at
the cationic termini ofthe a,a'-dibromo ketone in order to stabilise the reactive enolate (105) and
the oxyallyl-Fe(II) intermediate (106). As a,a'-dibromoacetone does not contain any such
substituents it is unable to stabilise the intermediates. Thus in order for the Noyori annulation
reaction to take place the reactivity and stability of the enolate (105) and oxyallyl (106)
intermediates needs to be controlled using the electronic effects of the dibromo ketone
substituents. With the Noyori annulation reaction and its mechanism now having been
introduced, the stage is set to discuss the work carried out using this reaction.
2.1.2. Synthesis of 1,3-Dimethyl-1,4,5,6,7,7a-hexahydro-2H-inden-2-one (115)
The conditions under the which the Noyori annulation are carried out were not standard practice
in our laboratories at the start ofthis project and so in order to ensure that the correct conditions
were used in our proposed spirocycle syntheses a "test" reaction was carried out. This reaction
involved the coupling ofa cyclic enamine, similar to those used by Noyori and co-workers.,54 and
a simple a,a'-dibromo ketone to give a known Noyori annulation product, 1,3-dimethyl-
1,4,5,6,7,7a-hexahydro-2H-inden-2-one (115).54 Both reactants, the enamine, 1-(l-cyclohexen-l-
yl)pyrrolidine (112), and the a,a'-dibromo ketone, 2,4-dibromo-3-pentanone (114), had to be
synthesised first. Synthesis ofthe enamine (112) was carried out by refluxing a toluene solution
of cyclohexanone (110) and pyrrolidine (111) in the presence of a catalytic amount of p-
toluenesulfonic acid (Scheme 2.2).60 Water was continuously removed from the reaction using
a Dean and Stark apparatus. The resulting liquid was purified using a Kugelrohr distillation
apparatus to remove the lower boiling impurities, giving enamine (112) in a 56 % yield. These
types of enamines are better used without purification as this results in lowering of the yield as
the mediocre 56 % seen here illustrates. However, for our purposes a pure product was required.
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The synthesis of the dibromo ketone, 2,4-dibromo-3-pentanone (114), was achieved by a
bromination of the corresponding ketone, 3-pentanone (113), using molecular bromine and
hydrobromic acid (Scheme 2.3). The method followed was that of De Kimpe et al. 61 who had
reported an explosion when carrying out this reaction on a molar scale, thus extreme caution was
exercised during the experiment. The product was purified by vacuum distillation and was kept
in the freezer under N2. Before use in any reactions the dibromo ketone (114) was passed
through a basic alumina column. As with a number oforganobromine compounds, this substance








In the GC-MS analysis, the GC trace of the dibromo ketone (114) showed two peaks, which
according to their mass spectra, both corresponded to the correct mass for the compound.
Similarly, in the lH and l3C NMR spectra two sets of signals were observed. This is as a result
of there being two diastereomers, (Ro, RO) and (Ro, s"), with stereogenic centres being present at
both carbons a to the carbonyl group. Thus one set of signals is attributable to the (Ro, RO)-
diastereomer and the other set ofsignals to the (RO, s")-diastereomer. This is clearly seen in the
lH NMR spectrum shown in Figure 2.1. The doublet at 1.80 and the quartet at 4.98 ppm are due
to the CH3 and CH, respectively, for one diastereomer while the doublet at 1.88 and quartet at
32
4.77 ppm are due to the other diastereomer. From the IH NMR spectrum shown it appears that
the reaction to form the dibromo ketone (114) is diastereoselective, with one diastereorner being
present in significant excess. This is however not the case as according to the literature the
reaction produces a 1: 1 diastereomeric mixture.62 In our case the ratio of diastereomers was
presumably altered during the distillation process. The yield for this reaction was low, being only
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Figure 2.1. IH NMR spectrum of2,4-dibromo-3-pentanone (114).
With both the required enamine (112) and dibromo ketone (114) in hand the "test" Noyori
annulation reaction could be carried out (Scheme 2.4). The required quantity of FeiCO)9 was
measured out into a flame-dried flask in a N2 atmosphere glove-box. The two flasks containing
the enamine (112) and dibromo ketone (114) were evacuated and then filled with nitrogen before
adding an equal quantity of anhydrous benzene to both flasks. The two benzene solutions were
then transferred via a cannula into the flask containing the Fe2(CO)9' The reaction mixture was
heated to 60°C for 10 minutes with irradiation using a 400 W high pressure Hg lamp. To block
wavelengths of less than 350 nm, a 10 % aqueous CuS04 solution was used as a filter, being
placed between the Hg lamp and the reaction flask. Though Noyori and co-workers54 did not
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elaborate on the need for the CuS04 solution, it is suspected that this prevents the occurrence of
unwanted side reactions that would be caused by the low wavelength radiation. After the 10
minutes of heating the reaction mixture was left to stir overnight at room temperature with
continued irradiation. After dilution with ethyl acetate, washing with aq. NaHC03 and brine
solutions, and evacuation, the remaining liquid was purified by radial chromatography to afford
the desired cyclopentenone (115) as a mixture of two diastereomers in a 35 % yield. The two
diastereomers were separated by preparative TLC and the NMR data compared favourably with
those reported by Noyori and co-workers54 who had synthesised the cyclopentenone (115) from
the morpholine enamine of cyclohexanone and the same dibromo ketone (114). In Noyori's
reaction the morpholine moiety was eliminated from the enamine during the reaction to give the
product (115). Similarly, from Scheme 2.4, it can be seen that the pyrrolidine moiety of the
enamine (112) was eliminated in the reaction which we carried out which is why the same
product was obtained in both cases. The elimination in these reactions takes place after the
annulation has occurred. From the annulation reaction the resulting ~-substitutedcyclopentanone
intermediate contains a labile hydrogen atom in the position a to the carbonyl. The loss of the
labile hydrogen atom results in facile elimination ofthe ~-substituent, in our case pyrrolidine, to
give the cydopentenone (115).





Though the 35 % overall yield of the reaction was low it had been successful meaning that the
intended spirocyde syntheses could be attempted.
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2.1.3. Attempted Reaction of MethyI2,4-dibromo-3-oxobutanoate (116) and 1-Benzyl-2-
methylenepyrrolidine (117)
It was our intention to carry out the Noyori annulation reaction using the dibromo ketoester (116)
and enamine (117) to give us our desired spirocycle product (118) (Scheme 2.5). The dibromo
ketoester (116) was chosen With the cephalotaxine synthesis in mind, the rationale being that the
ester moiety could be eliminated by hydrolysis and decarboxylation in order to obtain the correct
functionality on the cephalotaxine E ring. The enamine (117) was chosen as a model compound,








Once again both starting materials, the dibromo ketoester (116) and enamine (117), had to be
synthesised as they are not commercially available. The synthesis ofthe dibromo ketoester (116)
was not as simple as for 2,4-dibromo-3-pentanone (114) where the corresponding ketone was
brominated in a one step reaction. Rather, following the method of Chan and Brownbridge,63
dibromo ketoester (116) is synthesised in three consecutive steps from methyl acetoacetate, going
via the corresponding bis-silyl enol ether (121). Thus for the first step, as suggested by Chan and
Brownbridge,64 the method of Danishefsky and Kitahara6S was followed to convert methyl
acetoacetate (119) into methyl 3-[(trimethylsilyl)oxy]-2-butenoate (120) (Scheme 2.6). Zinc
chloride in triethylamine is used to promote enolate formation ofmethyl acetoacetate (119) with
the enolate subsequently being trapped by TMSCI to form the desired silyl enol ether (120).
Purification by distillation was carried out satisfactorily to afford a clear liquid in a 63 % yield,
though problems with "bumping" were encountered. The product was characterised by GC-MS,
IR and NMR spectroscopy with the lH NMR data showing a good correlation with the data
obtained by Chan and Brownbrigde.64 Both E and Z isomers (3: 1) are observed in both the GC-









Converting the silyl enol ether (120) to (1E)-1 ,3-bis[(trimethylsilyl)oxy]-1 ,3-butadienyl methyl
ether (121) (also known as Chan's diene) required the use of a stronger base for the enolate
formation than in the synthesis of (120). Thus following the method of Chan and co-workers,66
LDA formed from n-butyllithium and diisopropylamine, was used (Scheme 2.7). TMSCI was
once again used as the silylating agent. Because of the use of the moisture-sensitive reagent
LDA, great care was taken to ensure that both glassware and solvent (THF) were dry. The
reaction was carried out at -78°C as the research of Chan and co-workers showed that if the
temperature of the reaction increased above -42 °c formation of the desired product was
hindered. The crude bis-silyl enol ether (121) proved difficult to purify as the silyl enol ether
functional groups are highly labile on silica gel and distillation is precluded as the compound
decomposes at elevated temperatures. A IH NMR of the crude sample offered the necessary
proof that the compound had been formed and it was decided that the compound could be used







In a communication, Chan and Brownbridge had reported the formation ofthe dibromo ketoester
(116) from bis-silyl enol ether (121) by addition of2 molar equivalents ofbromine.63 No actual
method for the synthesis, or spectral data, was provided in the communication and since no
follow-up paper was published a method for the bromination reaction had to be developed.
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Attempted personal communication with the author was equally unhelpful. Various unsuccessful
attempts were made to form the dibromo ketoester (116) by adding bromine in chloroform to
(121) dropwise and leaving the mixture to stir for lengthy periods. Only complex mixtures of
products were obtained with no evidence of the desired product being seen. A method which
proved reasonably successful involved adding the bromine solution to bis-silyl enol ether (121)
at 0 °C in one portion, leaving the mixture for one minute and then quenching the reaction with
saturated aqueous NaHC03. Unfortunately this method was not reproducible and further
attempts at altering the conditions of the reaction were made. The method which finally proved
successful and reproducible is shown in Scheme 2.8 and involved adding bromine at -78°C







Various reaction times were investigated (5 minutes, 30 minutes, 1 hour, and 3 hours) and it was
found that the yields did not appear to differ significantly. However, the main factor in achieving
an acceptable yield proved to be the quality ofthe starting material. Though it was reported that
the bis-silyl enol ether (121) could keep in the freezer for up to two weeks without obvious
degradation,66 significantly better yields were obtained using freshly prepared (121). According
to the work of Chan and co-workers,64,66 the bis-silyl enol ether (121) reacts with electrophiles
preferentially at C-4, though there is also a second nucleophilic site at C-2. Scheme 2.9 shows
the first attack on the bromine taking place from the more reactive C-4 position and then the
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Purification of dibromoketo ester (116) proved problematic in that chromatographic methods
only resulted in its decomposition. The product also tends to decompose at high temperatures
which prevented the use of distillation. Thus the highest level of purification that was achieved
was by removing lower boiling impurities using Kugelrohr distillation under vacuum.
Unfortunately the purity ofthe dibromo ketoester (116) was not as high as desired. Like the bis-
silyl enol ether (121), the dibromo ketoester (116) also appeared to degrade with time even if
stored in the freezer under N2. A full range ofNMR spectra were obtained for dibromo ketoester
(116) as no data has been published on the compound. In the lH spectrum the methyl group
appeared as a singlet at 3.86 ppm, the diastereotopic CH2 protons as two doublets at 4.25 and
4.38 ppm, and the CH as a singlet at 5.20 ppm. Unfortunately a high resolution mass spectrum
(HRMS) was not obtained as the sample had decomposed on arrival at the laboratory which
carried out the analysis. Finding a method for the synthesis of the dibromo ketoester was
extremely time consuming, but finally with a reliable method in hand the synthesis of the
enamine (117) could be started.
The synthesis of the enamine (117) is documented by Petasis and Lu in their work on the
methylenations of heteroatom-substituted carbonyls.58 They achieved the fonnation of the
enamine (117) by reaction of N-benzyl-2-pyrrolidinone (123) with dimethyltitanocene
(CP2TiMe2)· As neither ofthese are commercially available both needed to be synthesised. The
N-benzyl-2-pyrrolidinone (123) was easily synthesised from 2-pyrrolidinone (18) and benzyl
bromide (122) with NaH acting as a base (Scheme 2.10) using the method of Bielawski et ai.67
Purification was carried out by column chromatography, rather than by distillation as Bielawski











The synthesis ofCP2TiMe2(125) was carried out using the method ofClauss and Bestian.
68 This
involved adding methyllithium (MeLi) to a THF solution of titanocene dichloride (124)
(Cp2TiC12) at 10-15 °c (Scheme 2.11). It was found that the speed at which the MeLi was added
affected the yield with better yields being achieved when the MeLi was added dropwise rather
than in one portion. The product, CP2TiMe2(125), was obtained as an orange solid which was
recrystallised from pentane by cooling to give needle-like crystals in a yield of 73 %. As the
compound decomposes at high temperatures68 it was not possible to confirm the successful
synthesis of CP2TiCl2by OC-MS. However, NMR and IR spectra clearly proved the presence
of the desired compound. The \H NMR spectrum contained only two singlets, one integrating
for the 10 cyclopentadienyl protons at 6.06 ppm and a second peak situated at - 0.15 ppm
integrating for the six methyl protons. This latter methyl peak is shifted further upfield than







The IR spectrum for CP2TiMe2 (125) as a KBr disc is shown in shown in Figure 2.2 and the
assignments are made as follows: 69 in the region 3150-2800 cm'! C-H stretchings are seen while
at 1442 cm'\ C-C bond stretching occurs. At 1014 cm· l in-plane C-H bending occurs with the
peak at 814 cm-1 being characteristic ofa C-H out-of-plane bending. Finally at 462 cm-! the Ti-



























Figure 2.2. IR spectrum ofCp2TiMe2 (125).
With the desired starting materials prepared the reaction to prepare the enamine (117) was carried
out using the method ofPetasis and co-workers.58•70 This involved heating a toluene solution of







Petasis and Lu stated in their work that the purification of this compound was difficult and that
it should rather be used in further reactions without isolation.58 As we were already in a situation
where one of our reactants for the intended Noyori annulation reaction, the dibromo ketoester
(116), was not as pure as desired, it was decided that an attempt should be made to purify the
enamine (117) but it was indeed found to be difficult. Detection of the enamine (117) was also
problematic as it appeared to decompose on being subjected to GC-MS analysis. Tentative proof
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of the product having been formed was the apparent presence of the two vinyl protons in the lH
NMR spectrum situated at approximately 3.6 ppm. According to the GHSQC spectrum these
vinyl peaks showed a correspondence to a methylene signal in the l3C NMR spectrum (identified
as such from the DEPT spectrum). Work by Tehrani and De Kimpe who had used Cp2TiMe2
(125) in the methylenation of lactams also spoke of the difficulties of purification of products
similar to ourS. 71 For their products, distillation resulted in severe degradation, but they were able
to achieve some degree of purification by suspending the evacuated reaction mixture in pentane
and then filtering the solution through Celite Filter Cel to remove the insoluble titanium salts
formed during the reaction. This procedure was carried out on our product until there was no
further precipitation ofthe titanium salts. Thus this was the partial purification procedure which
we adopted for the enamine (117) and as Petasis and LU58 had shown the enamine (117) could
be used successfully in a reaction without purification we decided to persevere with the Noyori
annulation reaction ofthe enamine (117) and dibromo ketoester (116) as shown earlier in Scheme
2.5.
The Noyori annulation of the enamine (117) and dibromo ketoester (116) was carried out under
the same conditions as the successful "test" reaction which formed the cyclopentenone (llS).
Thus benzene solutions ofthe enamine (117) and dibromo ketoester (116) were added to a flask
containing FelCO)9' The mixture was heated to 60°C for 10 minutes with irradiation, and then
left to stir overnight at room temperature with further irradiation. After the dilution of the
reaction mixture with ethyl acetate, and washing with NaHC03 and brine, the reaction mixture
was subjected to column chromatography in order to separate the reaction products. From the
fractions collected there were no spirocycle-type products seen when GC-MS or NMR analysis
was carried out. The only compound clearly isolated and positively identified was unreacted N-
benzyl-2-pyrrolidinone (123) from the reaction to form the enamine (117)! Overall there were
a number ofreaction products which gave complicated NMR spectra and any functional groups
present were difficult to identify. Even though Noyori and co-workers had stated that the
annulation reaction afforded good yields in benzene,54 toluene was also tried as a solvent for the
reaction. The change ofsolvent, however, did not appear to alter the situation at all, a complex
mixture ofcompounds still being observed in the reaction mixture. On reflection, it was realised
that considering this was a novel reaction that was being attempted, using two only partially
purified reactants was not at all sensible. A second and more important realisation was that the
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dibromo ketoester chosen for the reaction was not ideal when looking at the mechanism of the
Noyori reaction. As was discussed in Section 2.1.1, Noyori and co-workers had stated that a
dibromo ketone with carbocation-stablising substituents was required. An ester, if anything,
would have a destabilising effect on the carbocation intermediate. The ester functionality would
not stabilise the enolate (105) or oxyallyl-Fe(II) (106) intermediates seen in the mechanism
(Scheme 2.1). Thus, in retrospect, it is not altogether surprising that this reaction failed to give
a spirocycle. It was obvious then that a different dibromo ketone would have to be used in the
reaction. We decided to continue using enamine (117). Though it could not be purified,
literature precedent had shown the enamine (117) could be a useful reactant even in an impure
form. 58 As the dimethyl substituted a,a'-dibromo ketone (114) had been used for the "test"
Noyori reaction and could be synthesised and purified with relative ease, it was chosen as a
replacement for the dibromo ketoester (116).
2.1.4. Reaction of 2,4-Dibromo-3-pentanone (114) and 1-Benzyl-2-methylenepyrrolidine
(117)
Scheme 2.13 shows the intended reaction between dibromo ketone (114) and enamine (117) to









The reaction was carried out under the same conditions as the "test" reaction and the reaction of
the enamine (117) and dibromo ketoester (116). After column chromatography one product
which was isolated appeared from its NMR spectra to have most of the desired features of the
molecule except notably there was no evidence of a carbonyl carbon atom in the 13C NMR
spectrum. The yield ~f this particular compound was extremely low, being only 8 % based on
the dibromo ketone (114). Even though a signal characteristic of a carbonyl carbon was absent
from the NMR spectra of the compound, the spectra were analysed further as no other fractions
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collected from the chromatogaphy exhibited promising NMR spectra.
Shown in Figure 2.3 is the lH NMR spectrum of the compound and in Figure 2.4 the 13C
spectrum. Also shown in the two figures is the azaspirocycle (127) which was the structure
proposed based on the NMR data and a HRMS spectrum ofthe compound, which confirmed the





N. The IH and 13C NMR spectra were assigned with the aid of DEPT, COSY, GHSQC,
and GHMQC spectra and the proposed assignments will now be discussed.
In the IH NMR spectrum the two methyl protons are seen as singlets at 1.29 and 1.30 ppm, their
separation being only 0.01 ppm. As these peaks were singlets it immediately indicated that the
originally anticipated compound (126) had not been obtained as both methyl groups would have
been doublets due to adjacent CH's. From 1.5 ppm to 3.0 ppm the diastereotopic CH2 protons
on the pyrrolidine ring are seen and these were assigned using the COSY spectrum. Thus the
multiplet from 1.68 to 1.81 ppm is one of the C-4 protons, while the multiplet from 1.80 to 1.89
ppm is both C-3 protons. From 1.97 to 2.05 ppm, the second C-4 proton resonates, and finally
the two C-2 protons are each seen as separated multiplets at around 2.5 and 2.9 ppm. Two clear
doublets are seen at 3.22 and 3.60 ppm, both having the same coupling constant of 13.3 Hz and
are thus assigned as the diastereotopic benzyl methylene protons. In the region between 1 and
4 ppm that has been discussed to far, some impurities can be seen, notably the fairly large singlet
at around 3 ppm. Other smaller peaks have very similar shifts and appearances to the assigned
peaks, seeming to indicate a very similar compound was present in the solution. Up to this point
the assignments have been made with confidence though in the region from 6 to 7 ppm the
assignment of the cyclopentadiene protons ring are tentative. For our proposed structure only
two peaks are required for the C-9 and C-7 protons, but a number ofpeaks are seen in this region
which we attributed to impurities. However, as the C-9 and C-7 protons should be singlets we
assign the only two singlets seen in this region, at 6.21 and 6.41 ppm to the C-9 and C-7 methine
protons respectively. Finally, the phenyl protons are easily assigned as the multiplet in the region
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Figure 2.3. IH NMR spectrum of the product resulting from the reaction of 2,4-dibromo-3-
pentanone (114) and 1-benzyl-2-methylenepyrrolidine (117). The proposed structure of the
product, azaspirocycle (127), is shown.
Figure 2.4 shows the 13C NMR spectrum for the reaction product and the following assignments
are made. The only two methyl groups present according to the DEPT spectrum are at 17.06 and
17.67 ppm, however C-10 and C-ll could not be distinguished. According to the DEPT
spectrum the methylene groups are seen between 20 and 60 ppm. The C-3 carbon resonates at
21. 56 ppm, the C-4 carbon at 39.07 ppm and the C-2 carbon at 49.87 ppm. The benzyl
methylene carbon appears at 53.23 ppm. Most notably at 63.22 ppm a quaternary carbon is
observed, presumably the spiro carbon. This is one of the most convincing pieces of evidence
for the formation ofsome kind ofspirocycle. As for the methine peaks in the IH NMR spectrum
it becomes difficult to assign the carbon methine signals as there are more than required for the
proposed structure. However, using the peaks assigned in the IH NMR spectrum in conjunction
with the 2D GHSQC spectrum the C-9 and C-7 carbons are assigned to the peaks at 126.39 ppm
and 131.65 ppm respectively. The aromatic carbon atoms are assigned to the signals at 128.01,































Figure 2.4. 13C NMR spectrum of the product resulting from the reaction of 2,4-dibromo-3-
pentanone (114) and I-benzyl-2-methylenepyrrolidine (117). The proposed structure of the
product, azaspirocycle (127), is shown.
The remaining quaternary carbons were assigned with the aid of the GHMQC spectrum. The
phenyl quaternary carbon atom appears at 141.09 ppm and the C-6 and C-8 quaternary carbons,
which could not be distinguished, at 153.48 and 155.92 ppm. In the 13C NMR spectrum a similar
situation to that observed in the IH NMR spectrum was seen. A number of the peaks were
doubled up, again indicating the presence of a slightly smaller amount of a very similar
compound. For the proposed structure (127), two sets ofpeaks would not be expected as though
there should be two enantiomers of the compound these would not be distinguishable by NMR.
Thus the two possibilities are (a) there is a structurally similar impurity present or (b) our
proposed structure is incorrect and the actual product is diastereomeric and two of these
diastereomers are present in the NMR sample. To solve the problem it is obvious that a pure
sample was required but with the low yield of the reaction it was extremely difficult to separate
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the desired compound in a large enough quantity to obtain an NMR spectrum. Though the
reaction was repeated with different reaction conditions the yield was not increased and we failed
to obtain a purer sample.
The aim of the project was' to use the Noyori annulation reaction to form the cephalotaxine
spirocycle. Even though the reaction of 2,4-dibromo-3-pentanone (114) and I-benzyl-2-
methylenepyrrolidine (117) had appeared to form an azaspirocycle based on the NMR data, it
was felt that this reaction had not achieved the desired aim. The anticipated product (126) had
not been formed from the reaction and the putative spirocycle (127) had been achieved in
extremely small quantities and was very difficult to purify. Thus, it was decided that pursuing
this reaction would be fruitless considering the principal aim of the project.
2.1.5. Synthesis ofl-Benzyl-7,9-dimethyl-8-oxo-1-azaspiro[4.4]nonane-6-carbonitrile (130)
Thus learning from our experience gained from the previous spirocycle reactions the starting
materials for the Noyori annulation reaction were reexamined. The dibromo ketone (114) had
been successfully used in the original "test" reaction and was not considered to be problematic
and thus it was only the enamine that needed to be modified. From experience in our laboratory
it was known that a nitrile group placed at the terminal end ofthe enamine (117) would stabilise
this functionality. It was hoped that this electron-withdrawing moiety would also promote the
formation of the Noyori annulation reaction product. Before the Noyori annulation reaction
using these intended reactants could be carried out the vinylogous cyanamide (129) first had to
be synthesised in a two step process from N-benzyl-2-pyrrolidinone (123). Scheme 2.14 shows






(ii) Ph3P, Et3N, CH2Clr
(129)
The first step involved the conversion of N-benzyl-2-pyrrolidinone (123) to the corresponding
thiolactam (128) which was achieved using the method ofBrillon.72 Using this method P2SS and
N~C03 were reacted in a 1: 1 ratio for 30 minutes to allow the formation of the THF soluble
(P4S100fN~2+ complex. Once this thionating agent was formed the N-benzyl-2-pyrrolidinone
(123) was added and the resulting mixture left to stir for a further 3 hours. The product was
purified by flash column chromatography and its formation confirmed by NMR spectroscopy,
our NMR data agreeing with those ofBrillon who had prepared the same compound.72 The l3C
NMR spectrum of the thiolactam (128) showed clearly the appearence of the thiocarbonyl
quaternary peak at 201.73 ppm while the carbonyl quaternary signal ofthe lactam precursor (123)
had disappeared from its position at 174.97 ppm. The synthesis of the vinylogous cyanamide
(129) was then achieved using an Eschenrnoser coupling reaction. In general this reaction
involves the alkylation of a secondary or tertiary thioamide followed by a sulfide contraction,
resulting in the elimination ofthe sulfur atom. The method of forming a carbon-carbon bond by
this procedure was first noted by Knott in 1955.73 However it took a further 16 years for the
potential of the reaction to be realised by Eschenrnoser and co-workers who demonstrated its
general synthetic use.74 The mechanism of this reaction is shown in Scheme 2.15.75
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Scheme 2.15. Mechanism of the Eschenrnoser coupling reaction.
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In the first step of the mechanism an a-thioiminium salt (B) is formed by the alkylation of the
thioamide (A) with an electrophile. In the second step the addition of a base results in the
abstraction of an a-proton in the side chain of the salt (B) to form the carbanion (C). The
carbanion reacts with the iminium species to form the episulfide (D). The sulfur atom is
extruded by a thiophile and the double bond is formed resulting in the desired enamine (E).
Depending on the substrates used in the Eschenmoser coupling reaction, the product obtained can
be either an (E)- or (Z)-isomer or a mixture of both. In our situation only one isomer was
observed and is assigned to be the (E)-isomer as in the case oftertiary thiolactams the (E)-isomer
is found to form exclusively.75 No evidence ofthe vinylogous cyanamide (129) was found in the
literature but its formation was confirmed by GC-MS, IR and NMR spectroscopy. The 13C NMR
spectrum of the vinylogous cyanamide (129) shown in Figure 2.5 was particularly useful for its
characterisation. Though the spectrum is very similar to that of the thiolactam precursor (128),
two new peaks appear, these being the methine C-2' carbon at 54.46 ppm and the nitrile carbon
at 114.53 ppm as a small, obviously quaternary peak. In the GHMQC spectrum of the
compound, which shows correlations between a carbon atom and the protons ofthe neighboring
carbon atom, the quaternary peak at 114.53 ppm showed a correlation to the vinylic proton,
confirming that the peak is due to the nitrile carbon. This also confirmed that the peak at 122.66
ppm, which is slightly larger, is not the nitrile carbon but simply an impurity.
The IH NMR spectrum ofthe novel vinylogous cyanamide (129) is shown in Figure 2.6 with the
most notable peak being the vinyl proton at 3.58 ppm which once again confirms the formation
of the desired product. As for the 13C NMR spectrum the 'H NMR spectrum is very similar to
that of the thiolactam precursor (128). The C-4 protons appear at 2.01 ppm in the form of five
lines, the C-3 and C-5 protons both appear as triplets at 2.94 and 3.42 ppm respectively, the
benzyl methylene protons resonate as a singlet at 4.28 ppm, and the phenyl protons are found as
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Figure 2.6. lH NMR spectrum ofvinylogous cyanamide (129).
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The Noyori annulation reaction carried out between vinylogous cyanamide (129) and the a,a'-
dibromo ketone (114) is shown in Scheme 2.16. In a slight modification from the procedure for
the other Noyori annulation reactions carried out the reaction mixture was heated overnight with















The products were purified by radial chromatography and from the TLC ofthe fractions obtained,
five spots were seen to have very similar Rr values. From Scheme 2.16 it can be seen that the
expected product (130) has four stereogenic centres and thus 24 = 16 stereoisomers are possible.
This means there are eight possible diastereomers and their eight enantiomers. Therefore from
the TLC it appeared that if the observed spots were indeed attributable to this product then not
all possible diastereomers were formed in the reaction. Though the unwanted compounds had
been separated from the desired product, the separation of the diastereomers by radial
chromatography had not been fully achieved. At best, a mixture of two diastereomers had been
separated. The overall yield of the reaction was 24 %, which was obviously not as high as
desired but a great improvement on the previous annulation reaction attempt. NMR spectra were
run on selected fractions to confirm that the spots seen on the TLC did in fact correspond to the
desired product. Even though the NMR samples were mixtures it was clear to see that the
desired product had been formed as it was possible to identify the presence of the key features
of the molecule such as the phenyl ring, methyl groups, nitrile carbon, and carbonyl carbon.
Perhaps, for our purposes, the most important peak observed in the 13C NMR spectra was the
quaternary carbon at the spiro-fused centre which resonated between 70 and 75 ppm. Before an
attempt was made to separate the diastereomers by HPLC or preparative TLC it was found that
one of the diastereomers crystallised out selectively into large, colourless crystals. In the
fractions in which this occurred other smaller crystals were seen, possibly being another
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diastereomer, but these were not pure and covered in red oil, and so an attempt was made to
recrystallise these. NMR spectra were collected for the large, colourless crystals and indeed a
single diastereomer had crystallised out as clean spectra were obtained and the peaks in both the
IH and l3C spectra could be unambiguously assigned with the help of DEPT, COSY, GHSQC
and GHMQC spectra. The III NMR spectrum obtained from the crystals ofthis novel compound
is shown in Figure 2.7 and the assignments are made as follows. The two methyl groups adjacent
to the carbonyl group both appear as doublets as expected with the C-1 0 methyl group appearing
at 1.14 ppm while the C-11 methyl group is at 1.27 ppm. All the methylene protons on the
pyrrolidine ring are diastereotopic. Thus at around 1.8 ppm one C-3 proton resonates while the
other appears as part of the multiplet between 1.99 and 2.11 ppm. One C-4 proton appears at
around 1.9 ppm with the other also being part of the multiplet between 1.99 and 2.11 ppm. The
last pyrrolidine methylene group at C-2 has one diastereotopic proton appearing at around 2.8
ppm and the other at approximately 3.0 ppm. The two methine protons on C-9 and C-7 appear
as a multiplet between 2.36 and 2.46 ppm, while the methine proton which is a to the nitrile
group is clearly seen as a doublet at 2.75 ppm. The benzyl methylene protons are again
diasterotopic, each appearing as a doublet at 3.81 and 3.84 ppm, and finally the aryl protons
appear as a multiplet around 7.3 ppm. The peak at approximately 1.6 ppm is a minor impurity.
The l3C NMR spectrum for the spirocycle (130) is shown in Figure 2.8. Probably the most
important peak in the l3C NMR spectrum is the quaternary carbon at the spirofused centre which
appears clearly at 71.08 ppm. The other important features of the molecule are all evident such
as the two methyl groups at 8.70 and 14.06 ppm, the nitrile quaternary carbon at 119.69 ppm, the
aryl methine carbon atoms at ca. 128 ppm, and the carbonyl carbon atom signal is the furthest








Ii. j 'I i ' ii' . I iii I I I ii' iii Iii I • I ' I 'i
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0


















Figure 2.8. 13C NMR spectrum of spirocycle (130).
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Further NOESY experiments were carried on the crystalline diastereomer in an attempt to assign
the relative stereochemistry at the four stereogenic centres. Irradiation ofthe C-l 0 methyl group
showed a through space correlation to the methine proton at C-7 (Figure 2.9) apparently
indicating a trans relationship between the two methyl groups. Though the C-7 and C-9 protons
appear in the same multiplet, the COSY spectrum cleary indicated that the C-7 proton resonates
further downfield, thus the two protons could be distinguished in the proton spectrum even
though they were not perfectly resolved. The trans relationship ofthe methyl groups was further
confirmed by irradiation ofthe C-ll methyl group, as this showed a correlation to the C-9 proton
(Figure 2.10). Irradiation of this C-ll methyl group also showed a correlation to the C-6 proton
a to the nitrile group, thus again indicating a trans relationship between the C-ll methyl group
and the nitrile moiety. Finally irradiation ofthe benzyl methylene protons showed a correlation
to both the C-9 and C-6 protons (Figure 2.11). The C-9 and C-6 protons both appeared to be cis
to one another from the observations described above and thus ifthe benzyl group was showing
a correlation to both protons it appeared that the ring nitrogen would also be cis to them.
7
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Figure 2.9. NOESY spectrum showing irradiation of the spirocycle (130) C-I0 methyl group
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Figure 2.10. NOESY spectrum showing irradiation of the spirocycle (130) C-ll methyl group
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Figure 2.11. NOESY spectrum showing irradiation of the spirocycle (130) benzyl methylene
protons and the response exhibited by the C-6 and C-9 methine protons (methyl groups omitted
for clarity).
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Based on the above NOESY experimental data the relative stereochemistry of azaspirocycle
(130) was predicted to be 58", 68", 78", 98" as shown in Figure 2.12. The methyl groups are
trans to one another, the nitrile and C-1 0 methyl are cis, and the ring nitrogen trans to these latter
groups and cis to the C-11 methyl group.
Figure 2.12. Relative stereochemistry predicted from NOESY results for the crystalline
diastereomer of azaspirocyde (130).
As the diastereomer under investigation was crystalline and the crystals obtained were of
excellent quality it seemed obvious that an attempt should be made to obtain a crystal structure,
especially since the compound was novel and interesting from a stereochemical point of view.
The X-ray structure would confirm whether our prediction ofthe relative stereochemistry based
on the NOESY data was correct. The crystal structure was indeed obtained and is shown in
Figure 2.13.
Figure 2.13. X-ray crystal structure of spirocyde (130).
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From the X-ray crystal structure it was found that the crystal system was triclinic and the space
group Pi' The total number of molecules per unit cell (Z) was four, with two molecules per
asymmetric unit. The two molecules in the asymmetric unit showed no fundamental differences
from one another and so only one molecule from the asymmetric unit of the crystal structure is
shown in Figure 2.13. Further crystal structure data for the spirocycle (130) is shown in
Appendix A. The X-ray crystal structure confirmed that the relative stereochemistry for the
crystalline diastereomer ofazaspirocycle (130) was indeed 5s", 6s", 7s", 9s" as was predicted in
Figure 2.12 from the NOESY results.
Figure 2.14. shows the lattice packing diagram for the crystal structure. As can be seen the
molecules are close packed and arranged in an orderly fashion. Bond distances of atoms in
adjacent molecules were measured in order to assess whether any intermolecular interactions
were taking place, but this was not found to be the case.
Figure 2.14. Crystal packing diagram for spirocycle (130) as viewed down the a-axis.
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With one ofthe diastereomers ofthe spirocycle (130) successfully isolated and characterised the
focus was turned to the other remaining diastereomers. As was mentioned earlier, it was
observed that other crystals had fonned in the fractions obtained after the chromatography and
as these were covered in a red oil so an attempt was made to purify them by recrystallisation.
However, it was found that on evaporation ofthe recrystallisation solvent nothing but the red oil
remained and no crystals had fonned. At the same time it was noted that the crystals from which
the X-ray structure had been obtained were also fonning a red oil-like substance on the surface
ofthe solid. It was realised that the spirocycle is obviously not as stable as was initially assumed
after the fonnation ofthe large, colourless crystals. An NMR was run on some ofthe red oil-like
substance, and though it appeared as though a small amount of the spirocycle (130) remained,
at least one decomposition product, if not more, had indeed fonned. Unfortunately because the
compound decomposed before the diastereomers were properly separated their individual yields
could not be detennined. The diastereomer which crystallised out was at least 12 % ofthe total
diastereomeric mixture, though there was in all likelihood more of this diastereomer mixed in
fractions with other diastereomers. Because of time constraints and the fact that no more work
could be carried out on the spirocycle (130) diastereomers due to the decomposition of these
products, the investigation into the Noyori annulation reaction to fonn the cephalotaxine
spirocycle was concluded. The aim to synthesise the cephalotaxine spirocyle had been
successfully achieved in a reasonably efficient manner with a novel compound being synthesised,
one of its diastereomers fully characterised, and its crystal structure obtained. This work could
without doubt be continued as it shows much potential, but it was not possible to exploit the
possibilities in the framework ofthis masters project. The future ofthis work has been discussed
in Section 2.3.
2.2. PROGRESS TOWARDS THE CEPHALOTAXINE PENTACYCLIC SKELETON
Unfortunately the Noyori annulation studies carried out were not applied to the synthesis of the
cephalotaxine pentacyclic skeleton due to time constraints. However, preliminary work on the
cephalotaxine structure was carried out and was in its own right successful. The initial steps of
the proposed route to the cephalotaxine skeleton outlined in Chapter 1 that were successfully
carried out are now described.
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2.2.1 Synthesis of 2-(I,3-Benzodioxol-5-yl)-I-ethanol (60)
Using the method of Semmelhack et al. ,29,30 the alcohol (60) was synthesised from the
commercially available 3,4-methylenedioxyphenylacetic acid (9) (Scheme 2.17) using LiAIH4
as a reductant. The only modification ofthe literature procedure was the use ofTHF as a solvent
in place of diethyl ether. The reaction proceeded in a yield of 96 % with no purification being









2.2.2. Synthesis of 2-(6-Iodo-l,3-benzodioxol-5-yl)-1-ethanol (97)
The procedure of Semmelhack et aI., 29,30 with some modifications taken from the procedure of
Tietze et al. ,76 was used to iodinate the alcohol (60) to form 2-(6-iodo-l ,3-benzodioxol-5-yl)-I-
ethanol (97) (Scheme 2.18). This was carried out using molecular iodine and silver
trifluoroacetate. As iodine is the least reactive ofthe halogens in aromatic substitution reactions
silver trifluoroacetate is used to generate iodine trifluoroacetate. This causes the electrophilic
nature of the iodine to be enhanced and improves its reactivity in the electrophilic aromatic
substitution reaction.77 According to the method followed the product can be purified by
crystallisation, but it was found to be quicker to purify the reaction mixture by radial
chromotography rather than wait for crystals to grow, and then use the resulting pure oil of the
iodinated product (97) in the next reaction. The product was obtained in a 52 % yield, which
compared favourably with Semmelhack's 55 % yield.29•30 Tietze however reports a yield of97
%,76 and though the procedure was repeated numerous times, the 52 % yield could not be
improved upon. The iodination is extremely regioselective with the electrophilic substitution only
taking place at C-6 (Scheme 2.18). This is evident from the IH NMR spectrum which only
shows two singlets in the aromatic region corresponding to the C-4 and C-7 protons. Only on









2.2.3. Synthesis of2-(6-Iodo-l,3-benzodioxol-S-yl)ethyI4-methylbenzenesuIfonate (98) and
2-(6-Iodo-l,3-benzodioxol-S-yl)ethyl 4-nitrobenzenesulfonate (lSa)
With the A and B cephalotaxine rings intact it was our intention to add the D ring in the form of
2-pyrrolidinone. However, as in the work of Semmelhack et al. ,29,30 a better leaving group first
needed to replace the alcohol functionality to faciliate the addition of 2-pyrrolidinone.
Semmelhack et al. ,29,30 synthesised 2-(6-iodo-1 ,3-benzodioxol-5-yl)ethyI4-nitrobenzenesulfonate
(lSa) from the iodo alcohol (97) with the 4-nitrobenzenesulfonate, or nosylate, moiety acting as
a good leaving group. As was mentioned in the project aims the reagent required for this reaction
was 4-nitrobenzenesulfonyl chloride (4-NsCI) which we did not have available at the time and
thus it was decided that the 4-methylbenzenesulfonate, or tosylate, analogue would be
synthesised. Thus using the procedure of Semmelhack et al. the iodo alcohol (97) was reacted
withp-toluenesulfonyl chloride (p-TsCI) in the presence of freshly distilled pyridine to give the










Initial yields were extremely poor but were improved upon, however only to the extent that a
39 % yield was the highest obtained. It was found that the yield was reduced significantly if
undistilled pyridine was used. On being left to stand, the oil obtained after purification
crystallised out to give colourless, X-ray quality crystals. After a search of the Cambridge
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Crystallographic Database showed no crystal structure existed for this compound, further
database searches (Beilstein and Science Citation Index) were carried out and it was found that
the tosylate (98) was in fact novel. The X-ray structure ofthe tosylate was subsequently obtained
and was found to be confonnationally complex and warranted further study. The confonnational
analysis of the tosylate (98) which was carried out has been fully detailed in Chapter 3 of this
dissertation. The IH and l3C NMR spectra for the tosylate (98) are shown in Figures 2.15 and
2.16 respectively. The spectra are very similar to those collected for the iodo alcohol (97) except
for the loss of the hydroxyl proton in the I H NMR spectrum and the appearance in both the
proton and carbon NMR spectra of the peaks due to the tosylate functionality. In the lH NMR
spectrum (Figure 2.15) the new signals due to the tosylate are the methyl group at 2.44 ppm and
the tosyl ring protons which appear as doublets in the aromatic region. The H-3 and H-5 protons
nearest the methyl group give rise to the doublet at 7.29 ppm while the H-2 and H-6 protons
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Figure 2.15. IH NMR spectrum oftosylate (98).
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In the l3C NMR spectrum the tosylate methyl carbon is found at 21.61 ppm, the C-2 and C-6
methine carbons at 127.87 ppm and the C-3 and C-5 methine carbons at 129.74 ppm. Finally the
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Figure 2.16. l3C NMR spectrum oftosylate (98).
In order to conftrm a hypothesis made during the conformational analysis study it was necessary
to synthesise the nosylate (15a) ofSemmelhack et al. 29.30 The intention was to obtain the crystal
structure of this compound which is not present in the Cambridge Crystallographic Database,
though the compound itself is not novel. Thus the required reagent, 4-nitrobenzenesulfonyl
chloride, was purchased and the synthesis of the nosylate (15a) carried out using the method of
Tietze.76 This method differed from the tosylate synthesis as triethylamine and DMAP were used
in the place ofpyridine (Scheme 2.20). The synthesis was also notably quicker taking only four
hours as opposed to two days. The nosylate (15a) was successfully synthesised but unfortunately
the yield obtained was very low being only 25 %. This was attributed to the 4-
nitrobenzenesulfonyl chloride which was used. This particular reagent was 90 % technical grade
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and it was found to be extremely difficult to remove the impurities resulting from the starting
material which resulted in a reduction of the yield. Despite this the nosylate (lSa) was










2.2.4. Synthesis of 1-[2-(6-Iodo-l,3-benzodioxol-S-yl)ethyl]-2-pyrrolidinone (99)
With the nosylate (lSa) synthesised it was used in the next reaction of the proposed synthetic
sequence to add on the cephalotaxine D ring (Scheme 2.21). Though the original intention had
been to use the method of Semmelhack et al.,29,30 the method ofNagasaka et al.40 was preferred
as it specifically involved the addition of a lactam as in our work. Thus the nosylate (lSa) was
reacted with 2-pyrrolidinone (18) in the presence ofNaH to form the tertiary lactam (99). The
product was synthesised in a 47 % yield and was characterised by GC-MS, IR, and NMR
spectroscopy. This compound is novel and crystalline and an attempt was made to grow X-ray
quality crystals to complete the characterisation. Unfortunately, crystals of sufficient quality
were never obtained.




The IH NMR spectrum of the tertiary lactam (99) is shown below in Figure 2.17 and was
assigned with the aid of the DEPT, COSY, and GHSQC, spectra and also by comparison with
the other benzodioxol.and 2-pyrrolidinone derivatives that were synthesised during the course
of the project. The multiplet centred around 1.94 ppm is due to the C-4 protons, which are
coupled to the two CH2 groups on either side. Four triplets are seen moving further downfield
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at 2.32,2.82,3.30, and 3.37 ppm which correspond to the C-3, C-2", C-5, and C-l" methylene
groups respectively. The methylenedioxy protons resonate as a singlet at 5.89 ppm and finally































Figure 2.17. IH NMR spectrum of tertiary lactam (99).
The l3C NMR spectrum of tertiary lactam (99) is shown in Figure 2.18. All the methylene
carbons resonate between 15 and 50 ppm bar the methylene dioxy methylene group which
appears further downfield at 101.51 ppm due to the deshielding effect ofthe oxygen atoms which
flank it. The aromatic methine carbon atoms, C-7' and C-4', appear at 109.51 and 118.42 ppm
respectively. Finally the quaternary carbons are all seen above 130 ppm except for the C-6'
carbon which appears quite far upfield for a quaternary carbon at 87.48 ppm. This is, however,
characteristic for a sp2-hybridised carbon atom attached to an iodine atom. The quintet which
appears at 49 ppm is due to a small amount of CD30D which was added to the CDC13 solution
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Figure 2.18. l3C NMR spectrum of tertiary lactam (99).
Due to time constraints, no further work was carried out on the proposed route towards the
cephalotaxine pentacyclic structure. Thus unfortunately the work carried out on the spirocycle
synthesis using the Noyon annulation reaction could not be applied with the rest of the
cephalotaxine structure intact. However this has left much interesting work to be carried out in
the future which is discussed further in Section 2.3.
2.3. CONCLUSIONS AND FUTURE WORK
The first aim ofthe project, to use the Noyon annulation reaction to synthesise the cephalotaxine
spirocycle, was successful. Much was learnt during this process about the reactants and
ultimately the result was pleasing, a novel compound being produced, spirocycle (130), and a
crystal structure obtained to conclusively prove the success of the reaction. The reaction itself
which formed the spirocycle (130) was challenging with four stereogenic centres being created
in one step. There is much potential to exploit this reaction and there are still a number of
aspects of the reaction which deserve to be investigated. As a start the reaction conditions for
the spirocycle formation need to be altered to optimise the yield of the reaction. In Noyon's
annulation reactions involving enamines not all of the reactions were carried out under the same
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conditions but varied slightly.54 Conditions which were altered were temperature, length of
reaction, and use of irradiation, in a number of cases no irradiation was used at all. Change of
solvent from benzene was found to hinder the progress of the reaction. By altering our reaction
conditions the overall diastereomeric yield should be increased from the current mediocre 24 %
to yields comparable with those ofNoyori's in the 60 to 100 % range.
A second aspect of the reaction which reqUlres further investigation is the relative
stereochemistry ofthe other diastereomers. In our work only one diastereomer was successfully
isolated and characterised though from NMR analysis at least another four diastereomers had
been formed in the reaction. In future studies these need to be isolated and characterised fully
and for this to be achieved the decomposition of the compound needs to be addressed. Care
should being taken with the techniques used for separation and the products should be stored
preferably in solution, or if isolated, under nitrogen and at low temperatures.
In terms of exploiting this reaction further there are a number of interesting possibilities to be
pursued. By altering the various substituents on the enamine and a,a'-dibromo ketone reactants
it will be interesting to see what functional groups can be tolerated by the reaction and whether
the yield of the reaction can be improved. Substituents on the enamine used in the reaction to
form the azaspirocycle (130) that could be altered are the nitrile group and benzyl moiety. The
pyrrolidine ring ofthe enamine could even be replaced with a six membered piperidine ring. The
methyl groups ofthe a,a'-dibromo ketone could also be easily replaced with other functionalities.
Scheme 2.22 shows some possible functional groups which could be used in the Noyori
annulation to assess the generality ofthis reaction and to investigate the relative stereochemistry




RI = COzR, COR or NOz
Rz = alkyl or aryl
n = 1 or 2
Scheme 2.22.
R3, R4 = H, alkyl or aryl
R3 and R4 not both H
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The suggested functional group studies should not only create an interesting range ofcompounds
but also provide an insight into how this type of reaction could be used in the synthesis of
compounds other than cephalotaxine which contain azaspirocyclic systems. As noted by other
workers,78 there is a need for general methods which prepare suitably functionalised
azaspirocyclic systems, as often these systems are the structural core of various alkaloids which
are of synthetic and biological interest.
The second aim of the project, to pursue a novel route to the basic pentacyclic cephalotaxine
structure based on the spirocycle synthesis, was not fully achieved though the initial stages ofthe
synthetic route that had been proposed in the introduction were carried out. These initial
reactions that were completed were successful, with two novel compounds, the tosylate (98) and
tertiary lactarn (99), being synthesised and fully characterised during the work. The crystal
structure of the tosylate (98) also provided the basis for the conformational analysis study
described in Chapter 3. For future studies, the proposed synthetic route to the basic pentacyclic
cephalotaxine structure should be altered based on what was learnt during the work carried out



















Scheme 2.23. (i) PzSs,N~C03; (ii) (a) BrCHzCN, (b) Ph3P, Et3N; (iii) Fez(CO)9; (iv) potassium
t-butoxide, NH3, hv.
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Thus, as shown in Scheme 2.23, from the tertiary lactam (99) the corresponding thiolactam (131)
should be formed and then an Eschenmoser coupling reaction with bromoacetonitrile carried out
on this product to form the vinylogous cyanamide (132). Based on our observations this
vinylogous cyanamide (132) should be stable and will undergo the annulation reaction to form
the azaspirocycle thereby forming the tetracyclic compound (133). The suggested final step to
form the cephalotaxine pentacyclic structure is the same as in the initial proposed route in
Chapter 1 (Scheme 1.17).
Besides the above proposed route to the cephalotaxine pentacyclic structure, a second route can
also be suggested that can utilise the Noyori annulation reaction investigated during our work.
In the work ofAuerbach and Weinreb,27,28 the enamine intermediate (10) was synthesised in five
steps from 3,4-methylenedioxyphenylacetic acid (9) (Scheme 2.24). It is possible that this
enamine (10) could be subjected to the Noyori annulation reaction with an appropriate a,a'-
dibromo ketone (101) to form the pentacyclic skeleton (135). This would be an extremely
expeditious access to the basic pentacyclic cephalotaxine structure with only six steps required,









In conclusion, the work carried out during this project has achieved much ofwhat was originally
intended and has resulted in the synthesis of a number of novel compounds and in addition the
methodology which was investigated can now be exploited further. Firstly, it should be possible
to synthesise a range of azaspirocycles based on the studies carried out thus far and secondly,






When an X-ray quality crystal of the tosylate (98) was grown, it was already known that the
compound was novel, thus it was obvious that no crystal structure previously existed. Since no
other similar systems were documented in the Cambridge Crystallographic database it was
decided that it would be interesting to attempt to obtain a X-ray crystal structure. This was
carried out knowing that in general the crystal structures of small organic molecules are
straightforward and unsurprising, even though it would be pleasing to obtain a definitive
characterisation of the compound. When the X-ray structure was completed it was found that
in fact it was not simple or straightforward at all, with multiple conformations of the tosylate
molecule being present in the solid state. The excellent opportunity to analyse fully this
surprisingly complex conformational system could not be ignored and thus this chapter on





Conformational analysis is a powerful tool which elegantly combines experimental techniques
such as NMR spectroscopy and X-ray crystallography with a variety ofcomputational methods.
The actual conformations a molecule may take, the energetics of the conformations, and the
implications of their shape and form can be analysed and assessed using the various methods.
As conformational analysis research has grown dramatically in recent years a full literature
review would only find place in a dissertation purely dedicated to this field of work. However,
it is useful to gain some background knowledge by briefly looking at the general uses of
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conformational analysis and the tools employed in carrying out the actual analysis, before
discussing the conformational analysis which was carried out during our work.
The tools ofconformational analysis vary widely. The most obvious is X-ray crystallography in
which a molecule's conformation may be clearly observed in the solid state with little ambiguity.
Whether this conformation is still present in solution or is merely an artefact of crystal packing
may vary from system to system, though undoubtably an X-ray structure is a good starting point
for any conformational analysis study. The conformations of a molecule that are present in
solution is of great interest as this is more relevant in biological systems and for synthetic
reactions which are carried out in solution. The most popular technique used for solution
analysis is NMR spectroscopy, particularly variable temperature IH NMR spectroscopy. When
two conformations are present in solution and are in the slow exchange limit, two sets of IH
NMR signals are seen (if the temperature is feasible for attainment in an NMR spectroscopy
experiment). As the temperature is raised and the fast exchange limit is reached the signals
coalesce until finally only a single set of sharp peaks is seen. Even if two distinct sets of signals
cannot be observed because the slow exchange limit occurs at too low a temperature, some line
broadening is often seen when more than one conformation is present in solution. The line shapes
of the peaks in spectra such as these allow much kinetic information to be gained from the
results. This includes the rate constants for the interconversion between conformations, the
Arrhenius activation energy, Ea, and also the enthalpy and entropy ofactivation which naturally
lead to the free energy of activation being determined as wel1.79 This type of dynamic NMR
spectroscopy is extremely well documented and is a commonly used technique. The Nuclear
Overhauser Effect (NOE) is also vital in trying to identify a particular conformation and again
is a popular tool in conformational analysis. NOE is a through-space phenomenon and so is
ideally suited for analysis ofhow atoms are arranged in space.80 In conformational analysis, NOE
finds its best use in determining basic conformations of large molecules. It can be used for
analysis of smaller molecules but the ability of NOE to help conclusively assign a local
conformation is often limited. 80 NOE is more useful if only one conformation is present in
solution but has varied success when multiple conformations are present. If two conformations
are present in solution but are in the slow exchange limit and so cause two sets of IH NMR
signals, then NOE can assist in distinguishing between the conformations and identifying the
more dominant conformation. However, if conformations are in the fast exchange limit a
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restricted amount of information can be gathered from the NOE data in general. It is for these
reasons NOE is generally better for assessing the overall conformation of a macromolecule as
in solution these larger molecules tend not to have bulk conformation changes, only local ones.80
l3C NMR spectroscopy can also be used for conformational analysis though it is not as widely
used because often most aims can be achieved by using lH NMR spectroscopy and NOE
experiments alone. Low temperature carbon NMR spectroscopy, however, has found use and
it has been shown that variable temperature l3C NMR spectroscopy can be used for calculating
energy differences ofconformations. Surprisingly only two papers have been published on this
particular topic, one by Schneider and Freitag81 and the other more recently by Abraham and
Ribeiro.82 The limited research on this topic is possibly due to the general assumption that a IH
NMR spectrum is more easily obtained and provides all the necessary information in a one
dimensional conformational NMR spectroscopy study. However, as Schneider and Freitag point
out, carbon shifts can in some cases be determined more accurately than proton shifts when the
proton spectrum is very complicated, for instance when many aliphatic signals are present.
Though NMR spectroscopy is the most commonly used experimental tool in conformational
analysis, others methods have also found use. UV-visible spectroscopy, IR spectroscopy and
circular dichroism are all implemented periodically in conformational analysis. Raman
spectroscopy and the Kerr effect can also be used. Timosheva and co-workers even demonstrated
how the Cotton Mouton effect could be implemented in the conformational analysis of
pyridiniurnmethanes and their derivatives.83 Here NMR spectroscopy had not been able to
conclusively provide conformations for these types of molecules and the Cotton Mouton effect
was used to further investigate the systems.
Computational methods have now become increasingly important in conformational analysis.
For example, Monte Carlo conformational searches are used to try and identify possible low
energy conformations. Molecular mechanics (MM), molecular dynamics (MD), and quantum
mechanics are all used to varying degrees to calculate geometry optimized conformations,
energies and used in the general analysis of a conformationally interesting system. There are
currently numerous commercial software packages available to carry out calculations for
conformation analysis studies. In our work we have mainly used the HyperChem® Pro 6
program.
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Conformational analysis finds use in a variety of fields, with a large area of interest being
molecules with biological activity. These studies are used to assess the importance of a
molecule's conformation in a biological system as the shape ofa molecule is a leading factor in
how well it will interact with a receptor site. As a result, conformational analysis is routinely
employed in drug design. Conformational analysis on biological systems also extends to the
investigation of amino acids, proteins and peptides so as to provide further insight into their
behaviour. Obviously computational techniques are some of the more important tools in the
analysis ofbiological molecules and potentially biologically active compounds. Drug companies
use computational methods in attempts to find molecules with conformations which will not
hinder but rather assist in the binding of the molecule to a targeted receptor site, so the
conformational analysis is done even before a drug is made to try to predict its efficacy. With
anti-AIDS agents being one of the largest current research topics in the drug development
industry it is interesting that conformational analysis is being used in this research to assess the
effect of conformation on a drug's efficacy. In a recent study on disubstituted 3',4'-di-O-(S)-
camphanoyl-(+)-cis-khellactone analogues, which show varying degrees of anti-HIV activity,
computational methods, X-ray crystallography and UV-vis spectroscopy were used to carry out
a conformational analysis on these compounds.84 The results were able to identify the possible
reasons for some of the analogues being potent while others had no efficacy at all. This kind of
information gained from conformational studies will obviously assist in the design ofother anti-
HIV drugs. Studies other than those concerned with biological molecules are carried out for
various purposes. Often it is just to add to the body of knowledge in understanding how
conformationally flexible molecules behave, at other times it is to elucidate the behaviour of a
particular molecule in a reaction so that a reaction mechanism may be proposed.
In our work we have tried to combine several of the techniques mentioned above to carry out a
thorough conformational analysis ofthe tosylate system (98). As has been mentioned previously,
it was the unique X-ray structure ofthe tosylate which initiated this conformational analysis study









Figure 3.1. The four conformations of the tosylate (98) found in the X-ray structure.
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3.2. X-RAY STRUCTURE OF TOSYLATE (98)
The structure oftosylate (98) was solved in the triclinic space group PI and the dimensions ofthe
unit cell were found to be a = 7.816(2) A, b = 9.8178(18) A, c = 23.165 A, a = 82.667(14t, ~
= 85.473(19t, y = 73.273(19t (V = 1686.7(6) AJ). Further crystal structure data for the
tosylate is contained in Appendix B. The most interesting feature of the crystal structure is that
there are four independent molecules in the asymmetric unit, each molecule having a unique
conformation. The four conformations have been labeled molecules A to D and are shown in
Figure 3.1. Though superficially is may appear that molecules A and B are the same and
molecules C and D are the same, this is not the case. The similarity of molecules A and B is that
they have both assumed a conformation in which the two phenyl ring systems are essentially
coplanar and arranged in a step-like fashion.
Table 3.1. Selected values extracted from the tosylate crystal structure.
Molecule Dihedral angle Mean absolute Atom in fused bicycle
between ring planes deviation from moiety with the largest
C) planarity of the fused displacement
bicycle moiety (A) [displacement (A)]
A 6.7 0.04 0(1) [0.09]
B 10.3 0.04 C(7) [0.09]
C 14.6 0.03 0(1) [0.08]
D 15.5 0.02 C(2) [0.06]
Table 3.1 shows values for various features ofmolecules A to D: the dihedral angle between the
two ring planes, the mean absolute deviation from planarity of the fused 1,3-benzodioxole ring
system, and finally the atom in the fused ring moiety with the largest displacement. From Table
3.1 we see that the values for molecules A and B differ slightly but the most important difference
between the two molecules can be discovered on closer inspection of the two conformations.
Specifically, they are near mirror images with rotations having taken place in the chain linking
the ring systems. For molecule A the torsion angle C(1 0)-S(1)-0(3)-C(9) has the value 68.0 0 ,
S(1 )-0(3)-C(9)-C(8) is - 170.5 0 , and 0(3)-C(9)-C(8)-C(6) is - 65.1 0, while in molecule B the
same three torsion angles have the values -75.2, 172.0, and 64.0 0 , respectively. As can be seen
the torsion angles are essentially reversed moving from molecule A to molecule B. The same
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"mirror image" phenomenon also applies for molecules C and D though their "shape" is
distinctly different from molecules A and B with C and D adopting a hairpin conformation. The
torsion angles C(1O)-S(1)-0(3)-C(9), S(1)-0(3)-C(9)-C(8), and 0(3)-C(9)-C(8)-C(6) are - 62.1 ,
146.8, and -68.2 0 for molecule C and 68.4, -148.0, and 68.1 0 for molecule D, respectively.
More interestingly, the distance between the phenyl rings in both molecules C and D is
sufficiently small to suggest that intramolecular 1t-stacking is taking place. In both molecules the
mean interatomic spacing between the atoms of the two phenyl rings is 3.60(17) 'A which is
within the limits for a possible 1t-donor/1t-acceptor interaction.
The packing of the molecules in the crystal lattice is elegant (Figure 3.2) with a basic four row
pattern being evident. Row one consists of stepped molecules A, row two consists of hairpin
molecules D with row three containing hairpin molecules C. The hairpin shape of the row two
D molecules faces in the opposite direction from that of the row three C molecules. The final
row contains stepped molecules B. An important feature of the lattice is the intermolecular 1t-
stacking present in the rows of stepped molecules A and B. The 1t-stacking interactions take
place between the 1,3-benzodioxole ring of one molecule with the tosyl ring of its neighbour.
For the row comprising molecules A, the average interactomic distance of the interaction is
3.73(5) 'A, which is within 1t-stacking limits.
The presence of four distinct conformations in a crystal structure is of course an unusual
phenomenon, so as a result of the revelations of the tosylate crystal structure it was felt further
investigation ofthe system was required. This was to involve various computational techniques
such as MM which would be used to carry out geometry optimisations and dihedral angle
searches of conformational space to investigate the energetics of the system, for instance to see
ifthe solid state conformations ofthe tosylate are true minima on the potential energy surface of
the molecule. The possible significance of the inter- and intramolecular 1t-stacking was also an
area to be investigated using extended Huckel calculations. Ifused correctly MM is an especially
powerful tool in computational chemistry and some introduction to this method has been given.
Finally as was mentioned earlier, NMR spectroscopy is also an excellent tool for solution
conformational analysis so it was hoped that more than one tosylate conformation would be
identified using IH NMR spectroscopy so as to provide further understanding of the
conformationally flexible system in solution.
75
Figure 3.2. Unit cell crystal packing diagram for the tosylate (98).
3.3. INTRODUCTION TO MM CALCULATIONS
MM is one of the more commonly used methods in computational chemistry. It is generally fast
and when correctly used can give results which agree very well with experiment. MM uses
classical mechanics (as opposed to quantum mechanics) to calculate the potential energy surface
ofa molecule. Because MM does not treat electrons explicitly it is not used in the computational
modeling of situations where electron participation is important, e.g. bond breaking and bond
formation. MM is also known as force field methods85 because so called "force fields" are used
to describe how a collection of atoms that make up a molecule behave in relation to each other.
A number ofdifferent force fields have been developed to cope with different types ofmolecules.
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In general a force field designed for small molecules cannot be used for calculations on proteins
for instance, and vice versa. When dealing with force fields there are three important aspects to
consider: atom types, functional form and parameter sets. In a force field method each atom in
a molecule is classed as an atom type according to its type of bonding and possibly the atoms it
is bonded to as MM works on the basis that all similar structural units will behave in the same
fashion. For example, in the AMBER force field parameter set86 there are four defined oxygen
atom types: (i) 0, carbonyl oxygens; (ii) 02, carboxyl and phosphate nonbonded oxygens; (iii)
OS, ether and ester oxygens; and (iv) OH, alcohol oxygens. Each atom type has a set of
parameters associated with it which are the values used in the equations which calculate the
potential energy surface of a molecule.
The software package which we used to carry out our computational studies, Hyperchem® Pro
6, has four different force fields available for use. These are AMBER, OPLS, BIO+ and MM+.
AMBER stands for Assisted Model Building and Energy Refinement. It is primarily for
calculations on proteins and nucleic acids and was initially a united atom force field. 86 United
atom force fields include all atoms explicitly except for hydrogens bonded to carbon, whereas
an all atom force field even includes carbon bonded hydrogens explicitly. United atom force
fields are used to try to improve computational efficiency and its advantage can be seen for large
molecules like proteins. An all atom version ofAMBER has also been developed.87 The united
atom version of AMBER only has a limited number of atom types with an additional 5 being
defined in the all atom version.86, 87 As a result, ifcalculations are carried out on molecules other
than proteins or nucleic acids using AMBER it is possible that the force field parameters required
for the calculations will not be available. OPLS (Optimized Potentials for Liquid Simulations)
is a force field which was initially developed for computer simulations ofproteins in their natural
environment, i. e. in solution or crystalline states.88 A lot of the AMBER force field was
incorporated into OPLS which is a united atom force field. 88 OPLS has also been extended to
include parameters for nuceotide bases.89 BIO+ is a Hyperchem® force field based on the
CHARMM (Chemistry at HARvard Macromolecular Mechanics) force field. 90,91 It is mainly for
large molecules such as proteins. Many parameters used in CHARMM are unpublished and only
available commercially.92 Finally MM+ is the Hyperchem® force field based on the MM2 force
field of Allinger.93 MM2 was primarily designed for use with a wide range of small organic
molecules, i.e. not on the macromolecular scale, though it was extended to include calculations
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on peptides.94 MM+ uses the MM2( 1991) parameter set provided by Allinge~2and has a method
which determines default parameters for calculations ifthe required values are not present in the
MM2(l991) parameter set. It is important to be aware of the possibility that MM+ may use
default parameters as these can cause spurious results. Even a brief glance at the descriptions of
the force fields available with Hyperchem® is enough to see that MM+ was the most appropriate
force field for calculations on the tosylate molecule under investigation. It is a small organic
molecule and is certainly not on the macromolecular scale.
After initial calculations on the tosylate using MM+ it was discovered that certain parameters for
the molecule were not available in the MM2(l991) parameter set, for instance the parameters
required to calculate Estretch values were not available for the aromatic carbon-iodine bond as well
as two other bonds. Moreover, a number of torsional parameters and angle bending parameters
were unavailable. Using the MM+ default parameters for calculations on the tosylate did not
provide satisfactory results and so it was essential to develop the relevant force field parameters
before continuing with the intended calculations. In order to have an understanding of the force
field parameters required, the manner in which MM+ calculates the potential surface of a
molecule will be described.92 This description should also hopefully clarify the earlier qualitative
description ofhow molecular mechanics calculations are carried out. It is important to emphasise
that the description below only applies for MM+ as each force field uses its own set offunctions
to calculate the potential energy surface ofa molecule, though there may be similarities between
force fields.
To calculate the potential energy ofa system the difference energies for various distortions ofthe
molecule are added together:
Erot = Eoond + Edipole + Eoond angle + Estretch-bend + Etorsion + EvdW
(1)
where ETot is the total energy
Ebond is the energy required to stretch a bond between two atoms
Edipole is the energy arising from dipole-dipole interactions
Ebond angle is the energy required to bend a bond angle
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E h b d is the energy due to the coupling between bond stretching and angle bendingstretc - en
E . is the energy required for rotation about a torsion angletOrsIon
EvdW is the energy of non-bonded van der Waals interactions
Bond stretching energy
For small displacements from equilibrium the compression and stretching ofa bond is assumed
to mimic an harmonic oscillator and so Ebond can be calculated from Hooke's law:
E bond = I Kr(r - ro)2
bonds
(2)
where K is the force constant
r is the distance between two atoms in a bond
ro is the equilibrium bond length
However, to more accurately describe the stretching behaviour of a bond higher terms may be
used or even a Morse function. In the case ofMM+ a cubic stretch term is used and includes a
switching function to account for situations where bond lengths are much longer than their ro
values:
" 1 2Ebond = 143.88 LJ -Kr(r- ro) [1+ switch(r- ro,-lj3CS,- 4/3CS)CS(r- ro)]
bonds2
(3)
CS is a constant set to an arbitrary value (default in MM+ is -2.0). Hyperchem® often uses
switching functions to allow for smooth transitions on the potential energy surface. These
functions work as follows:
switch(x,a,b) = 1 if x ~ a
switch(x,a,b) = aif X z b
switch(x,a,b) = [(b - x)2(b + 2x - 3a)]/(b - a)3 if a<x<b
The factor of 143.88 in the Ebond term is simply to account for the fact that MM+ uses units of
millidynes per Angstrom for its force constants (as does MM2) and in order for energies to be
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given in kcallmol the conversion factor is required. Conversion factors are also seen in other
calculations below.
From equation (3) we can see that ~ and roas a pair should be unique for each pair of atoms.
These values are the force field parameters, so for each pair of atom types present in the MM+
force field there is a Kr and ro value which are used in the calculation of Ebond for a particular
molecule. In fact in the MM+ parameter set two values, ro
A and roB, are given for each rofor an
atom pair. The parameter r/ is used for bonds where the two atoms each have less than two
hydrogens attached while roB is used when the two atoms have two or more directly attached
hydrogens.
Dipole interaction energy
To account for the electrostatic contribution to the potential energy MM+ defines a set of bond
dipole moments that are associated with polar bonds and the dipole interaction energy takes the
following form:
[
cosx - cosa i cosa j]
Edipole = 14.39418e I Il ill j 3
ij polar bonds Rij
(4)
where Ili and Ilj are the two dipoles
e is the dielectric constant
Xis the angle between the two dipole vectors
~j is the distance between the centres of the two dipoles
U j and uj are the angles the dipole vectors make with the ~j vector
Ili and Ilj are the force field parameters in this situation, with x., ~j' Ui and uj are found from the
geometry of the dipoles in the molecule under investigation. 14.39418 is a conversion factor.
Angle bending energy
As for the stretching of a bond, the bending of an angles formed by three consecutively joined
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atoms can be modeled with a harmonic function for small displacements of the angle from
equilibrium. However, this function, as for bond stretching, does not always hold for large
displacements and so MM+ includes a higher order term to give the energy for the bending of
an angle as follows:
" 1 2 4Ebondangle = 0.043828 1. "2 Ke(8 - 8 0 ) [1 + SF(8 - 8 0 ) ]
angles
(5)
where ~ is the force constant
e is the angle formed by the three consecutively joined atoms
eo is the equilibrium angle
SF is called a scale factor and again is set to an arbitrary value, the default in MM+ being 7.0 x
10-8• Again there is a conversion factor (0.043828) to convert millidyne-A per radian2 to kcal/mol
per degree2•
For the calculation of the angle bending energy, ~ and eo are the force field parameters though
in MM+ three eo values (e\ es, and eC) are stipulated in the parameter set for each bond angle.
Often only eA is assigned in the parameter set but ifes is defined it is used when the central atom
has one hydrogen attached, while eC is used when the central atom has two hydrogen atoms
attached.
Stretch-bend energy
To account for the coupling between bond stretching and angle bending a stretch-bend cross term
is incorporated in MM+. Three consecutively joined atoms are labeled i,j, and k, where k is the
central atom and the coupling energy is calculated as follows:




Here Ksb is a force field parameter with eo and ro already having been parameterized for the
calculation of Estretch and E bend. 2.51119 is again a conversion factor to give the energy in
kcallmol.
Torsion angle energy
Torsion angles are widely recognised to have a significant effect upon the energy of a molecule,
a classic example being butane, which changes energy with rotation about the C(2)-C(3) bond
as it moves from a cis to a gauche to a trans conformation. In MM+ the dihedral angle energy
or torsional interaction energy takes the form of a truncated Fourier series:
" VI V2 V3
Etorsion = L.J - (1 + cos¢) + - (1- cos2¢) + - (1 + cos 3¢)
torsions 2 2 2
(7)
where Vn is the dihedral force constant, n being the periodicity of the Fourier term
q> is the torsion angle
The phase angle is not explicitly included in the above equation as it is taken to be zero. VI' V2,
and V3 are the force field parameters and being in kcallmol no conversion factor is required for
the Etorsion calculation.
Vander Waals energy
The van der Waals energy results from the repulsive or attractive forces experienced by two non-
bonded atoms. Often the Lennard-Jones potential is used to calculate the van der Waals energy
though it is not always considered to model the repulsive forces precisely. As a result MM+ uses
an exponential term to describe the repulsive forces more accurately while using a IIR6 term for
the attractive forces (similar to the term found in the Lennard-Jones equation). Thus the van der
Waals energy is calculated using what is known as a "Buckingham" or "Hill" type potential:




where E.. = (EE)Y' E and E being hardness parameters for atoms i and j respectively whichIJ I J 'I J
detennine the attractive well depth
P..=D Ir· D .. being the non-bonded distance between atoms i andj and riJ • being the sumIJ .l'jJ IJ' .l'jJ
of the van der Waals radii of atoms i andj, i.e. rij • = rio + rj •
Equation 8 does not work very well at short interatomic distances so when rjj • is less that 3.311
A, the van der Waals energy is calculated as follows:
EvdW = 336.176 I EijP ij-2
ijEvdW
(9)
In general, hydrogen bonds must be treated in a special manner and so in MM+ any XH bond
lengths are reduced by 0.915 A for calculations ofvander Waals interactions with H atoms. CH
interactions are also assigned specific E and r· values.
3.4. DEVELOPMENT OF FORCE FIELD PARAMETERS AND GEOMETRY
OPTIMISATION
The first calculations to be carried out on molecules A-D were gas phase geometry optimizations.
These were executed with the MM+ force field on HyperChem® Pro 6 using the Polak-Ribiere
conjugate gradient algorithm with a root mean square gradient tennination cut-off of 0.005
kcal A,-l mol-1and a dielectric constant of 1.5 D. The atomic coordinates of the X-ray structure
for molecules A-D were used as the input. The results appeared to deviate more seriously than
expected from the experimental X-ray data and it was discovered after using a facility provided
by HyperChem® to log the progress of the calculation that certain parameters required for the
tosylate were unavailable in the MM+ force field and default parameters had been used instead.
As a result the relevant force field parameters for 3 bond lengths, 5 bond angles, and 9 torsional
angles had to be developed. For the missing bond lengths the parameters required were the
stretching force constant, K, the equilibrium bond length, ro, and the dipole IJ.. For the missing
bond angles the bending constant, ~, and equilibrium bond angle, SA (SB and SC can be
neglected) were required. Finally for the missing torsion angles the three dihedral force constants
VI' V2, and V3 had to be entered in the force field. Initial roand SA values were taken from the
crystal structure data by averaging the values of the relevant bond lengths and angles for the
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molecules A-D. :K values were calculated using a method suggested by Allinger et. al. 95 while
~, VI' V2, and V3were initially chosen by using existing MM+ parameters for atom sequences
that were acceptably similar to those required. These parameters were then used for the geometry
optimization that had been attempted originally and the differences between the newly calculated
structure and X-ray structure were noted. The parameters were then adjusted slightly, the
optimization performed again and the calculated and X-ray structures again compared to see if
an improvement had been made. The process was repeated several times until it was felt that
there was satisfactory agreement between the calculated geometry optimized structures and the
observed structures. The new force field parameters that were developed are shown in Tables
3.2,3.3, and 3.4. Once the force field parameters were satisfactory it was possible to continue
with the geometry optimizations.
Table 3.2. Bond stretching parameters developed.
K r (mdyn/A)
0
Atom Atom ro (A) Il
C(Sp2) I 2.620 2.090 1.400
O(Sp3) S(Sp3) 4.620 1.580 0.000
C(Sp2) S(Sp3) 3.260 1.750 0.000
Table 3.3. Angle bending parameters developed.
Atom Atom Atom Ke (mdynNrad2) OAr)
C(Sp3) O(Sp3) S(Sp3) 0.770 110.000
C(Sp2) C(Sp2) S(Sp3) 0.550 121.400
O(Sp3) S(Sp3) C(Sp2) 0.700 103.600
O(Sp3) S(Sp3) O(Sp2) 0.560 106.200
C(Sp2) S(Sp3) O(Sp2) 0.650 109.600
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Table 3.4. Torsional parameters developed.
Atom Atom Atom Atom VI (kcal/mol) V1 (kcal/mol) V3 (kcal/mol)
C(Sp3) C(Sp3) O(Sp3) S(Sp3) 0.400 0.520 0.467
H C(Sp3) O(Sp3) S(Sp3) 0.000 0.000 0.530
C(Sp3) O(Sp3) S(Sp3) C(Sp2) 0.000 0.000 0.403
C(Sp3) O(Sp3) S(Sp3) O(Sp2) 0.000 0.000 0.530
C(Sp2) C(Sp2) C(Sp2) S(Sp3) -0.270 9.000 0.000
C(Sp2) O(Sp3) C(Sp3) O(Sp3) 0.000 5.000 0.000
C(Sp2) C(Sp2) S(Sp3) O(Sp3) 0.000 0.000 0.000
C(Sp2) C(Sp2) S(Sp3) O(Sp2) 1.243 1.445 -1.243
H C(Sp2) C(Sp2) S(Sp3) 0.000 9.000 0.000
For each molecule A-D a gas phase geometry optimized structure was obtained as well as a
calculated structure where the relevant molecule was optimized in its lattice environment. Figure
3.3 shows a least squares fit of the calculated gas phase structures and the experimentally
observed structures for the four molecules as well as a fit for the lattice optimized structures and
the observed structures. It is clear when observing these overlayed structures qualitatively that
the agreement between the calculated and observed structures is very good. For each fit the root
mean square deviation is given, but it should be noted that the average root mean square
deviation improves from 0.36(1) Afor the gas phase structures to 0.26(4) Afor the lattice
structures. The fact that the agreement between the calculated structures and observed structures
improves with inclusion of the neighbouring interactions shows that these non-bonded
interactions do affect the crystallographically observed conformations that the molecule assumes.
From Figure 3.3 it is clearly seen that the improvement of the fits for the lattice optimized
structures is caused by the closer agreement in the relative orientation ofthe two aromatic rings.
Thus by including the neighbouring interactions in the lattice for the geometry optimisation
calculations the intermoleculear1t-1t interactions mentioned in the earlier discussion ofthe crystal
packing diagram (Figure 3.2) are coming into playas a result. Finally it is noteworthy that the
gas phase geometry optimised structures, being so close to the observed X-ray structures, indicate
that the conformations observed in the crystal lattice appear to be genuine minima on the










Figure 3.3. Least square fits of calculated gas phase optimized structures (thin lines) with
observed X-ray structures (thick lines) (a(i)-d(i)), and also the calculated lattice optimized
structures (thin lines) with observed X-ray structures (thick lines) (a(ii)-d(ii)). RMS fit errors are
shown.
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Table 3.5. Calculated energies of the gas phase and lattice optimised structures.
Molecule Energy of gas phase optimised Energy of lattice optimised





Table 3.5 shows the energies of the gas phase and lattice optimised structures as calculated by
HyperChem®. These values may not be taken to have any intrinsic physical meaning in
themselves as calculated energies will vary from force field to force field, but they may be
compared in relation to each other.92 The solid state structures are slightly higher in energy than
the gas phase structures indicating a slight increase in strain for the conformations in the lattice.
However this energy difference is small « 1 kcaVmol) which shows the adjustments to the
conformations caused by neighbouring interactions in the lattice are fairly minor. We see from
the table that the two stepped conformations, A and B, are of similar energies as are the two
hairpin conformations, C and D. However the hairpin conformations are noticeably lower in
energy being more stable by 3.7 kcallmol for the gas phase optimised structures and 3.2 kcallmol
for the lattice optimised structures. It is quite feasible that the stabilisation of the hairpin
conformations is caused by intramolecular 1t-stacking. The stepped and hairpin conformations
are seen in both the crystal structure and the gas phase optimised structures so it appears that they
are indeed minima on the potential energy surface ofthe molecule. As a result it was questioned
whether it would be possible to detect these conformations in solution by NMR spectroscopy.
3.5. IH NMR SPECTROSCOPIC STUDIES
If the free energy of activation between two conformations is of the order of 5-24 kcaVmol, it
is generally possible to identify the presence of the two conformations in solution using variable
temperature NMR spectroscopy.96 With the energy barrier in this range the conformations will
be in slow exchange on the NMR timescale and as long as at least one proton is in a different
magnetic environment in the two conformations it will be possible to see this in a IH NMR
spectrum. For the tosylate no problems should be encountered in seeing the difference between
the basic hairpin and stepped conformation forms should they be present in solution. It is
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obvious that in the hairpin conformation the folding over of the molecule could cause the
magnetic environments of the protons on the tosyl and benzodioxole rings to differ from their
environments in the stepped conformation. The change in the magnetic environments should
result in different shifts for particular peaks in the 1H NMR spectrum ofeach conformation. Also
the NOE correlations for the two conformations should be different, for instance, a correlation
might be seen between the protons on the two phenyl rings when the molecule is in the hairpin
conformation which would not be observed in the stepped form. Ifmore than one conformation
is present in solution, each placing the protons in different magnetic environments, either some
line broadening should be seen or even two sets of distinct signals. A standard set of NMR
spectra were obtained for the tosylate (98) in CDCI) at room temperature as part of its full
characterisation. In Chapter 2 the lH NMR spectrum and l3C NMR spectrum were shown in
Figures 2.15 and 2.16 respectively.
The IH NMR ofthe tosylate showed only a single set ofsharp peaks indicating that either (i) only
one conformation is present at this temperature in solution or (ii) that the different conformations
of the molecule are in the fast exchange limit at room temperature so that the average spectrum
is observed with characteristically sharp peaks. The latter option is obviously the most
reasonable as it is unlikely that this conformationally flexible molecule.will stay in one
conformation when surrounded by, and interacting with, solvent molecules. It was assumed that
on cooling the exchange between the conformations would be slower and a change in the
spectrum would be seen. However, lowering the temperature to -60°C (with CDCI) as the
solvent) and re-recording the lH NMR spectrum showed no significant change. The shift values
of the peaks were essentially identical to those found in the spectrum recorded at 24°C. This
result is consistent with the magnetic environments ofall the protons in the molecule being the
same at 24 °c and -60°C. Dissolving the tosylate in acetone-d6 and lowering the temperature
further to -95°C still caused no apparent change in the spectrum. Since the X-ray structure
showed that for molecules C and D the methylene carbon atom on the benzodioxole ring is
within 4.5 Aofthe nearest carbon atom on the tosyl ring, it should be possible to see a correlation
between the protons on the benzodioxole methylene group and those on the tosyl ring if the
tosylate in solution was in the hairpin conformation. AID NOESY experiment was carried out
at - 95°C in acetone-d6 with irradiation ofthe O-CH2-O protons but no enhancements were seen
from any of the tosyl ring protons. As a NOESY experiment can result in a positive or negative
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response, it is possible under the correct conditions for no response to be seen in a NOESY
spectrum even though there is a through space correlation between two protons. In order to
ensure this was not the case here a further ID ROESY experiment was carried out. This is a
spin-lock experiment very similar to the NOESY experiment but which only shows a positive
response, and so if there is indeed a through space correlation between two protons it will be
seen. Generally the ROESY experiment is more time consuming to carry out which is why a
NOESY experiment is usually used. The ID ROESY experiment, however, also failed to show
any correlations with the 0-CH2-O protons. These results show that the free energy ofactivation
for conversion between the conformations is <5 kcallmol and thus unobservable by NMR
spectroscopy. It is quite possible that multiple conformations, not just the X-ray hairpin and
stepped conformations, are constantly interconverting in solution and even at -95 °C they are
in the fast exchange limit and so we see a time averaged signal.
3.6. TORSION ANGLE ANALYSIS
The geometry optimisation results give an indication that both the hairpin and stepped
conformations were potential energy minima of the tosylate molecule. However, whether any
one of the conformations ofmolecules A-D was the global minimum for the tosylate was as yet
undetermined. To investigate the potential energy surface of the molecule further a dihedral
angle search ofconformational space was carried out using the three torsion angles found along
the chain linking the two phenyl rings. These torsion angles are defined as follows: '1'1 is the
C(1 O)-S(I )-O(3)-C(9) torsion angle, '1'2 is the S(I )-0(3)-C(9)-C(8) torsion angle, and '1'3 is the
0(3)-C(9)-C(8)-C(6) torsion angle. These three torsion angles were chosen as they are the angles
about which rotation is most likely to occur to convert from the stepped to hairpin conformations,
and possibly other conformations as well. The torsion angle analysis was carried out using a
standard dihedral angle driving algorithm which, starting from the X-ray structure, rotated a
chosen pair of torsion angles in 5° increments from 0° to 360 ° with geometry optimisation of
the conformation at each grid point. The three conformation energy plots generated show the
change in steric energy (~UT) as a function of the relevant torsion angles. Figure 3.4 shows the
surface and contour plots for the combinations oftorsion angles '1'1 and '1'2' Figure 3.5 shows the
plots for '1'2 and '1'3' and Figure 3.6 for '1'1 and '1'3' On each of these plots an energy minimum can
be identified and Table 3.6 gives these values for each graph. By averaging the value for each
torsion angle we are able to find the conformation which these calculations indicate is the global
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minimwn for the tosylate. These average values are 75°, 215°, and 60° for 'l'1' 'l'2' and 'l'3'
respectively, which are in excellent agreement with the torsion angles ofthe gas phase geometry
optimised structure of the hairpin molecule ('l'1 = 71 0, 'l'2 = 209°, 'l'3 = 60°).
Table 3.6. Coordinates of the lowest energy conformations from each torsion angle analysis.
Torsion angles 'lite) '112 (0) '113 (0)
analysed
'l'l and 'l'2 70 210 -
'l'2 and 'l'3 - 220 60





Figure 3.4. Surface and contour plots showing the change in total stene energy as a function of
















Figure 3.5. Surface and contour plots showing the change in total steric energy as a function of






Figure 3.6. Surface and contour plots showing the change in total steric energy as a function of
the torsion angles 'l'l and 'l'3 for the tosylate (98).
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From Figures 3.4 and 3.5 we see that the rotations about 'V2involve much larger energy changes
than the rotations about 'VI and 'V3 (Figure 3.6). It thus appears that rotations about 'VI and 'V3 are
inherently responsible for the conformational flexibility of the molecule. This is supported by
Figure 3.6 where the four molecules A-D seen in the crystal structure can be clearly identified
as energy minima on the conformational energy surface. An interesting feature of the plots in
Figure 3.6 is the presence of a centre of inversion at the coordinates 'VI = 180° and 'V3 = 180°.
The crystal structure of the tosylate showed that molecules A and B are mirror images, as are
molecules C and D, and this is clearly reflected by the contour plot in Figure 3.6 where these four
conformations have been identified. The plot indicates that rotations about 'V I and 'V3 are the
cause of the mirror imaging phenomenon of the stepped and hairpin conformations in the X-ray
structure. Conformation D (~UT = 0 kcal/mol) is the lowest energy conformation along with its
mirror image C. Conformation A (~UT = 3,7 kcal/mol) and its mirror image B are also energy
minima but lie higher in energy relative to other conformations found on the surface such as
conformation E (Figure 3.6). E has coordinates 'VI = 178°, 'V3= 5r and ~UT= 2.8 kcal/mol with
its mirror image denoted EO, E is found half-way along the 'VI pathway from A to D and as a
result has a half-opened hairpin shape which has been shown in Figure 3.7. Other low energy
conformations identified on the contour map ofFigure 3.6 are F ('VI = 62 0, 'V3= 179°, ~UT = 3.6
kcal/mol) and its mirror image FO which are also opened hairpin conformations; conformation
G is situated on the centre of symmetry ('VI = 180°, 'V3= 180°, ~UT = 3.6 kcal/mol). G is an
extended stepped conformation having a staggered geometry. Conformations F and G are also
shown in Figure 3.7. In total there are five unique energy minima on the contour map ofFigure
3.6 (A, D, E, F, G) four of which have mirror images (A mirrored by B, C by D, E by EO, F by
F"). With the hairpin conformation D being the potential energy global minimum ofthe tosylate
it is obvious why it, along with its mirror image C, should appear in the crystal structure of (98).
It is interesting then that conformations A and B, although not global minima, are also packed
in the crystal structure to further stabilise the system.
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Conformation E Conformation F
Conformation G
Figure 3.7. Diagram showing confonnations E, F, and G which are seen on the contour map
generated from the torsion angle analysis of '1'1 and '1'3'
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3.7. 7t-STACKING AND X-RAY STRUCTURE OF NOSYLATE (15a)
The presence of intramolecular 1t-stacking in the hairpin molecules C and D, and intennolecular
1t-stacking in rows of A and B molecules in the crystal lattice has already been mentioned in the
discussion of the X-ray structure. Looking at the tosylate molecule it is evident that the phenyl
ring of the benzodioxole group is comparitively more electron rich than the tosyl ring as the
fonner has the two oxygens ofthe methylenedioxy ring donating electron density. The tosyl ring
is more electron poor mainly because of the electron-withdrawing sulfonyl group. Thus it
appears the tosyl ring is the 1t-acceptor, the other phenyl ring being the 1t-donor. An extended
Huckel single point calculation was carried out with HyperChem to assess this postulate. The
Extended Huckel Theory (EHT) or Extended Huckel Method (EHM) is attributed mainly to
Hoffmann.97 It is a simple and fast semi-empirical quantum mechanics method which provides
the approximate shape and energy ordering of molecular orbitals. It uses a single set of
parameters which represent the binding energies of the electrons in each atomic orbital. These
are the energies for the attraction between the nucleus of an atom and an electron in an atomic
orbital ofthat atom. In the method only valence electrons are considered and ther is no explicit
treatment of electron-electron interactions, though some of their effects are included by
parameterisation. Drawbacks of the method are that since electron-electron interactions are
neglected atomic orbital binding energies are fixed and not dependent on charge density. Most
notably in HyperChem®, geometry optimisations and molecular dynamics calculations cannot be
carried out with the method.92 However, an advantage of the method is that it is often the only
computational model that can be used for large systems which contain transition metals. This
is because the theory only needs atomic ionisation potentials so it is easily parameterised to the
whole periodic table.85 The most important point to note about the EHM is that its strength lies
in providing qualitative infonnation concerning the shape and ordering ofmolecular orbitals and
it should not be used as a quantitative method. Thus from a single point calculation using the
EHM, the molecular orbitals for the tosylate were calculated and could be qualitatively assessed.
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Figure 3.8. Plot ofthe HOMO calculated for the tosylate molecule using a single point extended
Huckel calculation.
Figure 3.9. Plot ofthe LUMO calculated for the tosylate molecule using a single point extended
_ Huckel calculation.
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Figure 3.8 gives a plot of the highest occupied molecular orbital (HOMO) calculated for the
tosylate and Figure 3.9 shows a plot of the calculated lowest unoccupied molecular orbital
(LUMO). The HOMO is clearly centered on the phenyl ring fused to the methylenedioxy ring
making this ring the 1t-donor, while the LUMO is found on the tosyl ring (the 1t-acceptor). The
intramolecular 1t-stacking of the tosylate does not appear to be very strong because of the
presence of the stepped molecules in the X-ray structure. If the intramolecular 1t-stacking were
stronger it would stabilise the molecule to such an extent that the hairpin conformation would
presumably be the exclusive conformation both in the solid state and in solution. As the
formation of the tosylate was not synthetically complex it was decided it would be relatively
simple to make an analogue of the tosylate such that the intramolecular 1t-stacking of the
analogue would be strengthened to see if the hairpin conformation could be exclusively
crystallised out. This would involve making the tosyl ring even more electron deficient or the
other phenyl ring more electron rich. From a synthetic point ofview making the tosyl ring more
electron deficient is the simplest option as there are a number of para-substituted sulfonyl
chloride derivatives commercially available which can be used for the synthesis, so the methyl
group on the tosyl ring could be easily substituted by a highly electron withdrawing substituent.
The substituent chosen was a nitro group, which is highly electron withdrawing and would
presumably, in conjunction with the sulfonyl group, make the phenyl ring to which it is bonded




Though no X-ray crystal structure of the nosylate (15a) has been published it is a known
compound and was synthesised with little difficulty following the method ofSemmelhack et al. 29,
30 After a bulk crystallisation from CCI4, X-ray quality crystals were grown by slow evaporation
from THF. The X-ray crystal structure was obtained under the same conditions as the tosylate
and is shown in Figure 3.10. Crystal structure data for the nosylate (15a) is contained in
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Appendix C. It is pleasing to see that our intention to "tune" the molecule and force it into the
hairpin conformation exclusively was successful. Only a single hairpin conformation is present
with no mirror image being evident. The space group of the molecule is PI'
Figure 3.10. X-ray crystal structure diagram for the nosylate (15a).
3.8. CONCLUSION
The discovery from its X-ray structure that the apparently simple tosylate molecule is
conformationally complex has led to an exciting conformational analysis study that has combined
experimental and computational techniques to answer various questions about the system. The
findings showed that of the conformations found in the tosylate (98) crystal structure, the two
hairpin molecules, C and D, were in fact the global minima with their energies appearing to be
stabilised by intermolecular x-stacking. This x-stacking effect was proved by synthesis of the
nosylate (15a) and the aquisition of its X-ray structure. Changing the methyl group of the
tosylate (98) for the electron withdrawing N02 group had increased the x-stacking effect as
anticipated and the X-ray structure indicated that the nosylate had crystallised out exclusively
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into the hairpin confonnation. The nosylate was a suitable conclusion to the study as it showed
how infonnation gained from a confonnational analysis could be used to "tune" a molecule's
confonnation. Though the tosylate and nosylate molecules in themselves may not have wide
applicability, the study itself is of academic interest. This work may be extended by
manipulating the basic tosylate structure further by trying to make both rings electron rich to
destroy the x-stacking effect and see if a situation arises where an analogue crystallises out
exclusively in the stepped confonnation, or perhaps even one ofthe other confonnations seen in
the preceding torsion angle analysis. Further analysis could even be carried out on the tosylate
itself, with molecular dynamics calculations being used to model the behaviour of the tosylate
in solution to try understand the NMR spectroscopy results that were obtained. Further NMR
spectroscopy studies can also be carried out on the nosylate to see if the hairpin confonnation
may be seen in solution as here the increased strength of the x-x interactions may force the




4.1. INSTRUMENTATION AND CHEMICALS
4.1.1. Solvents, Reagents and Reaction Conditions
Reagents were used as received from the supplier unless indicated otherwise. Solvents used in
reactions were purified by standard techniques.98 The BuLi solution in hexane was titrated with
diphenylacetic acid and calculated to have a concentration of 1.0 M. The MeLi solution in ether
was used from a newly-opened bottle and did not require titration. Et3N and diisopropylamine
were distilled from CaH2 before use. Pyridine was dried and purified by stirring over KOH and
then being distilled.
Reactions were carried out In flame-dried glassware under N2 unless stated otherwise.
Temperatures of -78°C were obtained using a dry ice/acetone mixture. Where reactions have
been irradiated a 400 W high pressure Hg lamp was used with a 10 % aqueous CuS04 solution
functioning as a filter thereby blocking wavelengths of less than 350 run. When solvents have
been removed in vacuo this implies their evaporation under reduced pressure using a rotary
evaporator.
4.1.2. Chromatography
For thin layer chromatography silica gel 60 F254 aluminium backed plates were used. Silica gel
60,230-400 mesh; and neutral aluminum oxide 90 (activity I), 70-230 mesh, were utilised for
column and flash chromatography and silica gel 60 PF254 for radial and preparative thin layer
chromatography.
4.1.3. Spectroscopy and Physical Data
IR spectra were recorded with a Perkin Elmer Spectrum One spectrometer (resolution 1 cm- I )
as KBr discs or neat liquids between NaCI plates. In general, all values given are stretches (v)
unless otherwise specified where Va is an assymetric stretch, Vs a symmetric stretch, 8 an in-plane
bending or deformation, and 1t an out of plane bending. IHand 13C NMR spectra were recorded
at 500 MHz and 125 MHz respectively with a 500 MHz Varian Unity Inova spectrometer
equipped with an Oxford magnet (11.744 T) and switchable 5 mm probe. Standard IH and 13C
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NMR pulse sequences were used for 10 and 20 spectra with all spectra being recorded in CDC13
unless specified otherwise. Spectra were referenced by taking the chloroform peak to be at 7.26
ppm in proton NMR spectra and 77.0 ppm in carbon NMR spectra. All shift values are reported
in ppm and coupling constants, J, are given in Hz. High resolution mass spectra were obtained
by the Mass Spectrometry Unit of the Cape Technikon on a double-focusing Kratos MS 80RP
mass spectrometer. Low resolution mass spectra were recorded on a Hewlett-Packard gas
chromatographic mass spectrometer (HP5988A). Melting points are uncorrected.
4.1.4. X-ray Structure Collection
The collections for all three crystal structures were carried out on an Enraf-Nonius CAD4
diffractometer using Mo Ka radiation. The unit cell for each crystal was determined from 25
reflections (8 = 12°). For all data collections the (0-28 scan method was used with 8 =
2-25°and a scan angle of 1.35°(60 kV, 35 rnA) for spirocycle (130), 8 =2-23 °and a scan angle
of 1.10°(55 kV, 20 rnA) for tosylate (98), and 8 = 2-25 °and a scan angle of 1.00°(55 kV, 25
rnA) for nosylate (15a). The crystal structure data was analysed and solved by Dr O.Q. Munro
ofthis department. The data were reduced with the program XCAD (Oscail V899) using Lorentz
and polarization correction factors. For the tosylate (98) a numerical absorption correction
(OIFABS 100) was applied to the data. The structure was solved with the direct methods program
SHELXS-97,101 as implemented by the crystallographic program Oscail.99 The E-map led to the
location of all non-hydrogen atoms; these were refined anisotropically with the program
SHELXL-97. 101 All hydrogens were included as idealized contributors in the least-squares
process with standard SHELXL-97 idealization parameters. The final model was plotted using
the program ORTEP. 102 The complete crystallographic details, fractional atomic coordinates for
all non-hydrogen atoms, fixed hydrogen atom coordinates, bond lengths, and bond angles, are







Cylohexallone (5.00 ml, 48.1 mmol), pyrrolidine (4.00 ml, 47.9 mmol) and a catalytic quantity
of toluene-4-sulfonic acid (0.1 g) were added to toluene (40 ml) in a round-bottomed flask
(flame-dried glassware and a nitrogen atmosphere were not required). With a Dean and Stark
water separator attached, the mixture was heated so that the toluene refluxed vigorously and
water collected in the trap of the Dean and Stark apparatus. After approximately 1 hour the
mixture was allowed to cool and the solvent and remaining pyrrolidine were removed in vacuo.
Low boiling impurities (b.p. :-:;; 100°C at 15 mm Hg) were separated from the desired product
by Kugelrohr distillation. The purified product was afforded as an orange coloured liquid (4.08
g, 56 %). Ymax (film) /cm-
1 3051 (alkene CH), 3022-2827 (CH), 1717, 1642 (C=C); DH (500
MHz; CDC13) 1.49-1.58 (2H, m, CHCH2CH2), 1.63-1.71 (2H, m, CCH2CH2), 1.76-1.88 (4H,
m, 2 NCH2CH2), 2.04-2.12 (2H, m, CHCH2), 2.13-2.22 (2H, m, CCH2), 2.94-3.03 (4H, m, 2 x
NCH2), 4.23-4.32 (1H, m, CH); Dc (125 MHz; CDC13) 22.97 (CHCH2CH2), 23.32 (CCH2CH2),
24.46,24.48 (CHCH2, NCH2CH2), 27.49 (CCH2), 47.39 (NCH2), 93.49 (CH), 143.39 (NC); m/z




3-Pentanone (15.0 ml, 0.143 mol) was mixed with 48 % hydrobromic acid (14.3 ml) and chilled
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with ice water (flame-dried glassware or a N2 atmosphere were not required). Bromine (14.7 ml,
0.286 mol) was then added dropwise over 30 to 45 minutes. After the addition of the bromine
was completed water (57 ml) was added and the organic layer separated and washed with an aq.
sat. solution ofsodium bicarbonate (50 ml) followed by an aq. sat. sodium bisulfite solution (50
ml). The organic layer was dried with MgS04 and then distilled under vacuum (b.p. 79-81 °C1l5
mm Hg; lit. 61 75-76 °C1l3 mmHg) to give a clear oil (12.416 g, 36 %) which was an inseparable
mixture of diastereomers. V rnax (film) !cm-
1 3000-2800 (CH), 1724 (C=O), 641 (CBr); bH (500
MHz; CDCI
3
) 1.80 and 1.88 (6H, both d, J6.9, 2 x CH3), 4.98 and 4.77 (4H, both q, J6.9, 2 x
Cli); Oc (125 MHz; CDC13) 19.49 and 21.74 (CH3), 43.82 and 44.00 (CH), 196.02 and 198.32
(C=O); m1z (EI) one diastereomer: 246 (M+, 9 %; 81Br, 8IBr), 244 (M+, 17; 81Br, 79Br), 242 (M+,
8; 79Br, 79Br), 137 (100; 8IBr), 135 (95; 79Br), 109 (95; 8IBr), 107 (92; 79Br), 56 (87), other
diastereomer: 246 (M+, 9 %; 81Br, 81Br), 244 (M+, 19; 81Br, 79Br), 242 (M+, 9; 79Br,79Br), 137 (85;
8IBr), 135 (83; 79Br), 109 (100; 8IBr), 107 (98; 79Br), 56 (67).
1,3-Dimethyl-1,4,5,6,7,7a-hexahydro-2H-inden-2-one (115)
FeiCO)9 (1.09 g, 3.00 mmol) was added to a flame-dried flask underN2• 1-(1-Cyclohexen-1-
yl)pyrrolidine (112) (1.02 g, 6.74 mmol) in benzene (6 ml) and 2,4-dibromo-3-pentanone (114)
(0.51 g, 2.09 mmol, passed through a basic alumina column before use) in benzene (6 ml) were
both added to the reaction flask which was then stirred at 60°C for 10 minutes with irradiation.
The heating was then stopped and the solution left to stir overnight with further irradiation. The
solution was diluted with ethyl acetate (20 ml) and then washed with saturated aqueous NaHC03
(25 ml) followed by a brine solution (25 ml). The organic layer was separated and dried with
MgS04, filtered and the solvent removed in vacuo. The residual oil was passed through a short
basic alumina column (Activity I) with ethyl acetate. After removal of the solvent the resulting
product was purified by radial chromatography (5 % ethyl acetatelhexane) giving a pale yellow
oil containing two diastereomers (0.12 g, 35 %) which were separated by preparative TLC (5 %
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ethyl acetate/hexane). Vmax (film) /cm-
1 3000-2800 (CH), 1700 (C=O), 1653 (C=C).
(1R", 7as'}diastereomer: Rf O.24 (10 % ethyl acetate/hexane); bH (500 MHz; CDCI)) 1.09 (3H,
d, J 7.8, CHCH)), 1.72 (3H, d, J 1.4, CCH)), 1.0-3.0 (m, 4 x CH2 and 2 x CH); be (125 MHz;
CDCI)) 7.75 (CH)C), 9.97 (CH)CH), 20.95 (CCH2), 25.56 (CCH2CH2), 26.93 (CHCH2GI2),
31.79 (CHCH
2
), 46.12 (CHCH)), 49.60 (CH2CHCH), 135.24 (CCH)), 168.58 (C=CCH)), 208.23
(C=O); m/z (El) 164 (M+, 75 %), 149 (100), 136 (70),107 (52), 79 (60).
(1R", 7aR")-diastereomer: Rf O.31 (10 % ethyl acetate/hexane); bH (500 MHz; CDCI)) or 1.14
(3H, d, J 7.8, CHCH)), 1.67 (3H, d, J 1.4, CCH)), 1.0-3.0 (m, 4 x CH2 and 2 x CH); be (125
MHz; CDCI)) 7.64 (CH3C), 14.95 (CH)CH), 25.50 (CCH2), 26.39 (CHCH2CH2), 28.27
(CCH
2
CH2), 33.75 (CHCH2), 46.84 (CHCH3), 49.25 (CH2CHCH), 131.69 (CCH3), 173.40
(C=CCH
3
), 211.36 (C=O); m/z (EI) 164 (M+, 78 %), 149 (100), 136 (73), 107 (56), 79 (49).
MethyI3-[(trimethylsiiyl)oxy]-2-butenoate (120)
A mixture of anhydrous powdered zinc chloride (1.0 g, 7.3 nunol) and triethylamine (freshly
distilled from CaH2, 20.3 ml, 146 nunol) was stirred for one hour at room temperature to suspend
the salt in the amine. Methyl acetoacetate (7.2 ml, 67 nunol) in toluene (ca. 30 ml) was added
followed by TMSCI (17.8 ml, 133 nunol). The resulting mixture was stirred for 30 minutes
before increasing the temperature to 40°C and then left to stir overnight. The solution was
allowed to cool to room temperature, added to diethyl ether (ca. 150 ml) and filtered through a
sintered glass filter containing Celite Filter Cel. The filtrate and ether washings were combined
and the solvent removed in vacuo. The remaining brown oil was distilled using short path
distillation apparatus to afford the product as an inseparable mixture of E and 2 isomers in the
form ofaclear, colourless liquid (7.92 g, 63 %); b.p 73-75 °C/12 nun Hg (lit.,65 54-55 °C/5 mm
Hg); Vmax (film) /cm-
1 3000-2840 (CH), 1718 (C=O), 1630 (C=C), 1387 (SiC), 1141 (va C-
C(=O)-O), 1039 (Va O-C-C), 849 (Si-O); bH (500 MHz; CDC13) 0.26 and 0.27 (E/2, 9H, each s,
SiMe)), 1.89 (2) and 2.26 (E) (3H, each s, CH3C=C), 3.64 (2) and 3.65 (E) (3H, each s, C02CH)),
5.09 (2) and 5.13 (E) (lH, each s, -CH=); be (125 MHz; CDC1)) 0.15 and 0.53 [£/2 (CH))J,
20.67 (E) and 24.37 (2) (CH)C), 50.45 (2) and 50.66 (E) (OCH3), 99.22 (E) and 99.95 (2) (CH),
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164.88 (2) and 169.92 (E) (COSiMe3), 165.96 (2) and 168.34 (E) (COMe); m1z (EI) one
structural isomer: 188 (M+, 6 %), 173 (100), 157 (33),89 (61), 73 (44), other structural isomer:
188 (M+, 1 %), 173 (100), 89 (54), 73 (33).
(1£)-1,3-Bis[(trimethylsilyl)oxy]-1 ,3-butadienyl methyl ether (121)
Diisopropylamine (freshly distilled from CaH2, 2.0 ml, 14 mmol) was added to THF (50 ml) and
after cooling the solution to 0 °C, n-BuLi (15 ml of 1.0 M solution in hexane, 15 mmol) was
added. The reaction mixture was further cooled to -78°C and methy13-[(trimethylsilyl)oxy]-2-
butenoate (120) (2.0 g, 11 mmol) was added. The solution was left to stir for 2 minutes before
being quenched with TMSCI (2.5 ml, 19 mmol). After 10 minutes the solvent was removed in
vacuo and the residue triturated with anhydrous hexane cooled to 0 °C. The precipitated salts
were filtered off and the solvent removed in vacuo to afford the crude product (3.37 g). This
compound was used without further purification. Vmax (film) /cm-
1 3000-2870 (CH), 1652
(C=C), 1251, (SiC), 844 (SiO); bH (500 MHz; CDCI3) 0.21 [9H, s, (CH3)3Si], 0.25 [9H, s,
(CHJ3Si], 3.55 (3H, s, OCH3), 3.95 (1H, d, J 1.1, H-CH=C), 4.15 (1H, d, J 1.1, H-CH=C), 4.47
(1H, s, C-CH=C); bc (125 MHz; CDCI3) 0.22 [(CH3)3Si], 0.45 [(CH3)3Si], 54.95 (OCH3), 77.56





Dichloromethane (35 ml) was added to freshly prepared crude (1E)-1 ,3-bis[(trimethylsilyl)oxy]-
1,3-butadienyl methyl ether (121) (3.37 g, 12.9 mmol) and the solution cooled to -78°C while
being stirred. Bromine (1.35 ml, 26.3 mmol) was added and the mixture left to stir for half an
hour before quenching with saturated aq. NaHC03 (15 ml). The product was extracted with
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hexane (3 x 30 ml) and the solution dried with MgS04 before the solvent was removed in vacuo.
Low-boiling impurities (b.p. $ 90°C at 6 mm Hg) were separated from the desired product by
Kugelrohr distillation. The residue was used without further purification. 0H (500 MHz; CDC13)
3.86 (3H, s, CH3), 4.25 (lH, d, J 13.3, CHaHb), 4.38 (lH, d, J 13.3, CHaHb) 5.20 (1H, s, CH); <>c
(125 MHz; CDC13) 31.04 (CH2), 45.63 (CH), 54.34 (CH3), 165.27 (C02Me), 190.60 (CO); rnIz
(EI) 276 (M+, 2 %; 81Br, 8IBr), 274 (M+, 4; 81Br, 79Br), 272 (M+, 2; 79Br, 79Br), 154 (95; 8IBr), 152
(100; 79Br), 123 (51; 8IBr), 121 (49; 79Br), 69 (20).
1-Benzyl-2-pyrrolidinone (123)
2-Pyrrolidinone (8.9 ml, 0.12 mol) and NaH (80 % suspension in oil, 3.5 g, 0.12 mol) were added
to toluene (ca. 175 ml) and left to stir at room temperature for 30 minutes. Benzyl bromide (14
ml, 0.12 mol) was added and the solution left to stir for a further 2 hours at 90°C. The mixture
was cooled and filtered and the product then purified by column chromatography using ethyl
acetate to give a pale yellow oil (17.7 g, 84 %) R f 0.53 (ethyl acetate); Y max (film) /cm-
I
3100-2900 (CH), 1685 (C=O), 1083 (C-N); 0H (500 MHz; CDCl3) 1.99 (2H, 5 lines, J 7.6,
CH2CH2CH2), 2.44 (2H, t,J8.1, CH2C=O), 3.26 (2H, t,J7.1, NCH2CH2), 4.45 (2H, s, CH2Ar),
7.23-7.35 (5H, m, ArH's); 0c (125 MHz; CDCl)) 17.74 (CH2CH2CH2), 30.95 (CH2C=O), 46.61
(CH2Ar), 46.62 (NCH2CH2), 127.55 (ArCH), 128.13 (ArCH), 128.68 (ArCH), 136.57 (NCH2C),




Titanocene dichloride (4.00 g, 16.1 mmol) was dissolved in dry THF (80 ml). While stirring at
10-15 °C in the dark (tin foil wrapped around the flask), MeLi (21.7 ml of 1.6 M in ether, 34.7
mmol) was added slowly to the solution. After stirring for approximately 5 minutes at room
temperature the reaction was quenched with ice leaving an orange solution which was dried over
anhydrous MgS04 • The solution was filtered and the solvent removed under vacuum leaving an
orange residue which was recrystallised from pentane by cooling to -78°C to give orange,
needle-like crystals (2.45 g, 73 %). vmax (KBr disc) /cm-
1 3150-2800 (CH), 1442 (CC), 1014
(8CH), 814 (nCH), 462 (Ti-Cp); 8H (500 MHz; CDCI3) -0.15 [6H, s, (CH3)2] , 6.06 (10H, s, CP2);
8c (125 MHz; CDCl3) 45.45 [(CH3)2], 113.07 (CP2)'
1-Benzyl-2-methylenepyrrolidine (117)
In a flask, toluene (10 ml) was added to dimethyl titanocene (125) (1.03 g, 4.95 mmol)
followed by I-benzyl-2-pyrrolidinone (123) (289 mg, 1.65 mmol) and the resulting mixture was
heated to 80°C and stirred overnight. On cooling to room temperature, pentane (20 ml) was
added to the reaction flask to precipitate out the titanium salts which were then filtered off
through Celite Filter Ce1 and the remaining solution concentrated in vacuo. The enamine was
used without any further purification.
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2.1.4. Reaction of 2,4-Dibromo-3-pentanone (114) and I-Benzyl-2-methylenepyrrolidine
(117)
Proposed product (127)
FeiCO)9 (235 mg, 0.647 mmol) was added to a flame-dried flask under N2• I-Benzyl-2-
methylenepyrrolidine (117) (0.29 g, 1.7 mmol) in benzene (2ml) and 2,4-dibromo-3-pentanone
(114) (134 mg, 0.549 mmol, passed through a basic alumina column before use) also in benzene
(2 ml) were both added to the reaction flask which was then stirred at 60°C for 10 minutes with
irradiation. The heating was then stopped and the solution left to stir overnight with further
irradiation. The solution was diluted with ethyl acetate (15 ml) and then washed with saturated
aqueous NaHC03 (15 ml) followed by a brine solution (15 ml). The organic layer was separated
and dried with MgS04, filtered and the solvent removed under vacuum. The product was then
purified on a neutral alumina column. Firstly, a solution of 1 % ethyl acetatelhexane was passed
through the column to elute the more non-polar components and this was followed by pure ethyl
acetate. The product was obtained as a yellow oil from the ethyl acetate fractions (11 mg, 8 %).
R f 0.66 (50 % ethyl acetatelhexane); vmax (film) /cm-
1 3100-2800 (CH), 1082 (C-N); DH (500
MHz; CDCI3) 1.29 (3H, s, CH3), 1.30 (3H, s, CH3), 1.68-1.73 (lH, m, NCCHaHb), 1.80-1.89
(2H, m, CH2CH2CH2), 1.97-2.05 (1H, m, NCCHaHb), 2.45-2.51 (lH, m, NCHaHbCH2),
2.88-2.95 (lH, m, NCHaHbCH2), 3.22 (lH, d,J13.3, ArCHaHb), 3.60 (1H, d,J13.3, ArCHaHb),
6.21 (1H, s, NCCH), 6.41 (1H, s, CH3CCHCCH3), 7.18-7.31 (5H, m, ArCHs); Dc (125 MHz;
CDCI3) 17.06 (CH3), 17.67 (CH3), 21.56 (CH2CH2CH2), 39.07 (NCCH2), 49.87 (NCH2CH2),
53.23 (ArCH2), 62.97 (NC), 126.39 (NCCH), 128.01 (ArCH), 128.13 (ArCH), 128.34 (ArCH),
131.65 (CH3CCHCCH3), 141.09 (NCH2C), 153.48 (CCH3), 155.92 (CCH3); m/z (EI) 239 (M+,




To a flask containing THF (70 ml), phosphorus pentasulfide (5.64 g, 12.7 mmol) was added
followed by sodium carbonate (1.35 g, 12.7 mmol). After the mixture was stirred for 30 minutes
to ensure homogeneity, 1-benzyl-2-pyrrolidinone (123) (1.86 g, 10.6 mmol) was added and the
mixture left to stir for a further 3 hours at room temperature. The reaction was then quenched
with 10 % aqueous trisodium phosphate (50 ml) and the aqueous phase extracted with ethyl
acetate (3 x 50 ml). The combined organic portions were dried with MgS04 and concentrated
in vacuo. The remaining liquid was purified by flash chromatography (50 % ethyl
acetatelhexane) to afford the product as a yellow oil (1.10 g, 54 %). Rr 0.36 (20 % ethyl
acetatelhexane); vmax (film) /cm-
1 3100-2875 (CH), 1507 (C=S), 1116 (C-N); 8H (500 MHz;
CDC13) 2.10 (2H, 5 lines, J7.6, CHzCHzCHz), 3.10 (2H, t, J7.9, CHzC=S), 3.58 (2H, t, J7.3,
NCHzCHz), 4.99 (2H, s, CH2Ar), 7.29-7.36 (5H, m, ArH's); Dc (125 MHz; CDC13) 19.39
(CH2CHzCH2), 44.86 (CHzC=S), 51.56 (CHzAr), 53.93 (NCHzCHz), 128.01 (ArCH), 128.26
(ArCH), 128.81 (ArCH), 135.07 (NCH2C), 201.73 (C=S); m/z (El) 191 (M+, 100 %),149 (27),
148 (39), 106 (20), 103 (22),91 (61, CHzAr).
2-(1-Benzyl-2-pyrrolidinylidene)acetonitrile (129)
1-Benzyl-2-pyrrolidinethione (128) (1.10 g, 5.75 mmol) and bromoacetonitrile (0.60 ml, 8.67
mmol) were added to acetonitrile (5 ml) and the resulting mixture left to stir overnight at room
temperature. Triphenylphosphine (2.26 g, 8.63 mmol) and triethylamine (freshly distilled from
CaHz, 1.20 m1, 8.63 mmol) were mixed in dichloromethane (5 ml) and this solution was then
110
added to the reaction mixture and left to stir. After 2 hours the reaction was quenched with
saturated aqueous NaHCO) (10 ml) and the aqueous layer extracted with ethyl acetate (3 x 15
ml). The combined organic portions were dried with MgS04, filtered and the solvent removed
in vacuo. The remaining oil was dissolved in a 50 % CH2Cl/hexane mixture (50 ml) and cooled
to cause the precipitation ofthe triphenylphoshpine oxide by-product which was filtered off. The
solids were washed with the cold CH2Cl/hexane mixture. This was repeated and then the
remaining solution was reduced in vacuo and purified by radial chromatography (50 %
CH2Cl/hexane) to afford a yellow oil (853 mg, 75 %). Rr O.36 (100 % CH2C12); Vmax (film) /cm-
I
3100-2860 (CH), 2248 (C=N), 1617 (C=C), 1082 (C-N); bH (500 MHz; CDC1) 2.01 (2H, 5
lines, J7.3, CH2CH2CH2), 2.94 (2H, t, J7.7, NCCH2), 3.42 (2H, t, J 6.9, NCH2CH2), 3.58 (lH,
s, NC=CH), 4.28 (2H, s, CH2Ar), 7.16-7.36 (5H, m, ArH's); bc (125 MHz; CDC13) 20.81
(CH2CB2CH2), 32.75 (NCCB2), 50.08 (CB2Ar), 53.62 (NCB2CH2), 54.46 (C=CBCN), 114.53
(C=N),127.17 (ArCB), 127.77 (ArCB), 128.86 (ArCB), 135.33 (NCH2C), 165.82 (NC=C); mlz




Fe2(CO)9 (1.49 g, 4.10 mmol) was added to a flame-dried flask under N2• 2-(1-Benzyl-2-
pyrrolidiny1idene)acetonitrile (129) (0.85 g, 4.3 mmol) dissolved in benzene (10-15 ml) and 2,4-
dibromo-3-pentanone (114) (1.57 g, 6.44 mmol, passed through a basic alumina column before
use) also dissolved in benzene (10-15 ml) were both added to the reaction flask which was then
stirred overnight under N2 at 50°C with irradiation. The solution was diluted with ethyl acetate
(30 ml) and then washed with saturated aqueous NaHCO) (40 ml) followed by a brine solution
(40 ml). The organic layer was separated and dried with MgS04, filtered and the solvent
removed under vacuum. The resulting product was purified by radial chromatography (10 %
ethyl acetate/hexane) to give a mixture of diastereomers (292 mg, 24 %) with Rc values values
ranging from 0.36 to 0.65 (20 % ethyl acetate/hexane). The (58*, 68*, 78*, 98*) diastereomer was
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selectively crystallised out from an ethyl acetate/hexane solution to give large, colourless crystals.
R f 0.49 (20 % ethyl acetate/hexane), m.p. 108.5-110.5 °C; vmax (KBr disc) !cm-
I 3100-2800
(CH), 2237 (C=N), 1747 (C=O), 1076 (C-N); bH (500 MHz; CDC13) 1.14 (3H, d, J 6.9,
CCHCH3), 1.27 (3H, d, J7.3, CHCHCH3), 1.75-1.85 (1H, m, CH2CHaHbCH2), 1.88-1.93 (1H,
m, NCCHaHb), 1.99-2.11 (2H, m, CH2CHaHbCH2 and NCCHaHb), 2.36-2.46 (2H, m, 2CH3Cll),
2.75 (1H, d,J11.4, CHC=N), 2.80-2.84 (1H, m, NCHaHbCH2), 2.98-3.03 (1H, m, NCHaHbCH2),
3.81 (1H, d, J 13.3, ArCHaHb), 3.84 (1H, d, J 13.3, ArCHaHb), 7.25-7.35 (5H, m, ArCH's); bc
(125 MHz; CDC13) 8.70 (CCHCH3), 14.06 (CHCHCH3), 22.16 (CH2CH2CH2), 29.76 (NCCH2),
40.88 (CHC=N), 46.40 (CHCHCH3), 49.44 (CCHCH3), 51.72 (CH2Ar), 52.17 (NCH2CH2), 71.08
(C-N), 119.69 (C=N), 127.29 (ArCH), 127.99 (ArCH), 128.52 (ArCH), 138.94 (CCH2N), 213.71
(C=O); m1z (El) 282 (M+, 18 %), 200 (13), 188 (14), 187 (100), 186 (28), 91 (71, CH2Ar)






3,4-Methylenedioxyphenylacetic acid (0.50 g, 2.8 mmol) was added to a stirred solution of
LiAlH4 (0.2 g, 5.3 mmol) in THF (15 ml). The solution was stirred for 1.5 hours at 25°C and
then quenched with water (0.3 ml) followed by aq. NaOH (15 %, 0.3 ml) and finally additional
water (1 m1). The resulting suspension was filtered and the unwanted solids washed thoroughly
with chlorofonn. The combined filtrate and washings were dried with MgS04, filtered and
concentrated in vacuo to give the desired product analytically pure as a colourless liquid (449 mg,
96 %). V max (film) !cm-
1 3362 (OH), 3100-2800 (CH), 1247 and 1041 (C-O); b
H
(500 MHz;
CDCl3) 1.58 (lH, s, Oll), 2.79 (2H, t, J 6.4, ArCH2), 3.81 (2H, t, J 6.4, CH20H), 5.93 (2H, s,
OCH20), 6.68 (1H, dd, J7.9, 1.7, Hb), 6.72 (1H, d, J 1.8, HJ, 6.76 (1H, d, J7.9, He); bc (125
MHz; CDCl3) 38.87 (ArCH2), 63.76 (CH20H), 100.89 (OCH20), 108.36 (CHe), 109.34 (CHJ,
121.91 (CHb), 132.18 (CCH2), 146.20 (OCCHCH), 147.81 (OCCHC); m1z (El) 166 (M+, 24 %),






To a stirred mixture of 2-(1 ,3-benzodioxol-5-yl)-1-ethanol (60) (1.14 g, 6.87 mmol) and silver
trifluoroacetate (1.67 g, 7.56 mmol) in CH2Cl2 (40 ml) under N2, solid iodine (2.09 g, 8.24 mmol)
was added. The mixture was then left to stir at 25 DC for 2 hours after which it was washed with
saturated aqueous sodium thiosulfate (40 ml). The aqueous phase was extracted with CH2Cl2 (2
x 40 ml) and the combined organic layers were dried with MgS04 and concentrated in vacuo
leaving a brown residue which was taken up in hot CCl4 (30 ml) and treated with activated
charcoal (ca. 1 g). The charcoal was filtered off, the solvent removed in vacuo and the remaining
oil purified by radial chromatography (10 % ethyl acetatelhexane) to give the product (1.04 g,
52 %) which was recrystallised from CCl4 giving colourless, needle-like crystals with m.p.
63.5-64.5 DC (lit. 30 68-69.5 DC). Rf O.17 (20 % ethyl acetatelhexane); Vmax (KBr disc) !cm-
I 3313
(OH), 2950-2800 (CH), 1225 and 1037 (C-O), 532 (CI); DH (500 MHz; CDCI3) 1.53 (1H, s, Oli),
2.94 (2H, t, J 6.7, ArCH2) , 3.81 (2H, t, J 6.7, CH20H) 5.95 (2H, s, OCH20), 6.79 (1H, s,
CHCCH2), 7.25 (1H, s, CHCI); Dc (125 MHz; CDCI3) 43.50 (ArCH2), 62.47 (CH20H), 88.07
(0), 101.60 (OCH20), 110.13 (CHCCH2), 118.76 (CHCI), 134.29 (CCH2), 147.20 (CCHCCH2),




2-(6-lodo-1,3-benzodioxol-5-yl)-1-ethanol (97) (512 mg,1.75 mmol) and p-toluenesulfonyl
chloride (0.50 g, 2.6 mmol) were dissolved separately in diethylether (5 ml each) and then
combined. Pyridine (0.5 m1, dried over KOH and fresWy distilled) was then added to the solution
and the mixture left overnight (not under N2) to allow formation ofcolorless and yellow crystals.
The supernatant liquid was then removed and left to stand allowing more crystals to form. The
combined crystals and remaining liquid were partitioned between CH2Cl2 (30 ml) and water (15
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ml). The organic layer was separated, washed with ice-cold HCl (5 %, 30 ml), dried with MgS04,
filtered and concentrated in vacuo leaving a yellow residue which was purified by radial
chromatography (15 % ethyl acetatelhexane) giving an oil (315 mg, 39 %) which crystallised on
standing. The colorless crystalline product had m.p. 50-54°C; Rr 0.33 (20 % ethyl
acetatelhexane); Vmax (KBr disc) /cm-
1 3100-2900 (CH), 1358 (va S(=O)2)' 1248 and 1096 (C-O),
1176 (Vs S(=O)2)' 554 (CI); bH (500 MHz; CDCl)) 2.44 (3H, s, Me), 2.98 (2H, t, J 6.9, ArCH2),
4.16 (2H, t, J 6.9, CH20Ts), 5.95 (2H, s, OCH20), 6.67 (1H, s, CHCCH2), 7.13 (1H, s, CHCI),
7.29 (2H, d,J8.2, CHCMe), 7.71 (2H, d,J8.2, CHCS); bc (125 MHz; CDCl)) 21.61 (Me), 39.81
(ArCB2), 69.10 (CB20Ts), 87.78 (CI), 101.67 (OCB20), 110.42 (CBCCH2), 118.64 (CBCI),
127.87 (CBCS), 129.74 (CBCMe), 131.97 (CCH2), 132.86 (CMe), 144.68 (CS), 147.52
(CCHCCH2), 148.45 (CCHCI); rn/z (EI) 446 (M+, 19 %), 274 (100, M+ - HOTs), 261 (29, M+




2-(6-lodo-1,3-benzodioxol-5-yl)-1-ethanol (97) (1.04 g, 3.56 mmol) was added to CH2Cl220 ml)
and cooled to 0 °C. Et)N (freshly distilled from CaH2, 0.14 ml, 1.0 mmol) and DMAP (43 mg,
0.36 mmol) were added to the stirred solution followed by p-nitrobenzenesulfonyl chloride (90
% technical grade, 1.14 g, 4.63 mmol) in small portions. The mixture was allowed to warm to
room temperature and then left to stir for a further four hours. After this time further CH2C12was
added (ca. 20 ml) and the mixture washed with aq. sat. sodium chloride (20 ml). The organic
layer was dried with MgS04 and concentrated in vacuo. Repeated recrystallisation from 20 %
CH2Cl/ethyl acetate resulted finally in the collection ofyellow crystals (432 mg, 25 %). X-ray
quality crystals were grown by slow evaporation from THF. The strongly coloured yellow
crystals had m.p. 114-116 °C (lit. 126.5-127 °C); vmax (KBr disc) /cm-
13100-2900 (CH), 1529
[va (N=O)2], 1364 [Va S(=O)2l, 1350 [Vs (N=O)2], 1245 and 1095 (C-O), 1187 [Vs S(=O)2], 849
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(CN), 569 (CI); DH (500 MHz; CDC13) 3.02 (2H, t, J 6.5, ArCH2), 4.32 (2H, t, J 6.5, CH20S02),
5.94 (2H, s, OCH20), 6.60 (lH, s, CHCCH2), 7.11 (lH, s, CHCI), 7.96 (2H, dd, J 7.0, 2.0,
CHCS), 8.31 (2H, dd, J 7.0, 2.0, CHCN); eSc (125 MHz; CDC13) 39.65 (ArCH2) , 70.58
(CH20S02), 87.78 (CI), 101.86 (OCH20), 110.41 (CHCCH2), 118.73 (CHCI), 124.24 (CHCN),




2-(6-lodo-1,3-benzodioxol-5-yl)ethyI4-nitrobenzenesulfonate (15a) (155 mg, 0.325 mmol), NaH
(80 % suspension in oil, 0.02 g), and 2-pyrrolidinone (50 ,ul, 650 ,umol) were added to benzene
(10 ml). The mixture was heated under reflux and the progress ofthe reaction monitored by TLC
(50 % ethyl acetate/hexane). When it was observed that all the nosylate (15a) had reacted the
mixture was passed through a silica gel plug column with ethyl aceate and then the solvent
removed in vacuo. The product was purified by radial chromatography (25 % ethyl
acetate/hexane) and was obtained as cream coloured crystals (55 mg, 47 %) on removal of the
solvent in vacuo. The crystals had m.p. 96.5-99.5 °C; RrO.23 (50 % ethyl acetate/hexane); Vmax
(KEr disc) /cm- I 3070-2850 (CH), 1685 (C=O), 1231 and 1040 (C-O); eSH (500 MHz; CDC13)
1.94 (2H, 5 lines, J 7.6, CH2CH2CH2), 2.32 (2H, t, J8.1, CH2C=0), 2.82, (2H, t, J7.5, ArCH2),
3.30 (2H, t, J7.1, CH2CH2CH2N), 3.37 (2H, t, J7.5, ArCH2CH2), 5.89 (2H, s, OCH20), 6.74
(1H, s, CHCCH2), 7.15 (1H, s, CHCI); eSc (125 MHz; CDC13) 17.79 (CH2CH2CH2), 30.82
(CH2C=0), 38.06 (ArCH2) , 42.88 (ArCH2CH2), 47.91 (CH2CH2CH2N), 87.48 (CI), 101.51
(OCH20), 109.51 (CHCCH2), 118.42 (CHCI), 134.40 (CHCCH2), 147.11 (CCHCCH2), 148.51
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Completeness to theta = 24.92°
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit (based on F2)
Final R indices [1>20(1)]
R indices (all data)







a = 10.543(3) A
b = 10.614(4) A















5716 (Rint = 0.0180)
99.7%
None
Full-matrix least-squares on F
5716/0/399
1.107
R1 = 0.0719, WR2 = 0.2259
R1 = 0.0835, WR2 = 0.2384
0.568 and -0.305 e.A-3
II
Table A2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2
x 103) for spirocycle (130).a
Atom x y z U(eq)
C(1A) 2166(2) 7829(2) 3844(1) 50(1)
C(2A) 2703(2) 8376(2) 2968(2) 61(1)
C(3A) 1981(3) 7730(3) 2175(2) 83(1)
C(4A) 766(3) 7334(3) 2544(2) 87(1)
C(5A) 1819(2) 8896(2) 4523(2) 57(1)
C(6A) 3106(2) 9339(3) 4958(2) 68(1)
C(7A) 3883(3) 8150(3) 4979(2) 72(1)
C(8A) 3165(3) 7121(2) 4468(2) 67(1)
C(9A) 1045(3) 9897(2) 4103(2) 72(1)
C(10A) 3062(4) 9982(4) 5887(2) 101(1)
C(11A) 3974(4) 6141(4) 4004(3) 115(1 )
C(l3A) -727(3) 5675(2) 3743(2) 68(1)
C(14A) -2074(3) 5801(3) 3621(2) 85(1)
C(15A) -2815(3) 4795(3) 3330(2) 84(1)
C(16A) -2249(3) 3697(3) 3137(2) 84(1)
C(17A) -987(4) 3545(3) 3230(2) 88(1)
C(18A) -262(3) 4523(3) 3531(2) 77(1)
N(1A) 1118(2) 7024(2) 3495(1) 53(1)
N(2A) 436(3) 10685(3) 3773(3) 107(1 )
O(lA) 4945(2) 8060(3) 5344(2) 107(1)
C(12A) 49(3) 6799(3) 4062(2) 66(1)
C(19A) 956(15) 5988(13) 4089(10) 74(5)
C(1B) 2837(2) 2829(2) 1156(1) 50(1)
C(2B) 2295(2) 3379(2) 2035(2) 61(1)
C(3B) 3016(3) 2731(3) 2825(2) 84(1)
C(4B) 4231(3) 2333(3) 2458(2) 88(1)
C(5B) 3179(2) 3893(2) 479(2) 56(1)
C(6B) 1894(2) 4340(3) 42(2) 68(1)
C(7B) 1118(3) 3152(3) 22(2) 72(1)
C(8B) 1833(3) 2121(2) 532(2) 67(1)
C(9B) 3958(3) 4899(2) 900(2) 71(1)
C(lOB) 1936(4) 4978(4) -882(2) 100(1)
C(11B) 1022(4) 1148(4) 996(3) 116(1 )
C(13B) 5727(3) 673(2) 1256(2) 68(1)
C(14B) 5259(3) -475(3) 1469(2) 77(1)
C(15B) 5985(4) -1454(3) 1767(2) 90(1)
C(16B) 7246(3) -1299(3) 1862(2) 84(1)
C(17B) 7811(3) -208(3) 1668(2) 84(1)
C(18B) 7074(3) 804(3) 1376(2) 85(1)
N(1B) 3881(2) 2025(2) 1504(1 ) 53(1)
N(2B) 4560(3) 5686(3) 1229(3) 108(1)
III
Table A2. Continued
O(1B) 57(2) 3062(3) -344(2) 107(1)
C(12B) 4949(3) 1801(3) 939(2) 63(1)
C(19B) 4036(14) 973(13) 917(10) 86(5)
a U(eq) is defined as one third of the trace of the orthogonalized U!i tensor. The esd' s of the
least significant digits are given in parentheses.
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a The esd' s of the least significant digits are given in parentheses.
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a The esd's of the least significant digits are given in parentheses.
VI
Table AS. Anisotropic displacement parameters (A2 x 103) for spirocycle (130).a
Atom Ull U22 U33 U23 U13 Un
C(1A) 51 (1) 51(1) 48(1) -2(1) 6(1) 8(1)
C(2A) 55(1) 72(1) 56(1) 2(1) 14(1) 5(1)
C(3A) 103(2) 98(2) 50(1) 6(1) 11(1) -22(2)
C(4A) 96(2) 104(2) 60(2) 6(2) -9(2) -20(2)
C(5A) 55(1) 56(1) 60(1) -7(1) 12(1) 5(1)
C(6A) 67(2) 73(2) 63(1) -13(1 ) 6(1) -7(1)
C(7A) 63(2) 97(2) 55(1) 0(1) -2(1) 10(1)
C(8A) 72(2) 68(1) 60(1) -1(1) -4(1) 21(1)
C(9A) 67(2) 62(1) 89(2) -9(1) 17(1) 10(1)
C(lOA) 113(3) 108(2) 82(2) -42(2) 5(2) -11(2)
C(11A) 123(3) 111 (3) 109(3) -22(2) -19(2) 74(2)
C(13A) 78(2) 67(1) 62(1) -5(1) 23(1) -14(1)
C(14A) 89(2) 69(2) 97(2) -3(2) 16(2) 12(2)
C(15A) 60(2) 87(2) 106(2) -5(2) 8(2) -7(1)
C(16A) 91(2) 82(2) 82(2) 3(2) 23(2) -10(2)
C(17A) 115(3) 68(2) 83(2) 3(1) 27(2) 12(2)
C(18A) 78(2) 84(2) 72(2) 2(1) 16(1) 14(1)
N(1A) 55(1) 58(1) 45(1) 1(1) 8(1) 1(1)
N(2A) 97(2) 81(2) 145(3) 12(2) 20(2) 37(2)
O(lA) 76(1) 144(2) 97(2) -8(1) -27(1) 12(1)
C(12A) 61(2) 72(2) 67(2) -16(2) 20(1) -7(2)
C(19A) 81(10) 69(8) 71(8) 14(6) -6(7) -19(7)
C(lB) 50(1) 53(1) 47(1) -7(1) 7(1) -5(1)
C(2B) 56(1) 73(1) 55(1) -10(1) 14(1) -2(1)
C(3B) 106(2) 97(2) 49(1) -14(1) 10(1) 23(2)
C(4B) 95(2) 106(2) 61(2) -14(2) -9(2) 25(2)
C(5B) 54(1) 57(1) 59(1) -2(1) 13(1) -1(1)
C(6B) 68(2) 74(2) 63(1) 6(1) 6(1) 10(1)
C(7B) 63(2) 97(2) 55(1) -8(1) -1(1) -7(1)
C(8B) 72(2) 69(1) 58(1) -8(1) -4(1) -17(1)
C(9B) 64(2) 62(1) 89(2) 2(1) 18(1) -7(1)
C(10B) 110(3) 107(2) 84(2) 34(2) 5(2) 16(2)
C(11B) 126(3) 112(3) 107(3) 13(2) -22(2) -72(2)
C(13B) 78(2) 68(2) 61(1) -2(1) 21(1) 18(1)
C(14B) 79(2) 85(2) 70(2) -9(1) 17(1) -11(2)
C(15B) 120(3) 69(2) 82(2) -12(1) 29(2) -11(2)
C(16B) 89(2) 82(2) 83(2) -10(2) 24(2) 13(2)
C(17B) 60(2) 87(2) 107(2) -2(2) 7(2) 11 (1)
C(18B) 90(2) 69(2) 98(2) -6(2) 19(2) -8(2)
N(1B) 55(1) 59(1) 45(1) -8(1) 8(1) 2(1)





















a The esd' s of the least significant digits are given in parentheses. The anisotropic
displacement factor exponent takes the fonn: -2 1t [ h2 a*2 UII + ... + 2 h k a* b* Ud.
VIII
Table A6. Hydrogen atom coordinates (x 104) and equivalent isotropic displacement
°2 3 D' aparameters (A x 10) or splrocycle (130).
Atom x y z U(eq)
H(2Al) 2574 9280 2938 73
H(2A2) 3605 8205 2960 73
H(3Al) 1831 8304 1662 100
H(3A2) 2447 7006 1970 100
H(4Al) 150 8013 2502 105
H(4A2) 412 6607 2214 105
H(5A) 1344 8514 5008 68
H(6A) 3477 9930 4533 81
H(8A) 2695 6665 4923 80
H(10A) 2550 10728 5823 151
H(lOB) 3908 10208 6111 151
H(10C) 2700 9418 6314 151
H(lIA) 3429 5520 3704 173
H(llB) 4535 5740 4459 173
H(IIC) 4465 6549 3557 173
H(l4A) -2453 6570 3740 102
H(15A) -3696 4869 3268 101
H(l6A) -2753 3021 2932 101
H(17A) -620 2779 3088 106
H(l8A) 613 4404 3600 93
H(l2A) -491 7538 4047 79
H(l2B) 368 6667 4694 79
H(l9A) 1083 6220 4732 89
H(l9B) 1501 5285 3956 89
H(2B1) 2427 4283 2067 73
H(2B2) 1392 3206 2043 73
H(3B1) 3169 3304 3339 101
H(3B2) 2547 2007 3029 101
H(4B1) 4851 3010 2503 106
H(4B2) 4579 1604 2787 106
H(5B) 3654 3512 -7 68
H(6B) 1525 4932 467 81
H(8B) 2298 1664 76 80
H(lOD) 2438 5732 -818 150
H(lOE) 1088 5189 -1110 150
H(lOF) 2309 4418 . -1307 150
H(llD) 1564 529 1299 174
H(llE) 461 743 542 174
H(lIF) 531 1559 1441 174
H(14B) 4384 -594 1404 93
H(15B) 5617 -2222 1905 107
H(l6B) 7749 -1972 2071 101
H(17B) 8692 -134 1729 101
IX
Table A6. Continued
H(l8B) 7455 1573 1258 103
H(12C) 5491 2542 957 76
H(l2D) 4631 1671 306 76
H(19C) 3901 1191 271 103
H(19D) 3493 271 1060 103
a U(eq) is defined as one third of the trace of the orthogonalized U!i tensor.
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Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit (based on F2)
Final R indices [1>20(1)]
R indices (all data)
Absolute structure parameter







a = 7.816(2) A
b = 9.8178(18) A









0.85 x 0.60 x 0.60 mm
2.18 to 22.98°
-2 ~ h ~ 8
-10 ~ k ~ 10
-25 ~ I ~ 25
6672
6672 (Rint = O.oooot
6204
0.3735 and 0.2755
Full-matrix least-squares on F
6672/555 /829
1.183
R I = 0.0394, wR2 = 0.1304
RI = 0.0474, wR2 = 0.1673
0.26(4)
0.891 and -1.190 e.A-3
a DIFABS absorption correction applied. Rint before correction = 0.0075.
XI
Table 82. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2
x 103) for tosylate (98).a
Atom x y z U(eq)
l(lA) 1069(2) 2492(1) 8569(1) 74(1)
S(lA) -5116(6) 5391(4) 9944(2) 50(1)
0(1 A) -200(20) -2171(13) 9895(7) 72(4)
0(2A) -600(20) -1229(12) 10748(6) 64(4)
0(3A) -3128(13) 4539(9) 10086(5) 38(2)
0(4A) -5470(20) 5129(13) 9385(7) 68(4)
0(5A) -6150(20) 5032(14) 10467(7) 78(4)
C(1A) 340(20) 1357(16) 9355(8) 46(4)
C(2A) 330(30) -61(15) 9279(8) 60(5)
C(3A) 10(20) -829(19) 9775(8) 55(5)
C(4A) -390(20) -225(18) 10314(7) 48(4)
C(5A) -460(30) 1180(19) 10338(8) 60(5)
C(6A) 40(20) 1941(14) 9842(7) 40(3)
C(7A) -410(20) -2534(16) 10494(8) 54(4)
C(8A) 10(20) 3537(15) 9861(8) 50(4)
C(9A) -1750(30) 4650(18) 9670(6) 53(5)
C(10A) -5183(18) 7183(14) 9900(7) 39(4)
C(11A) -4930(30) 7843(17) 9376(9) 69(6)
C(12A) -4870(20) 9324(18) 9341(9) 59(5)
C(13A) -5010(30) 9978(19) 9851(10) 55(5)
C(14A) -5190(30) 9240(30) 10310(9) 72(6)
C(15A) -5240(20) 7814(14) 10387(7) 44(4)
C(16A) -4790(30) 11484(18) 9741(8) 69(5)
I(1B) 389(2) 8462(1) 3472(1) 73(1)
S(1B) 6602(7) 5604(4) 2088(2) 54(1)
O(lB) 1510(20) 13146(13) 2161(7) 71(4)
0(2B) 2240(20) 12092(16) 1273(6) 69(4)
0(3B) 4674(19) 6496(12) 1889(4) 56(3)
0(4B) 7668(19) 5920(14) 1629(7) 69(4)
0(5B) 6880(20) 5940(14) 2641(8) 71(4)
C(1B) 1160(20) 9520(19) 2735(8) 52(4)
C(2B) 1150(20) 10926(19) 2735(9) 60(5)
C(3B) 1540(20) 11686(14) 2217(8) 53(5)
C(4B) 1810(20) 11146(16) 1709(7) 53(5)
C(5B) 1787(16) 9795(14) 1663(6) 32(3)
C(6B) 1520(20) 8882(16) 2187(8) 44(4)
C(7B) 1800(30) 13370(20) 1545(10) 82(7)
C(8B) 1540(20) 7422(18) 2113(8) 52(4)
C(9B) 3160(20) 6355(13) 2347(7) 48(4)
C(10B) 6500(20) 3804(16) 2148(8) 53(4)
C(llB) 6600(30) 3160(20) 1630(9) 68(6)
XII
Table 82. Continued
Atom x y z U(eq)
C(12B) 6550(20) 1761(16) 1658(9) 50(4)
C(13B) 6440(30) 987(18) 2242(9) 48(5)
C(14B) 6440(30) 1660(20) 2734(9) 72(6)
C(15B) 6460(20) 2989(16) 2669(7) 48(4)
C(16B) 6480(30) -567(17) 2194(12) 95(8)
I(lC) 389(2) 3446(1) 6042(1) 63(1)
S(1C) -2590(6) 505(4) 4786(2) 43(1)
O(lC) -2830(20) 7106(16) 4239(7) 77(4)
O(2C) -5543(19) 6633(17) 4346(8) 93(5)
O(3C) -3648(16) 1404(13) 5302(6) 51(3)
O(4C) . -1589(16) -856(11) 5040(5) 48(3)
O(5C) -3901(19) 635(16) 4391(7) 67(4)
C(lC) -1650(20) 4454(17) 5514(9) 57(5)
C(2C) -1370(20) 5494(16) 5060(8) 52(5)
C(3C) -2980(20) 6195(17) 4705(7) 43(4)
C(4C) -4340(20) 5807(17) 4794(9) 46(4)
C(5C) -4686(19) 4852(18) 5187(7) 44(4)
C(6C) -3240(30) 4182(19) 5543(7) 50(4)
C(7C) -4720(40) 7530(30) 4060(11) 84(7)
C(8C) -3510(30) 2855(19) 6024(8) 62(5)
C(9C) -2780(20) 1497(18) 5803(7) 49(4)
C(10C) -1150(20) 1511(19) 4491(7) 49(4)
C(llC) -1810(20) 2749(16) 4146(7) 41(3)
C(12C) -580(30) 3520(15) 3917(8) 50(5)
C(13C) 1080(30) 3118(18) 4013(10) 72(6)
C(14C) 1770(30) 1780(20) 4423(10) 84(7)
C(15C) 660(20) 1081(19) 4629(9) 62(6)
C(16C) 2500(40) 3980(30) 3771(16) 128(12)
I(1D) 1057(2) 7502(1) 5997(1) 64(1)
S(1D) 4051(6) 10420(5) 7246(2) 50(1)
O(lD) 4240(30) 3703(16) 7812(7) 82(5)
O(2D) 6920(30) 4340(17) 7703(8) 116(7)
O(3D) 5182(16) 9530(13) 6770(5) 50(3)
O(4D) 3060(20) 11766(15) 6977(8) 80(5)
O(5D) 5331(17) 10361(15) 7670(7) 62(4)
C(lD) 3250(20) 6442(16) 6561(6) 42(4)
C(2D) 2960(30) 5355(18) 6956(8) 60(5)
C(3D) 4060(30) 4789(18) 7314(7) 51(4)
C(4D) 5930(40) 5030(30) 7314(10) 73(5)
C(5D) 6100(30) 6160(20) 6836(11) 80(7)
C(6D) 4840(20) 6868(15) 6457(7) 38(4)
C(7D) 5850(40) 3460(20) 8027(10) 85(7)
C(8D) 5120(30) 7959(18) 6060(8) 55(4)
C(9D) 4150(30) 9495(18) 6255(8) 52(4)
C(10D) 2600(20) 9451(14) 7529(7) 39(4)
XIII
Table B2. Continued
Atom x y z
C(11D) 870(30) 9920(20) 7406(8)
C(120) -260(20) 9020(20) 7652(9)
C(13D) 300(20) 7850(20) 7991(8)
C(140) 2200(30) 7380(20) 8146(8)
C(150) 3230(30) 8190(20) 7921(7)








a U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. The esd' s of the
least significant digits are given in parentheses.
XIV
Table B3. Bond lengths for tosylate (98). a
Bond Length (A) Bond Length (A)
I(1A)-C(lA) 2.136(17) S(lA)-0(4A) 1.416(16)
S(1A)-0(5A) 1.467(14) S(lA)-0(3A) 1.576(11)
S(1 A)-C(1 OA) 1.734(14) 0(1A)-C(3A) 1.37(2)
0(lA)-C(7A) 1.40(2) 0(2A)-C(4A) 1.35(2)
0(2A)-C(7A) 1.443(18) 0(3A)-C(9A) 1.41(2)
C(1A)-C(6A) 1.31(2) C(1A)-C(2A) 1.43(2)
C(2A)-C(3A) 1.34(3) C(3A)-C(4A) 1.42(2)
C(4A)-C(5A) 1.37(2) C(5A)-C(6A) 1.38(3)
C(6A)-C(8A) 1.57(2) C(8A)-C(9A) 1.55(2)
C(10A)-C(11A) 1.33(2) C(10A)-C(15A) 1.35(2)
C(11A)-C(12A) 1.46(2) C(12A)-C(13A) 1.40(3)
C(13A)-C(14A) 1.23(3) C(13A)-C(16A) 1.52(3)
C(14A)-C(15A) 1.40(3) I(1B)-C(1B) 2.03(2)
S(lB)-0(4B) 1.358(15) S(lB)-0(5B) 1.412(17)
S(1B)-0(3B) 1.580(14) S(1 B)-C(1 OB) 1.780(16)
O(1B)-C(7B) 1.43(3) O(1B)-C(3B) 1.416(18)
0(2B)-C(4B) 1.37(2) O(2B)-C(7B) 1.42(3)
0(3B)-C(9B) 1.55(2) C(lB)-C(2B) 1.38(3)
C(lB)-C(6B) 1.46(2) C(2B)-C(3B) 1.39(3)
C(3B)-C(4B) 1.33(2) C(4B)-C(5B) 1.35(2)
C(5B)-C(6B) 1.45(2) C(6B)-C(8B) 1.46(2)
C(8B)-C(9B) 1.48(2) C(10B)-C(15B) 1.36(2)
C(10B)-C(11B) 1.41(3) C(11B)-C(12B) 1.38(3)
C(12B)-C(13B) 1.47(3) C(13B)-C(14B) 1.39(3)
C(13B)-C(16B) 1.54(2) C(14B)-C(15B) 1.30(3)
I(1C)-C(1C) 2.025(19) S(1 C)-0(5C) 1.395(15)
S( 1C)-O(4C) 1.419(12) S(1C)-O(3C) 1.606(13)
S(lC)-C(10C) 1.747(18) 0(1 C)-C(3C) 1.33(2)
0(lC)-C(7C) 1.49(3) 0(2C)-C(7C) 1.32(3)
0(2C)-C(4C) 1.46(2) O(3C)-C(9C) 1.42(2)
C(1C)-C(6C) 1.34(3) C(l C)-C(2C) 1.42(3)
C(2C)-C(3C) 1.50(3) C(3C)-C(4C) 1.22(3)
C(4C)-C(5C) 1.29(3) C(5C)-C(6C) 1.40(2)
C(6C)-C(8C) 1.65(2) C(8C)-C(9C) 1.43(3)
C(1OC)-C( 11 C) 1.36(2) C(1OC)-C(15C) 1.41(2)
C(11C)-C(12C) 1.42(2) C(12C)-C(13C) 1.27(3)
C(13C)-C(14C) 1.51(3) C( 13C)-C(16C) 1.61(3)
C(14C)-C(15C) 1.28(3) I(1D)-C(lD) 2.173(15)
S(1D)-0(4D) 1.418(15) S(lD)-0(5D) 1.441(15)
S(1D)-O(3D) 1.552(12) S(lD)-C(10D) 1.722(16)
0(lD)-C(7D) 1.33(3) O(lD)-C(3D) 1.45(2)
0(2D)-C(4D) 1.23(3) 0(2D)-C(7D) 1.47(3)
0(3D)-C(9D) 1.50(2) C(1D)-C(6D) 1.41(2)
C(lD)-C(2D) 1.37(3) C(2D)-C(3D) 1.21(3)



























a The esd's of the least significant digits are given in parentheses.
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a The esd's ofthe least significant digits are given in parentheses.
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Table B5. Anisotropic displacement parameters (A2 x 103) for tosylate (98).a
Atom Ull U22 U33 U23 Uu Uu
l(lA) 93(1) 51(1) 65(1) -3(1) 17(1) -6(1)
S(1A) 37(2) 30(2) 80(3) -7(2) -8(2) -5(2)
O(lA) 92(11) 36(6) 91(10) -19(6) 11(8) -19(6)
O(2A) 100(10) 24(5) 76(8) -2(5) -9(7) -29(6)
O(3A) 30(5) 16(4) 55(6) 9(4) 11(4) 4(4)
O(4A) 77(10) 35(6) 90(9) -10(6) -26(8) -5(6)
O(5A) 77(9) 49(6) 92(9) 19(6) 32(8) -14(6)
C(1A) 46(9) 22(7) 67(10) 4(7) -14(8) -3(7)
C(2A) 74(12) 22(7) 72(10) -7(6) -31 (8) 13(7)
C(3A) 47(10) 46(9) 76(12) -41(8) -10(8) -4(8)
C(4A) 30(8) 60(10) 58(10) -11(8) 10(7) -24(7)
C(5A) 72(12) 55(10) 47(9) -22(7) -31(8) 8(8)
C(6A) 31(7) 22(6) 68(9) 3(6) -3(6) -11(6)
C(7A) 51(9) 27(7) 87(12) -19(7) 16(8) -14(6)
C(8A) 46(9) 22(6) 72(8) -18(6) 22(7) 7(6)
C(9A) 76(12) 61(9) 21(7) -16(6) -3(7) -11(9)
C(10A) 24(7) 21(6) 61(9) 0(6) 24(6) 1(5)
C(11A) 88(13) 27(7) 81(12) -20(8) -50(10) 18(8)
C(12A) 51 (1 0) 37(8) 93(12) 16(8) -41 (9) -17(7)
C(13A) 38(9) 37(8) 94(14) -19(8) 16(9) -13(7)
C(14A) 62(13) 89(15) 62(10) -35(10) -1(9) -7(11)
C(15A) 55(9) 26(7) 52(8) -25(6) 23(7) -9(7)
C(16A) 79(13) 38(8) 81(9) -4(6) -31(9) 3(8)
I(1B) 92(1) 51(1) 64(1) -4(1) 16(1) -7(1)
S(lB) 60(3) 25(2) 68(3) 0(2) 11(2) -5(2)
O(1B) 95(10) 35(6) 87(10) -4(6) -24(8) -21(6)
O(2B) 68(8) 66(8) 65(8) 5(6) 4(7) -14(6)
O(3B) 79(8) 48(6) 30(4) -1(4) -5(5) 1(6)
O(4B) 51(8) 46(7) 104(10) -3(6) 6(7) -10(6)
O(5B) 75(10) 45(6) 96(10) -13(6) -25(8) -14(6)
C(1B) 39(9) 49(9) 61(11) -21(8) 10(8) 0(8)
C(2B) 49(10) 55(10) 78(12) -36(9) 22(8) -14(8)
C(3B) 44(9) 15(6) 90(13) 11(7) -5(9) 1(6)
C(4B) 59(10) 31(8) 58(10) -4(7) -29(8) 14(7)
C(5B) 17(6) 30(7) 44(7) 0(5) 2(5) -3(5)
C(6B) 31(7) 37(7) 53(10) -24(7) -6(7) 16(6)
C(7B) 70(14) 68(12) 98(15) 31(11) -22(11) -16(10)
C(8B) 48(9) 47(8) 66(10) 5(7) -30(8) -19(7)
C(9B) 42(9) 9(5) 82(10) 6(5) 8(8) 3(6)
C(10B) 40(9) 30(7) 84(11) -3(7) -39(8) 6(6)
C(11B) 58(12) 59(11 ) 75(12) 16(9) -12(10) -5(9)
C(12B) 52(9) 27(7) 71(11) -14(7) -8(8) -5(7)
C(13B) 41(9) 28(8) 71(11) -2(7) -22(8) 1(7)
C(14B) 81(14) 45(10) 68(12) 13(8) 27(10) 0(9)
XIX
Table 85. Continued
Atom Un U22 U33 Un U13 Un
C(15B) 45(8) 36(8) 59(9) 6(6) 8(7) -13(7)
C(16B) 50(9) 21(7) 220(20) -17(10) 2(12) -14(7)
I(lC) 62(1) 48(1) 84(1) -6(1) -20(1) -22(1)
S(lC) 37(2) 39(2) 55(3) -10(2) -5(2) -13(2)
O(lC) 86(10) 71(8) 79(9) 3(7) -14(7) -33(7)
O(2C) 51(7) 81(10) 134(13) 26(9) -16(7) -12(7)
O(3C) 35(6) 54(7) 62(8) -15(6) 3(6) -8(5)
0(4C) 50(7) 32(5) 66(6) -20(4) -3(5) -8(5)
0(5C) 50(8) 73(9) 88(10) -16(7) . -23(7) -23(7)
C(1C) 40(9) 32(7) 112(13) -29(8) -2(9) -22(7)
C(2C) 47(9) 30(7) 86(11 ) -21(7) 25(8) -23(7)
C(3C) 55(9) 40(7) 34(8) -5(6) -12(6) -12(7)
C(4C) 41(8) 27(7) 72(11) -5(7) -24(7) -6(6)
C(5C) 22(7) 54(10) 57(9) -30(8) -9(7) -2(7)
C(6C) 47(10) 57(9) 48(7) -18(6) 11(7) -18(8)
C(7C) 90(14) 67(12) 99(15) -10(10) -45(12) -14(10)
C(8C) 52(9) 51(9) 70(10) 15(7) 19(8) -9(7)
C(9C) 46(9) 60(10) 43(9) 7(7) 8(7) -25(8)
C(10C) 49(10) 61(10) 44(8) -18(7) -6(7) -20(9)
C(11C) 28(7) 38(7) 55(9) -7(6) 1(7) -8(6)
C(12C) 67(12) 19(6) 57(10) 1(6) 18(9) -8(7)
C(13C) 103(18) 29(8) 79(13) -11(8) 11(12) -11(10)
C(14C) 60(12) 74(13) 96(14) 25(10) 25(11) -5(10)
C(15C) 21(9) 47(9) 103(15) 27(9) -8(9) -2(7)
C(16C) 110(20) 140(20) 160(30) -30(19) 53(19) -94(18)
I(1D) 67(1) 46(1) 86(1) -5(1) -24(1) -19(1)
S(lD) 39(2) 41(2) 75(3) -11(2) -3(2) -17(2)
0(1 D) 124(14) 56(7) 77(9) 28(6) -36(9) -51(8)
0(2D) 165(16) 75(9) 128(14) 26(9) -114(12) -53(10)
0(3D) 47(7) 54(7) 60(6) -12(5) 12(5) -33(6)
0(4D) 66(9) 55(8) 118(13) 25(7) -20(9) -28(7)
0(5D) 42(7) 52(7) 97(9) -37(7) -1(7) -8(6)
C(lD) 55(10) 44(8) 24(6) -8(5) -13(6) -4(7)
C(2D) 63(11) 47(9) 73(11) -2(8) -44(9) -13(8)
C(3D) 65(11) 41(8) 57(9) -8(7) 10(8) -30(8)
C(4D) 84(14) 80(12) 58(9) -21(8) -1(9) -23(11)
C(5D) 86(16) 57(12) 102(17) -7(11) 22(14) -37(12)
C(6D) 47(9) 25(6) 45(8) -10(6) 3(7) -16(6)
C(7D) 130(20) 52(11) 70(12) 14(9) -6(13) -33(12)
C(8D) 63(11) 58(10) 58(9) -25(8) 8(8) -33(8)
C(9D) 64(11) 44(9) 54(10) -11(7) 3(8) -25(8)
C(10D) 24(8) 22(6) 65(10) 2(6) 0(7) 1(6)
C(llD) 49(10) 50(9) 66(11) -13(8) -4(8) -14(8)
C(12D) 20(7) 59(10) 94(13) -19(9) -1(8) -19(7)
C(13D) 29(8) 78(12) 65(10) -17(9) 21(7) -34(8)
xx
Table 85. Continued
Atom Un U22 U33 Un Uu Un
C(14D) 72(13) 67(11) 44(9) 3(8) -6(9) -5(10)
C(15D) 61(11) 61(11) 30(8) 2(7) -2(8) -3(9)
C(16D) 73(13) 49(9) 129(18) -5(10) 37(13) -22(9)
a The esd's of the least significant digits are given in parentheses. The anisotropic
displacement factor exponent takes the form: -2 11: [ h2 a*2 U II + ... + 2 h k a* b* Ud.
XXI
Table B6. Hydrogen atom coordinates (x 104) and equivalent isotropic displacement
°2 3 aparameters (A x 10 ) for tosylate (98).
Atom x y z U(eq)
H(2A) 519 -417 8919 71
H(5A) -837 1609 10679 72
H(7Al) 627 -3278 10637 65
H(7A2) -1464 -2867 10583 65
H(8Al) 992 3728 9610 60
H(8A2) 228 3662 10255 60
H(9Al) -1601 5606 9637 64
H(9A2) -2046 4479 9293 64
H(lIA) -4787 7376 9043 82
H(12A) -4750 9832 8980 71
H(14A) -5306 9685 10648 86
H(l5A) -5307 7327 10756 53
H(l6A) -4678 11747 9329 103
H(l6B) -3740 11510 9922 103
H(16C) -5821 12144 9902 103
H(2B) 893 11362 3077 72
H(5B) 1938 9453 1301 39
H(7B1) 2760 13822 1460 98
H(7B2) 725 14029 1380 98
H(8B1) 1494 7341 1702 62
H(8B2) 489 7218 2311 62
H(9B1) 3022 5397 2387 58
H(9B2) 3413 6567 2724 58
H(lIB) 6690 3682 1271 81
H(l2B) 6592 1322 1323 60
H(l4B) 6425 1162 3104 86
H(15B) 6454 3419 3005 58
H(16D) 6380 -1051 2577 143
H(16E) 7584 -1046 2003 143
H(16F) 5496 -576 1972 143
H(2C) -294 5720 4989 62
H(5C) -5774 4634 5228 52
H(7C1) -5312 8499 4148 101
H(7C2) -4743 7505 3644 101
H(8C1) -2932 2860 6378 74
H(8C2) -4779 2997 6120 74
H(9C1) -1515 1357 5706 59
H(9C2) -2901 740 6103 59
H(lIC) -3018 3077 4062 49
H(12C) -1012 4375 3682 60
H(14C) 2957 1469 4522 101
H(l5C) 1077 252 4882 74
H(16G) 3645 3483 3923 192
XXII
Table B6. Continued
Atom x y z U(eq)
H(16H) 2108 4924 3891 192
H(16I) 2585 4043 3353 192
H(2D) 1927 5063 6948 72
H(5D) 7175 6397 6797 96
H(7D1) 6489 2456 8018 102
H(7D2) 5696 3653 8431 102
H(8D1) 4689 7888 5687 66
H(8D2) 6398 7848 6009 66
H(9D1) 4242 10246 5948 62
H(9D2) 2905 9594 6365 62
H(llD) 413 10775 7175 65
H(12D) -1461 9307 7559 66
H(14D) 2653 6552 8393 78
H(15D) 4415 7929 8023 66
H(16J) -136 6153 8470 128
H(16K) -1414 6728 7950 128
H(l6L) -1728 7546 8505 128
a U(eq) is defined as one third of the trace of the orthogonalized UIi tensor.
XXIII
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Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit (based on F2)
Final R indices [1>20(1)]
R indices (all data)







a = 7.363(2) A
b = 9.482(2) A









0.60 x 0.40 x 0.20 mm
2.23 to 24.93 0
-1 ~ h ~ 8
-ll~k~ll
-15 ~ 1 ~ 15
3845
3018 (Rint = 0.0101)
2891
0.6878 and 0.3766
Full-matrix least-squares on F
3018/0/226
1.117
R I = 0.0408, WR2 = 0.1 002
R I = 0.0422, wR2 = 0.1010
1.148 and -1.181 e.A-3
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Table C2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (A2
x 103) for nosylate (15a).a
Atom x y z U(eq)
I 2254(1) 3646(1) 8217(1) 72(1)
S 7491(2) 6693(1) 5327(1) 55(1)
0(1) 1458(5) 8650(4) 9744(3) 76(1)
0(2) 4676(6) 8709(5) 9497(4) 85(1)
0(3) 8007(4) 5683(4) 6341(3) 59(1)
0(4) 8944(5) 7598(4) 4937(3) 71(1)
0(5) 7150(6) 5859(4) 4656(3) 75(1)
0(6) 300(5) 11260(4) 7611(3) 77(1)
0(7) -1278(6) 10022(6) 7128(5) 122(2)
N 214(6) 10299(5) 7180(4) 65(1)
C(1) 3289(6) 5300(5) 8625(3) 45(1)
C(2) 1895(6) 6384(5) 9059(3) 50(1)
C(3) 2532(6) 7460(5) 9324(3) 50(1)
C(4) 4449(7) 7490(5) 9174(3) 53(1)
C(5) 5819(6) 6437(5) 8752(3) 53(1)
C(6) 5233(6) 5299(5) 8464(3) 46(1)
C(7) 2794(9) 9428(6) 9888(5) 76(2)
C(8) 6736(7) 4129(5) 7979(4) 57(1)
C(9) 7118(7) 4356(5) 6785(4) 63(1)
C(10) 5312(6) 7776(5) 5846(3) 47(1)
C(11) 5385(6) 8929(5) 6306(4) 52(1)
C(12) 3706(6) 9762(5) 6735(4) 52(1)
C(13) 2004(6) 9415(5) 6693(3) 49(1)
C(14) 1910(7) 8287(6) 6230(4) 63(1)
C(15) 3602(7) 7449(5) 5799(4) 60(1)
a U(eq) is defined as one third of the trace of the orthogonalized UIi tensor. The esd' s of the
least significant digits are given in parentheses.
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a The esd's of the least significant digits are given in parentheses.
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a The esd's of the least significant digits are given in parentheses.
XXVII
Table C5. Anisotropic displacement parameters (A2x 103) for nosylate (15a).a
Atom Un U22 U33 U23 Ul3 Ul2
I 65(1) 73(1) 81 (1) -36(1) -2(1) -17(1)
S 50(1) 58(1) 44(1) -15(1) 1(1) 8(1)
0(1) 62(2) 62(2) 101(3) -43(2) 2(2) 2(2)
0(2) 76(3) 89(3) 102(3) -50(2) -1(2) -27(2)
0(3) 43(2) 63(2) 57(2) -11 (2) -3(1) 7(1)
0(4) 55(2) 74(2) 63(2) -9(2) 7(2) -1(2)
0(5) 83(3) 79(2) 57(2) -34(2) -7(2) 10(2)
0(6) 68(2) 74(2) 85(3) -43(2) -6(2) 10(2)
0(7) 43(2) 145(5) 196(6) -105(4) -7(3) -3(2)
N 48(2) 67(3) 74(3) -26(2) -6(2) 3(2)
C(1) 43(2) 50(2) 40(2) -12(2) -5(2) -4(2)
C(2) 37(2) 59(3) 52(2) -17(2) -2(2) -2(2)
C(3) 46(2) 50(2) 46(2) -15(2) -1(2) 1(2)
C(4) 54(3) 59(3) 46(2) -16(2) -6(2) -11(2)
C(5) 35(2) 73(3) 48(2) -12(2) -7(2) -4(2)
C(6) 41(2) 53(2) 35(2) -6(2) -5(2) 4(2)
C(7) 88(4) 56(3) 78(4) -26(3) 2(3) -13(3)
C(8) 45(2) 59(3) 53(2) -8(2) -4(2) 15(2)
C(9) 61(3) 50(3) 58(3) -16(2) 6(2) 11(2)
C(10) 44(2) 47(2) 44(2) -12(2) -9(2) 4(2)
C(II) 41(2) 59(3) 58(3) -20(2) -13(2) 0(2)
C(12) 50(2) 51(2) 57(3) -22(2) -12(2) -1(2)
C(13) 42(2) 49(2) 52(2) -15(2) -7(2) 4(2)
C(14) 47(3) 63(3) 86(4) -28(3) -17(2) -4(2)
C(15) 55(3) 54(3) 75(3) -30(2) -16(2) 2(2)
a The esd's of the least significant digits are given in parentheses. The anisotropic
displacement factor exponent takes the fonn: -2 1t [ h2 a*2 U II + ... + 2 h k a* b* U12].
XXVIII
Table C6. Hydrogen atom coordinates (x 104) and equivalent isotropic displacement
parameters (A2 x 103) for nosylate (15a).a
Atom x y z U(eq)
H(2) 598 6368 9161 60
H(5) 7109 6472 8658 64
H(7A) 2587 9453 10636 91
H(7B) 2631 10429 9505 91
H(8A) 7919 4113 8173 69
H(8B) 6324 3182 8281 69
H(9A) 7965 3518 6526 75
H(9B) 5930 4466 6572 75
H(lI) 6555 9136 6324 62
H(l2) 3720 10544 7046 62
H(14) 738 8089 6206 76
H(l5) 3584 6674 5483 72
a U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
XXIX
